id	sid	tid	token	lemma	pos
admet-1042	1	1	investigating	investigate	VERB
admet-1042	1	2	antimicrobial	antimicrobial	ADJ
admet-1042	1	3	features	feature	NOUN
admet-1042	1	4	and	and	CCONJ
admet-1042	1	5	drug	drug	NOUN
admet-1042	1	6	interactions	interaction	NOUN
admet-1042	1	7	of	of	ADP
admet-1042	1	8	sedoanalgesics	sedoanalgesic	NOUN
admet-1042	1	9	in	in	ADP
admet-1042	1	10	intensive	intensive	ADJ
admet-1042	1	11	care	care	NOUN
admet-1042	1	12	unit	unit	NOUN
admet-1042	1	13	:	:	PUNCT
admet-1042	1	14	an	an	DET
admet-1042	1	15	experimental	experimental	ADJ
admet-1042	1	16	study	study	NOUN
admet-1042	1	17	doi	doi	PROPN
admet-1042	1	18	:	:	PUNCT
admet-1042	1	19	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	PUNCT
admet-1042	1	20	219	219	NUM
admet-1042	1	21	admet	admet	PROPN
admet-1042	1	22	&	&	CCONJ
admet-1042	1	23	dmpk	dmpk	PROPN
admet-1042	1	24	9(3	9(3	NUM
admet-1042	1	25	)	)	PUNCT
admet-1042	1	26	(	(	PUNCT
admet-1042	1	27	2021	2021	NUM
admet-1042	1	28	)	)	PUNCT
admet-1042	1	29	219	219	NUM
admet-1042	1	30	-	-	SYM
admet-1042	1	31	226	226	NUM
admet-1042	1	32	;	;	PUNCT
admet-1042	1	33	doi	doi	NOUN
admet-1042	1	34	:	:	PUNCT
admet-1042	1	35	https://doi.org/10.5599/admet.1042	https://doi.org/10.5599/admet.1042	PRON
admet-1042	1	36	open	open	ADJ
admet-1042	1	37	access	access	NOUN
admet-1042	1	38	:	:	PUNCT
admet-1042	1	39	issn	issn	PROPN
admet-1042	1	40	:	:	PUNCT
admet-1042	1	41	1848	1848	NUM
admet-1042	1	42	-	-	SYM
admet-1042	1	43	7718	7718	NUM
admet-1042	1	44	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1042	1	45	original	original	ADJ
admet-1042	1	46	scientific	scientific	ADJ
admet-1042	1	47	paper	paper	NOUN
admet-1042	1	48	investigating	investigate	VERB
admet-1042	1	49	antimicrobial	antimicrobial	ADJ
admet-1042	1	50	features	feature	NOUN
admet-1042	1	51	and	and	CCONJ
admet-1042	1	52	drug	drug	NOUN
admet-1042	1	53	interactions	interaction	NOUN
admet-1042	1	54	of	of	ADP
admet-1042	1	55	sedoanalgesics	sedoanalgesic	NOUN
admet-1042	1	56	in	in	ADP
admet-1042	1	57	intensive	intensive	ADJ
admet-1042	1	58	care	care	NOUN
admet-1042	1	59	unit	unit	NOUN
admet-1042	1	60	:	:	PUNCT
admet-1042	1	61	an	an	DET
admet-1042	1	62	experimental	experimental	ADJ
admet-1042	1	63	study	study	NOUN
admet-1042	1	64	ozge	ozge	PROPN
admet-1042	1	65	unlu1	unlu1	PROPN
admet-1042	1	66	,	,	PUNCT
admet-1042	1	67	emre	emre	PROPN
admet-1042	1	68	sertac	sertac	PROPN
admet-1042	1	69	bingul2	bingul2	PROPN
admet-1042	1	70	,	,	PUNCT
admet-1042	1	71	sevgi	sevgi	PROPN
admet-1042	1	72	kesici3	kesici3	PROPN
admet-1042	1	73	*	*	PROPN
admet-1042	1	74	,	,	PUNCT
admet-1042	1	75	mehmet	mehmet	PROPN
admet-1042	1	76	demirci4	demirci4	PROPN
admet-1042	1	77	1	1	NUM
admet-1042	1	78	istanbul	istanbul	PROPN
admet-1042	1	79	atlas	atlas	PROPN
admet-1042	1	80	university	university	PROPN
admet-1042	1	81	,	,	PUNCT
admet-1042	1	82	faculty	faculty	NOUN
admet-1042	1	83	of	of	ADP
admet-1042	1	84	medicine	medicine	NOUN
admet-1042	1	85	,	,	PUNCT
admet-1042	1	86	department	department	NOUN
admet-1042	1	87	of	of	ADP
admet-1042	1	88	medical	medical	ADJ
admet-1042	1	89	microbiology	microbiology	NOUN
admet-1042	1	90	,	,	PUNCT
admet-1042	1	91	turkey	turkey	PROPN
admet-1042	1	92	2	2	NUM
admet-1042	1	93	recep	recep	PROPN
admet-1042	1	94	tayyip	tayyip	PROPN
admet-1042	1	95	erdogan	erdogan	PROPN
admet-1042	1	96	university	university	PROPN
admet-1042	1	97	,	,	PUNCT
admet-1042	1	98	training	training	NOUN
admet-1042	1	99	and	and	CCONJ
admet-1042	1	100	research	research	NOUN
admet-1042	1	101	hospital	hospital	NOUN
admet-1042	1	102	,	,	PUNCT
admet-1042	1	103	department	department	NOUN
admet-1042	1	104	of	of	ADP
admet-1042	1	105	anesthesiology	anesthesiology	NOUN
admet-1042	1	106	and	and	CCONJ
admet-1042	1	107	reanimation	reanimation	NOUN
admet-1042	1	108	,	,	PUNCT
admet-1042	1	109	turkey	turkey	NOUN
admet-1042	1	110	3	3	NUM
admet-1042	1	111	health	health	PROPN
admet-1042	1	112	sciences	sciences	PROPN
admet-1042	1	113	university	university	PROPN
admet-1042	1	114	,	,	PUNCT
admet-1042	1	115	hqamidiye	hqamidiye	NOUN
admet-1042	1	116	etfal	etfal	NOUN
admet-1042	1	117	training	training	NOUN
admet-1042	1	118	and	and	CCONJ
admet-1042	1	119	research	research	NOUN
admet-1042	1	120	hospital	hospital	NOUN
admet-1042	1	121	,	,	PUNCT
admet-1042	1	122	department	department	NOUN
admet-1042	1	123	of	of	ADP
admet-1042	1	124	anesthesiology	anesthesiology	NOUN
admet-1042	1	125	and	and	CCONJ
admet-1042	1	126	reanimation	reanimation	NOUN
admet-1042	1	127	,	,	PUNCT
admet-1042	1	128	turkey	turkey	NOUN
admet-1042	1	129	4	4	NUM
admet-1042	1	130	kirklareli	kirklareli	PROPN
admet-1042	1	131	university	university	NOUN
admet-1042	1	132	,	,	PUNCT
admet-1042	1	133	faculty	faculty	NOUN
admet-1042	1	134	of	of	ADP
admet-1042	1	135	medicine	medicine	NOUN
admet-1042	1	136	,	,	PUNCT
admet-1042	1	137	department	department	NOUN
admet-1042	1	138	of	of	ADP
admet-1042	1	139	medical	medical	ADJ
admet-1042	1	140	microbiology	microbiology	NOUN
admet-1042	1	141	,	,	PUNCT
admet-1042	1	142	turkey	turkey	PROPN
admet-1042	1	143	*	*	PUNCT
admet-1042	1	144	sevgi	sevgi	PROPN
admet-1042	1	145	kesici	kesici	NOUN
admet-1042	1	146	:	:	PUNCT
admet-1042	1	147	e	e	X
admet-1042	1	148	-	-	NOUN
admet-1042	1	149	mail	mail	NOUN
admet-1042	1	150	:	:	PUNCT
admet-1042	1	151	md.kesici@mynet.com	md.kesici@mynet.com	NOUN
admet-1042	1	152	;	;	PUNCT
admet-1042	1	153	tel	tel	PROPN
admet-1042	1	154	.	.	PUNCT
admet-1042	1	155	:	:	PUNCT
admet-1042	1	156	+902124426649	+902124426649	NUM
admet-1042	1	157	received	receive	VERB
admet-1042	1	158	:	:	PUNCT
admet-1042	1	159	july	july	PROPN
admet-1042	1	160	03	03	NUM
admet-1042	1	161	,	,	PUNCT
admet-1042	1	162	2021	2021	NUM
admet-1042	1	163	;	;	PUNCT
admet-1042	1	164	revised	revise	VERB
admet-1042	1	165	:	:	PUNCT
admet-1042	1	166	august	august	PROPN
admet-1042	1	167	25	25	NUM
admet-1042	1	168	,	,	PUNCT
admet-1042	1	169	2021	2021	NUM
admet-1042	1	170	;	;	PUNCT
admet-1042	1	171	available	available	ADJ
admet-1042	1	172	online	online	NOUN
admet-1042	1	173	:	:	PUNCT
admet-1042	1	174	september	september	PROPN
admet-1042	1	175	06	06	NUM
admet-1042	1	176	,	,	PUNCT
admet-1042	1	177	2021	2021	NUM
admet-1042	1	178	abstract	abstract	ADJ
admet-1042	1	179	study	study	NOUN
admet-1042	1	180	objective	objective	NOUN
admet-1042	1	181	:	:	PUNCT
admet-1042	1	182	aim	aim	NOUN
admet-1042	1	183	of	of	ADP
admet-1042	1	184	this	this	DET
admet-1042	1	185	study	study	NOUN
admet-1042	1	186	was	be	AUX
admet-1042	1	187	to	to	PART
admet-1042	1	188	evaluate	evaluate	VERB
admet-1042	1	189	antimicrobial	antimicrobial	ADJ
admet-1042	1	190	effects	effect	NOUN
admet-1042	1	191	and	and	CCONJ
admet-1042	1	192	interaction	interaction	NOUN
admet-1042	1	193	between	between	ADP
admet-1042	1	194	analgesic	analgesic	ADJ
admet-1042	1	195	combinations	combination	NOUN
admet-1042	1	196	of	of	ADP
admet-1042	1	197	fentanyl	fentanyl	ADJ
admet-1042	1	198	citrate	citrate	NOUN
admet-1042	1	199	,	,	PUNCT
admet-1042	1	200	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	1	201	hydrochloride	hydrochloride	NOUN
admet-1042	1	202	and	and	CCONJ
admet-1042	1	203	tramadol	tramadol	NOUN
admet-1042	1	204	hydrochloride	hydrochloride	NOUN
admet-1042	1	205	on	on	ADP
admet-1042	1	206	staphylococcus	staphylococcus	NOUN
admet-1042	1	207	aureus	aureus	NOUN
admet-1042	1	208	,	,	PUNCT
admet-1042	1	209	klebsiella	klebsiella	NOUN
admet-1042	1	210	pneumoniae	pneumoniae	NOUN
admet-1042	1	211	,	,	PUNCT
admet-1042	1	212	escherichia	escherichia	NOUN
admet-1042	1	213	coli	coli	NOUN
admet-1042	1	214	,	,	PUNCT
admet-1042	1	215	pseudomonas	pseudomona	VERB
admet-1042	1	216	aeruginosa	aeruginosa	NOUN
admet-1042	1	217	and	and	CCONJ
admet-1042	1	218	candida	candida	NOUN
admet-1042	1	219	albicans	albican	NOUN
admet-1042	1	220	which	which	PRON
admet-1042	1	221	are	be	AUX
admet-1042	1	222	some	some	PRON
admet-1042	1	223	of	of	ADP
admet-1042	1	224	the	the	DET
admet-1042	1	225	most	most	ADV
admet-1042	1	226	common	common	ADJ
admet-1042	1	227	nosocomial	nosocomial	ADJ
admet-1042	1	228	infection	infection	NOUN
admet-1042	1	229	related	relate	VERB
admet-1042	1	230	microorganisms	microorganism	NOUN
admet-1042	1	231	.	.	PUNCT
admet-1042	2	1	design	design	NOUN
admet-1042	2	2	:	:	PUNCT
admet-1042	2	3	in	in	ADP
admet-1042	2	4	vitro	vitro	X
admet-1042	2	5	prospective	prospective	ADJ
admet-1042	2	6	study	study	NOUN
admet-1042	2	7	.	.	PUNCT
admet-1042	3	1	setting	set	VERB
admet-1042	3	2	:	:	PUNCT
admet-1042	3	3	university	university	NOUN
admet-1042	3	4	clinical	clinical	ADJ
admet-1042	3	5	microbiology	microbiology	NOUN
admet-1042	3	6	laboratory	laboratory	NOUN
admet-1042	3	7	.	.	PUNCT
admet-1042	4	1	measurements	measurement	NOUN
admet-1042	4	2	:	:	PUNCT
admet-1042	4	3	in	in	ADP
admet-1042	4	4	order	order	NOUN
admet-1042	4	5	to	to	PART
admet-1042	4	6	evaluate	evaluate	VERB
admet-1042	4	7	in	in	ADP
admet-1042	4	8	vitro	vitro	X
admet-1042	4	9	antimicrobial	antimicrobial	ADJ
admet-1042	4	10	effects	effect	NOUN
admet-1042	4	11	and	and	CCONJ
admet-1042	4	12	interaction	interaction	NOUN
admet-1042	4	13	between	between	ADP
admet-1042	4	14	analgesic	analgesic	ADJ
admet-1042	4	15	combinations	combination	NOUN
admet-1042	4	16	,	,	PUNCT
admet-1042	4	17	tramadol	tramadol	NOUN
admet-1042	4	18	hydrochloride	hydrochloride	NOUN
admet-1042	4	19	,	,	PUNCT
admet-1042	4	20	fentanyl	fentanyl	ADJ
admet-1042	4	21	citrate	citrate	NOUN
admet-1042	4	22	and	and	CCONJ
admet-1042	4	23	dexmedetomidin	dexmedetomidin	NOUN
admet-1042	4	24	were	be	AUX
admet-1042	4	25	used	use	VERB
admet-1042	4	26	against	against	ADP
admet-1042	4	27	s.	s.	PROPN
admet-1042	4	28	aureus	aureus	PROPN
admet-1042	4	29	atcc	atcc	PROPN
admet-1042	4	30	29213	29213	NUM
admet-1042	4	31	,	,	PUNCT
admet-1042	4	32	k.	k.	PROPN
admet-1042	4	33	pneumoniae	pneumoniae	PROPN
admet-1042	4	34	,	,	PUNCT
admet-1042	5	1	e.	e.	PROPN
admet-1042	5	2	coli	coli	PROPN
admet-1042	5	3	atcc	atcc	PROPN
admet-1042	5	4	25922	25922	NUM
admet-1042	5	5	,	,	PUNCT
admet-1042	5	6	p.	p.	NOUN
admet-1042	5	7	aeruginosa	aeruginosa	PROPN
admet-1042	5	8	atcc	atcc	PROPN
admet-1042	5	9	27853	27853	NUM
admet-1042	5	10	and	and	CCONJ
admet-1042	5	11	c.	c.	NOUN
admet-1042	5	12	albicans	albican	NOUN
admet-1042	5	13	atcc	atcc	PROPN
admet-1042	5	14	10231	10231	NUM
admet-1042	5	15	standard	standard	PROPN
admet-1042	5	16	strains	strain	NOUN
admet-1042	5	17	by	by	ADP
admet-1042	5	18	microdilution	microdilution	NOUN
admet-1042	5	19	method	method	NOUN
admet-1042	5	20	.	.	PUNCT
admet-1042	6	1	main	main	ADJ
admet-1042	6	2	results	result	NOUN
admet-1042	6	3	:	:	PUNCT
admet-1042	6	4	according	accord	VERB
admet-1042	6	5	to	to	ADP
admet-1042	6	6	microdilution	microdilution	NOUN
admet-1042	6	7	assays	assay	NOUN
admet-1042	6	8	tramadol	tramadol	NOUN
admet-1042	6	9	has	have	AUX
admet-1042	6	10	shown	show	VERB
admet-1042	6	11	the	the	DET
admet-1042	6	12	most	most	ADV
admet-1042	6	13	efficient	efficient	ADJ
admet-1042	6	14	antimicrobial	antimicrobial	ADJ
admet-1042	6	15	activity	activity	NOUN
admet-1042	6	16	also	also	ADV
admet-1042	6	17	it	it	PRON
admet-1042	6	18	has	have	AUX
admet-1042	6	19	been	be	AUX
admet-1042	6	20	observed	observe	VERB
admet-1042	6	21	that	that	SCONJ
admet-1042	6	22	10	10	NUM
admet-1042	6	23	g	g	NOUN
admet-1042	6	24	/	/	SYM
admet-1042	6	25	ml	ml	ADP
admet-1042	6	26	concentrated	concentrate	VERB
admet-1042	6	27	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	6	28	has	have	VERB
admet-1042	6	29	antimicrobial	antimicrobial	ADJ
admet-1042	6	30	effects	effect	NOUN
admet-1042	6	31	on	on	ADP
admet-1042	6	32	s.	s.	PROPN
admet-1042	6	33	aureus	aureus	PROPN
admet-1042	6	34	,	,	PUNCT
admet-1042	6	35	k.	k.	PROPN
admet-1042	6	36	pneumoniae	pneumoniae	NOUN
admet-1042	6	37	and	and	CCONJ
admet-1042	6	38	p.	p.	NOUN
admet-1042	6	39	aeruginosa	aeruginosa	PROPN
admet-1042	6	40	.	.	PUNCT
admet-1042	7	1	fentanyl	fentanyl	PROPN
admet-1042	7	2	has	have	AUX
admet-1042	7	3	displayed	display	VERB
admet-1042	7	4	evident	evident	ADJ
admet-1042	7	5	inhibitory	inhibitory	ADJ
admet-1042	7	6	potency	potency	NOUN
admet-1042	7	7	on	on	ADP
admet-1042	7	8	the	the	DET
admet-1042	7	9	pathogens	pathogen	NOUN
admet-1042	7	10	except	except	SCONJ
admet-1042	7	11	for	for	ADP
admet-1042	7	12	klebsiella	klebsiella	NOUN
admet-1042	7	13	pneumoniae	pneumoniae	NOUN
admet-1042	7	14	,	,	PUNCT
admet-1042	7	15	nevertheless	nevertheless	ADV
admet-1042	7	16	our	our	PRON
admet-1042	7	17	predefined	predefine	VERB
admet-1042	7	18	minimum	minimum	ADJ
admet-1042	7	19	concentration	concentration	NOUN
admet-1042	7	20	inhibited	inhibit	VERB
admet-1042	7	21	growth	growth	NOUN
admet-1042	7	22	by	by	ADP
admet-1042	7	23	9.5	9.5	NUM
admet-1042	7	24	%	%	NOUN
admet-1042	7	25	.	.	PUNCT
admet-1042	8	1	fentanyl	fentanyl	PROPN
admet-1042	8	2	and	and	CCONJ
admet-1042	8	3	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	8	4	together	together	ADV
admet-1042	8	5	exhibited	exhibit	VERB
admet-1042	8	6	more	more	ADJ
admet-1042	8	7	antimicrobial	antimicrobial	ADJ
admet-1042	8	8	effect	effect	NOUN
admet-1042	8	9	on	on	ADP
admet-1042	8	10	p.	p.	PROPN
admet-1042	8	11	aeruginosa	aeruginosa	PROPN
admet-1042	8	12	and	and	CCONJ
admet-1042	8	13	e.	e.	PROPN
admet-1042	8	14	coli	coli	NOUN
admet-1042	8	15	growth	growth	NOUN
admet-1042	8	16	.	.	PUNCT
admet-1042	9	1	additionally	additionally	ADV
admet-1042	9	2	,	,	PUNCT
admet-1042	9	3	when	when	SCONJ
admet-1042	9	4	the	the	DET
admet-1042	9	5	three	three	NUM
admet-1042	9	6	drugs	drug	NOUN
admet-1042	9	7	examined	examine	VERB
admet-1042	9	8	together	together	ADV
admet-1042	9	9	,	,	PUNCT
admet-1042	9	10	microbial	microbial	ADJ
admet-1042	9	11	inhibition	inhibition	NOUN
admet-1042	9	12	occurred	occur	VERB
admet-1042	9	13	more	more	ADV
admet-1042	9	14	than	than	SCONJ
admet-1042	9	15	expected	expect	VERB
admet-1042	9	16	on	on	ADP
admet-1042	9	17	e.	e.	PROPN
admet-1042	9	18	coli	coli	PROPN
admet-1042	9	19	again	again	ADV
admet-1042	9	20	and	and	CCONJ
admet-1042	9	21	also	also	ADV
admet-1042	9	22	on	on	ADP
admet-1042	9	23	c.	c.	NOUN
admet-1042	9	24	albicans	albican	NOUN
admet-1042	9	25	growth	growth	NOUN
admet-1042	9	26	.	.	PUNCT
admet-1042	10	1	conclusions	conclusion	NOUN
admet-1042	10	2	:	:	PUNCT
admet-1042	10	3	our	our	PRON
admet-1042	10	4	results	result	NOUN
admet-1042	10	5	revealed	reveal	VERB
admet-1042	10	6	the	the	DET
admet-1042	10	7	antimicrobial	antimicrobial	ADJ
admet-1042	10	8	properties	property	NOUN
admet-1042	10	9	and	and	CCONJ
admet-1042	10	10	synergy	synergy	NOUN
admet-1042	10	11	with	with	ADP
admet-1042	10	12	the	the	DET
admet-1042	10	13	different	different	ADJ
admet-1042	10	14	combinations	combination	NOUN
admet-1042	10	15	of	of	ADP
admet-1042	10	16	fentanyl	fentanyl	NOUN
admet-1042	10	17	,	,	PUNCT
admet-1042	10	18	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	10	19	and	and	CCONJ
admet-1042	10	20	tramadol	tramadol	NOUN
admet-1042	10	21	against	against	ADP
admet-1042	10	22	the	the	DET
admet-1042	10	23	most	most	ADV
admet-1042	10	24	common	common	ADJ
admet-1042	10	25	nosocomial	nosocomial	ADJ
admet-1042	10	26	infection	infection	NOUN
admet-1042	10	27	agents	agent	NOUN
admet-1042	10	28	in	in	ADP
admet-1042	10	29	the	the	DET
admet-1042	10	30	icu	icu	PROPN
admet-1042	10	31	.	.	PUNCT
admet-1042	11	1	this	this	PRON
admet-1042	11	2	is	be	AUX
admet-1042	11	3	the	the	DET
admet-1042	11	4	first	first	ADJ
admet-1042	11	5	study	study	NOUN
admet-1042	11	6	in	in	ADP
admet-1042	11	7	the	the	DET
admet-1042	11	8	literature	literature	NOUN
admet-1042	11	9	looking	look	VERB
admet-1042	11	10	into	into	ADP
admet-1042	11	11	the	the	DET
admet-1042	11	12	microbial	microbial	ADJ
admet-1042	11	13	“	"	PUNCT
admet-1042	11	14	interactions	interaction	NOUN
admet-1042	11	15	”	"	PUNCT
admet-1042	11	16	of	of	ADP
admet-1042	11	17	opioids	opioid	NOUN
admet-1042	11	18	and	and	CCONJ
admet-1042	11	19	sedative	sedative	ADJ
admet-1042	11	20	drugs	drug	NOUN
admet-1042	11	21	but	but	CCONJ
admet-1042	11	22	more	more	ADJ
admet-1042	11	23	research	research	NOUN
admet-1042	11	24	is	be	AUX
admet-1042	11	25	needed	need	VERB
admet-1042	11	26	in	in	ADP
admet-1042	11	27	order	order	NOUN
admet-1042	11	28	to	to	PART
admet-1042	11	29	define	define	VERB
admet-1042	11	30	clinico	clinico	NOUN
admet-1042	11	31	-	-	PUNCT
admet-1042	11	32	laboratory	laboratory	NOUN
admet-1042	11	33	correlation	correlation	NOUN
admet-1042	11	34	.	.	PUNCT
admet-1042	12	1	©	©	PROPN
admet-1042	12	2	2021	2021	NUM
admet-1042	12	3	by	by	ADP
admet-1042	12	4	the	the	DET
admet-1042	12	5	authors	author	NOUN
admet-1042	12	6	.	.	PUNCT
admet-1042	13	1	this	this	DET
admet-1042	13	2	article	article	NOUN
admet-1042	13	3	is	be	AUX
admet-1042	13	4	an	an	DET
admet-1042	13	5	open	open	ADJ
admet-1042	13	6	-	-	PUNCT
admet-1042	13	7	access	access	NOUN
admet-1042	13	8	article	article	NOUN
admet-1042	13	9	distributed	distribute	VERB
admet-1042	13	10	under	under	ADP
admet-1042	13	11	the	the	DET
admet-1042	13	12	terms	term	NOUN
admet-1042	13	13	and	and	CCONJ
admet-1042	13	14	conditions	condition	NOUN
admet-1042	13	15	of	of	ADP
admet-1042	13	16	the	the	DET
admet-1042	13	17	creative	creative	ADJ
admet-1042	13	18	commons	common	NOUN
admet-1042	13	19	attribution	attribution	NOUN
admet-1042	13	20	license	license	NOUN
admet-1042	13	21	(	(	PUNCT
admet-1042	13	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1042	13	23	)	)	PUNCT
admet-1042	13	24	.	.	PUNCT
admet-1042	14	1	keywords	keyword	NOUN
admet-1042	14	2	sedoanalgesics	sedoanalgesic	NOUN
admet-1042	14	3	;	;	PUNCT
admet-1042	14	4	nosocomial	nosocomial	ADJ
admet-1042	14	5	agents	agent	NOUN
admet-1042	14	6	;	;	PUNCT
admet-1042	14	7	antimicrobial	antimicrobial	ADJ
admet-1042	14	8	effects	effect	NOUN
admet-1042	14	9	;	;	PUNCT
admet-1042	14	10	drug	drug	NOUN
admet-1042	14	11	interactions	interaction	NOUN
admet-1042	14	12	.	.	PUNCT
admet-1042	15	1	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	X
admet-1042	15	2	https://doi.org/10.5599/admet.1042	https://doi.org/10.5599/admet.1042	PRON
admet-1042	15	3	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1042	15	4	mailto:md.kesici@mynet.com	mailto:md.kesici@mynet.com	PROPN
admet-1042	16	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1042	16	2	sevgi	sevgi	PROPN
admet-1042	16	3	kesici	kesici	PROPN
admet-1042	16	4	et	et	PROPN
admet-1042	16	5	al	al	PROPN
admet-1042	16	6	.	.	PROPN
admet-1042	16	7	admet	admet	PROPN
admet-1042	16	8	&	&	CCONJ
admet-1042	16	9	dmpk	dmpk	PROPN
admet-1042	16	10	9(3	9(3	NUM
admet-1042	16	11	)	)	PUNCT
admet-1042	16	12	(	(	PUNCT
admet-1042	16	13	2021	2021	NUM
admet-1042	16	14	)	)	PUNCT
admet-1042	16	15	219	219	NUM
admet-1042	16	16	-	-	SYM
admet-1042	16	17	226	226	NUM
admet-1042	16	18	220	220	NUM
admet-1042	16	19	introduction	introduction	NOUN
admet-1042	16	20	intensive	intensive	ADJ
admet-1042	16	21	care	care	NOUN
admet-1042	16	22	patients	patient	NOUN
admet-1042	16	23	often	often	ADV
admet-1042	16	24	require	require	VERB
admet-1042	16	25	sedation	sedation	NOUN
admet-1042	16	26	procedures	procedure	NOUN
admet-1042	16	27	for	for	ADP
admet-1042	16	28	several	several	ADJ
admet-1042	16	29	reasons	reason	NOUN
admet-1042	16	30	during	during	ADP
admet-1042	16	31	their	their	PRON
admet-1042	16	32	hospitalization	hospitalization	NOUN
admet-1042	16	33	.	.	PUNCT
admet-1042	17	1	since	since	SCONJ
admet-1042	17	2	intensive	intensive	ADJ
admet-1042	17	3	care	care	NOUN
admet-1042	17	4	units	unit	NOUN
admet-1042	17	5	(	(	PUNCT
admet-1042	17	6	icu	icu	PROPN
admet-1042	17	7	)	)	PUNCT
admet-1042	17	8	are	be	AUX
admet-1042	17	9	prone	prone	ADJ
admet-1042	17	10	to	to	ADP
admet-1042	17	11	nosocomial	nosocomial	ADJ
admet-1042	17	12	infections	infection	NOUN
admet-1042	17	13	;	;	PUNCT
admet-1042	17	14	intravenous	intravenous	ADJ
admet-1042	17	15	(	(	PUNCT
admet-1042	17	16	iv	iv	X
admet-1042	17	17	)	)	PUNCT
admet-1042	17	18	medications	medication	NOUN
admet-1042	17	19	gain	gain	VERB
admet-1042	17	20	more	more	ADJ
admet-1042	17	21	importance	importance	NOUN
admet-1042	17	22	in	in	ADP
admet-1042	17	23	the	the	DET
admet-1042	17	24	aspect	aspect	NOUN
admet-1042	17	25	of	of	ADP
admet-1042	17	26	microbial	microbial	ADJ
admet-1042	17	27	features	feature	NOUN
admet-1042	17	28	.	.	PUNCT
admet-1042	18	1	contamination	contamination	NOUN
admet-1042	18	2	based	base	VERB
admet-1042	18	3	infections	infection	NOUN
admet-1042	18	4	may	may	AUX
admet-1042	18	5	complicate	complicate	VERB
admet-1042	18	6	clinical	clinical	ADJ
admet-1042	18	7	follow	follow	NOUN
admet-1042	18	8	-	-	PUNCT
admet-1042	18	9	up	up	NOUN
admet-1042	18	10	and	and	CCONJ
admet-1042	18	11	little	little	ADJ
admet-1042	18	12	is	be	AUX
admet-1042	18	13	known	know	VERB
admet-1042	18	14	whether	whether	SCONJ
admet-1042	18	15	the	the	DET
admet-1042	18	16	sedative	sedative	ADJ
admet-1042	18	17	agents	agent	NOUN
admet-1042	18	18	have	have	VERB
admet-1042	18	19	antimicrobial	antimicrobial	ADJ
admet-1042	18	20	properties	property	NOUN
admet-1042	18	21	.	.	PUNCT
admet-1042	19	1	among	among	ADP
admet-1042	19	2	them	they	PRON
admet-1042	19	3	,	,	PUNCT
admet-1042	19	4	propofol	propofol	NOUN
admet-1042	19	5	is	be	AUX
admet-1042	19	6	a	a	DET
admet-1042	19	7	well	well	ADV
admet-1042	19	8	-	-	PUNCT
admet-1042	19	9	studied	study	VERB
admet-1042	19	10	drug	drug	NOUN
admet-1042	19	11	that	that	PRON
admet-1042	19	12	is	be	AUX
admet-1042	19	13	now	now	ADV
admet-1042	19	14	known	know	VERB
admet-1042	19	15	to	to	PART
admet-1042	19	16	be	be	AUX
admet-1042	19	17	inducing	induce	VERB
admet-1042	19	18	bacterial	bacterial	ADJ
admet-1042	19	19	growth	growth	NOUN
admet-1042	19	20	[	[	X
admet-1042	19	21	1–4	1–4	NOUN
admet-1042	19	22	]	]	X
admet-1042	19	23	.	.	PUNCT
admet-1042	20	1	however	however	ADV
admet-1042	20	2	,	,	PUNCT
admet-1042	20	3	there	there	PRON
admet-1042	20	4	are	be	VERB
admet-1042	20	5	many	many	ADJ
admet-1042	20	6	other	other	ADJ
admet-1042	20	7	drug	drug	NOUN
admet-1042	20	8	combinations	combination	NOUN
admet-1042	20	9	used	use	VERB
admet-1042	20	10	in	in	ADP
admet-1042	20	11	routine	routine	ADJ
admet-1042	20	12	practice	practice	NOUN
admet-1042	20	13	to	to	PART
admet-1042	20	14	maintain	maintain	VERB
admet-1042	20	15	sedation	sedation	NOUN
admet-1042	20	16	.	.	PUNCT
admet-1042	21	1	-2	-2	NOUN
admet-1042	21	2	selective	selective	ADJ
admet-1042	21	3	blocker	blocker	NOUN
admet-1042	21	4	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	21	5	has	have	AUX
admet-1042	21	6	become	become	VERB
admet-1042	21	7	more	more	ADV
admet-1042	21	8	popular	popular	ADJ
admet-1042	21	9	and	and	CCONJ
admet-1042	21	10	widely	widely	ADV
admet-1042	21	11	used	use	VERB
admet-1042	21	12	for	for	ADP
admet-1042	21	13	its	its	PRON
admet-1042	21	14	less	less	ADV
admet-1042	21	15	respiratory	respiratory	ADJ
admet-1042	21	16	depressant	depressant	NOUN
admet-1042	21	17	effects	effect	NOUN
admet-1042	21	18	instead	instead	ADV
admet-1042	21	19	of	of	ADP
admet-1042	21	20	midazolam	midazolam	PROPN
admet-1042	21	21	which	which	PRON
admet-1042	21	22	triggers	trigger	VERB
admet-1042	21	23	delirium	delirium	NOUN
admet-1042	21	24	in	in	ADP
admet-1042	21	25	the	the	DET
admet-1042	21	26	elderly	elderly	ADJ
admet-1042	21	27	[	[	X
admet-1042	21	28	5–7	5–7	NOUN
admet-1042	21	29	]	]	PUNCT
admet-1042	21	30	.	.	PUNCT
admet-1042	22	1	many	many	ADJ
admet-1042	22	2	clinicians	clinician	NOUN
admet-1042	22	3	also	also	ADV
admet-1042	22	4	add	add	VERB
admet-1042	22	5	opioids	opioid	NOUN
admet-1042	22	6	to	to	ADP
admet-1042	22	7	the	the	DET
admet-1042	22	8	treatment	treatment	NOUN
admet-1042	22	9	just	just	ADV
admet-1042	22	10	to	to	PART
admet-1042	22	11	deepen	deepen	VERB
admet-1042	22	12	sedation	sedation	NOUN
admet-1042	22	13	and	and	CCONJ
admet-1042	22	14	fentanyl	fentanyl	NOUN
admet-1042	22	15	appears	appear	VERB
admet-1042	22	16	to	to	PART
admet-1042	22	17	be	be	AUX
admet-1042	22	18	one	one	NUM
admet-1042	22	19	of	of	ADP
admet-1042	22	20	the	the	DET
admet-1042	22	21	most	most	ADV
admet-1042	22	22	common	common	ADJ
admet-1042	22	23	choices	choice	NOUN
admet-1042	22	24	due	due	ADP
admet-1042	22	25	to	to	ADP
admet-1042	22	26	its	its	PRON
admet-1042	22	27	hemodynamic	hemodynamic	ADJ
admet-1042	22	28	stable	stable	ADJ
admet-1042	22	29	properties	property	NOUN
admet-1042	22	30	.	.	PUNCT
admet-1042	23	1	there	there	PRON
admet-1042	23	2	are	be	VERB
admet-1042	23	3	studies	study	NOUN
admet-1042	23	4	comparing	compare	VERB
admet-1042	23	5	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	23	6	and	and	CCONJ
admet-1042	23	7	midazolam	midazolam	NOUN
admet-1042	23	8	from	from	ADP
admet-1042	23	9	the	the	DET
admet-1042	23	10	microbiological	microbiological	ADJ
admet-1042	23	11	aspect	aspect	NOUN
admet-1042	23	12	in	in	ADP
admet-1042	23	13	the	the	DET
admet-1042	23	14	literature	literature	NOUN
admet-1042	23	15	[	[	X
admet-1042	23	16	8,9	8,9	NUM
admet-1042	23	17	]	]	PUNCT
admet-1042	23	18	.	.	PUNCT
admet-1042	24	1	but	but	CCONJ
admet-1042	24	2	since	since	SCONJ
admet-1042	24	3	midazolam	midazolam	PROPN
admet-1042	24	4	has	have	AUX
admet-1042	24	5	gained	gain	VERB
admet-1042	24	6	a	a	DET
admet-1042	24	7	bad	bad	ADJ
admet-1042	24	8	reputation	reputation	NOUN
admet-1042	24	9	for	for	ADP
admet-1042	24	10	delirium	delirium	NOUN
admet-1042	24	11	triggering	trigger	VERB
admet-1042	24	12	properties	property	NOUN
admet-1042	24	13	another	another	DET
admet-1042	24	14	sedative	sedative	ADJ
admet-1042	24	15	agent	agent	NOUN
admet-1042	24	16	fentanyl	fentanyl	NOUN
admet-1042	24	17	is	be	AUX
admet-1042	24	18	yet	yet	ADV
admet-1042	24	19	to	to	PART
admet-1042	24	20	be	be	AUX
admet-1042	24	21	explored	explore	VERB
admet-1042	24	22	.	.	PUNCT
admet-1042	25	1	this	this	DET
admet-1042	25	2	study	study	NOUN
admet-1042	25	3	aimed	aim	VERB
admet-1042	25	4	to	to	PART
admet-1042	25	5	evaluate	evaluate	VERB
admet-1042	25	6	antimicrobial	antimicrobial	ADJ
admet-1042	25	7	effects	effect	NOUN
admet-1042	25	8	and	and	CCONJ
admet-1042	25	9	interaction	interaction	NOUN
admet-1042	25	10	between	between	ADP
admet-1042	25	11	analgesic	analgesic	ADJ
admet-1042	25	12	combinations	combination	NOUN
admet-1042	25	13	of	of	ADP
admet-1042	25	14	fentanyl	fentanyl	ADJ
admet-1042	25	15	citrate	citrate	NOUN
admet-1042	25	16	,	,	PUNCT
admet-1042	25	17	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	25	18	hydrochloride	hydrochloride	NOUN
admet-1042	25	19	and	and	CCONJ
admet-1042	25	20	tramadol	tramadol	NOUN
admet-1042	25	21	hydrochloride	hydrochloride	NOUN
admet-1042	25	22	on	on	ADP
admet-1042	25	23	staphylococcus	staphylococcus	NOUN
admet-1042	25	24	aureus	aureus	NOUN
admet-1042	25	25	,	,	PUNCT
admet-1042	25	26	klebsiella	klebsiella	NOUN
admet-1042	25	27	pneumoniae	pneumoniae	NOUN
admet-1042	25	28	,	,	PUNCT
admet-1042	25	29	escherichia	escherichia	NOUN
admet-1042	25	30	coli	coli	NOUN
admet-1042	25	31	,	,	PUNCT
admet-1042	25	32	pseudomonas	pseudomona	VERB
admet-1042	25	33	aeruginosa	aeruginosa	NOUN
admet-1042	25	34	and	and	CCONJ
admet-1042	25	35	candida	candida	NOUN
admet-1042	25	36	albicans	albican	NOUN
admet-1042	25	37	which	which	PRON
admet-1042	25	38	are	be	AUX
admet-1042	25	39	some	some	PRON
admet-1042	25	40	of	of	ADP
admet-1042	25	41	the	the	DET
admet-1042	25	42	most	most	ADV
admet-1042	25	43	common	common	ADJ
admet-1042	25	44	nosocomial	nosocomial	ADJ
admet-1042	25	45	infection	infection	NOUN
admet-1042	25	46	related	relate	VERB
admet-1042	25	47	microorganisms	microorganism	NOUN
admet-1042	25	48	.	.	PUNCT
admet-1042	26	1	these	these	DET
admet-1042	26	2	drugs	drug	NOUN
admet-1042	26	3	were	be	AUX
admet-1042	26	4	chosen	choose	VERB
admet-1042	26	5	for	for	ADP
admet-1042	26	6	being	be	AUX
admet-1042	26	7	the	the	DET
admet-1042	26	8	most	most	ADV
admet-1042	26	9	frequently	frequently	ADV
admet-1042	26	10	used	use	VERB
admet-1042	26	11	infusion	infusion	NOUN
admet-1042	26	12	sedoanalgesics	sedoanalgesic	NOUN
admet-1042	26	13	in	in	ADP
admet-1042	26	14	our	our	PRON
admet-1042	26	15	institute	institute	NOUN
admet-1042	26	16	.	.	PUNCT
admet-1042	27	1	materials	material	NOUN
admet-1042	27	2	and	and	CCONJ
admet-1042	27	3	methods	method	NOUN
admet-1042	27	4	tested	test	VERB
admet-1042	27	5	sedoanalgesics	sedoanalgesic	NOUN
admet-1042	27	6	tramadol	tramadol	NOUN
admet-1042	27	7	hydrochloride	hydrochloride	NOUN
admet-1042	27	8	(	(	PUNCT
admet-1042	27	9	ultramex	ultramex	NOUN
admet-1042	27	10	)	)	PUNCT
admet-1042	27	11	,	,	PUNCT
admet-1042	27	12	fentanyl	fentanyl	ADJ
admet-1042	27	13	citrate	citrate	NOUN
admet-1042	27	14	(	(	PUNCT
admet-1042	27	15	talinat	talinat	NOUN
admet-1042	27	16	)	)	PUNCT
admet-1042	27	17	and	and	CCONJ
admet-1042	27	18	dexmedetomidin	dexmedetomidin	VERB
admet-1042	27	19	(	(	PUNCT
admet-1042	27	20	hipnodex	hipnodex	NOUN
admet-1042	27	21	)	)	PUNCT
admet-1042	27	22	were	be	AUX
admet-1042	27	23	tested	test	VERB
admet-1042	27	24	to	to	PART
admet-1042	27	25	reveal	reveal	VERB
admet-1042	27	26	their	their	PRON
admet-1042	27	27	antimicrobial	antimicrobial	ADJ
admet-1042	27	28	activity	activity	NOUN
admet-1042	27	29	and	and	CCONJ
admet-1042	27	30	interaction	interaction	NOUN
admet-1042	27	31	between	between	ADP
admet-1042	27	32	analgesic	analgesic	ADJ
admet-1042	27	33	combinations	combination	NOUN
admet-1042	27	34	.	.	PUNCT
admet-1042	28	1	bacterial	bacterial	ADJ
admet-1042	28	2	strains	strain	NOUN
admet-1042	28	3	s.	s.	PROPN
admet-1042	28	4	aureus	aureus	PROPN
admet-1042	28	5	atcc	atcc	PROPN
admet-1042	28	6	29213	29213	NUM
admet-1042	28	7	,	,	PUNCT
admet-1042	28	8	k.	k.	PROPN
admet-1042	28	9	pneumoniae	pneumoniae	PROPN
admet-1042	28	10	,	,	PUNCT
admet-1042	28	11	e.	e.	PROPN
admet-1042	28	12	coli	coli	PROPN
admet-1042	28	13	atcc	atcc	PROPN
admet-1042	28	14	25922	25922	NUM
admet-1042	28	15	,	,	PUNCT
admet-1042	28	16	p.	p.	NOUN
admet-1042	28	17	aeruginosa	aeruginosa	PROPN
admet-1042	28	18	atcc	atcc	PROPN
admet-1042	28	19	27853	27853	NUM
admet-1042	28	20	and	and	CCONJ
admet-1042	28	21	c.	c.	NOUN
admet-1042	28	22	albicans	albican	NOUN
admet-1042	28	23	atcc	atcc	PROPN
admet-1042	28	24	10231	10231	NUM
admet-1042	28	25	standard	standard	ADJ
admet-1042	28	26	strains	strain	NOUN
admet-1042	28	27	,	,	PUNCT
admet-1042	28	28	which	which	PRON
admet-1042	28	29	are	be	AUX
admet-1042	28	30	primary	primary	ADJ
admet-1042	28	31	pathogens	pathogen	NOUN
admet-1042	28	32	of	of	ADP
admet-1042	28	33	bacteremia	bacteremia	NOUN
admet-1042	28	34	and	and	CCONJ
admet-1042	28	35	sepsis	sepsis	NOUN
admet-1042	28	36	were	be	AUX
admet-1042	28	37	chosen	choose	VERB
admet-1042	28	38	in	in	ADP
admet-1042	28	39	order	order	NOUN
admet-1042	28	40	to	to	PART
admet-1042	28	41	compare	compare	VERB
admet-1042	28	42	analgesics	analgesic	NOUN
admet-1042	28	43	antimicrobial	antimicrobial	ADJ
admet-1042	28	44	activity	activity	NOUN
admet-1042	28	45	.	.	PUNCT
admet-1042	29	1	antibacterial	antibacterial	ADJ
admet-1042	29	2	broth	broth	ADJ
admet-1042	29	3	test	test	NOUN
admet-1042	29	4	antimicrobial	antimicrobial	ADJ
admet-1042	29	5	activity	activity	NOUN
admet-1042	29	6	of	of	ADP
admet-1042	29	7	the	the	DET
admet-1042	29	8	selected	select	VERB
admet-1042	29	9	analgesics	analgesic	NOUN
admet-1042	29	10	was	be	AUX
admet-1042	29	11	measured	measure	VERB
admet-1042	29	12	with	with	ADP
admet-1042	29	13	microdilution	microdilution	NOUN
admet-1042	29	14	method	method	NOUN
admet-1042	29	15	according	accord	VERB
admet-1042	29	16	to	to	ADP
admet-1042	29	17	the	the	DET
admet-1042	29	18	instructions	instruction	NOUN
admet-1042	29	19	of	of	ADP
admet-1042	29	20	clinical	clinical	ADJ
admet-1042	29	21	laboratory	laboratory	NOUN
admet-1042	29	22	standards	standard	NOUN
admet-1042	29	23	institute	institute	PROPN
admet-1042	29	24	(	(	PUNCT
admet-1042	29	25	clsi	clsi	PROPN
admet-1042	29	26	)	)	PUNCT
admet-1042	29	27	.	.	PUNCT
admet-1042	30	1	tramadol	tramadol	NOUN
admet-1042	30	2	hydrochloride	hydrochloride	NOUN
admet-1042	30	3	(	(	PUNCT
admet-1042	30	4	abbott	abbott	PROPN
admet-1042	30	5	,	,	PUNCT
admet-1042	30	6	rocky	rocky	PROPN
admet-1042	30	7	mount	mount	PROPN
admet-1042	30	8	,	,	PUNCT
admet-1042	30	9	nc	nc	PROPN
admet-1042	30	10	,	,	PUNCT
admet-1042	30	11	usa	usa	PROPN
admet-1042	30	12	,	,	PUNCT
admet-1042	30	13	supplied	supply	VERB
admet-1042	30	14	in	in	ADP
admet-1042	30	15	a	a	DET
admet-1042	30	16	2	2	NUM
admet-1042	30	17	ml	ml	NOUN
admet-1042	30	18	ampoule	ampoule	NOUN
admet-1042	30	19	containing	contain	VERB
admet-1042	30	20	50	50	NUM
admet-1042	30	21	µg	µg	NOUN
admet-1042	30	22	/	/	SYM
admet-1042	30	23	ml	ml	NOUN
admet-1042	30	24	in	in	ADP
admet-1042	30	25	sodium	sodium	NOUN
admet-1042	30	26	chloride	chloride	NOUN
admet-1042	30	27	solution	solution	NOUN
admet-1042	30	28	)	)	PUNCT
admet-1042	30	29	was	be	AUX
admet-1042	30	30	diluted	dilute	VERB
admet-1042	30	31	with	with	ADP
admet-1042	30	32	brain	brain	NOUN
admet-1042	30	33	heart	heart	NOUN
admet-1042	30	34	infusion	infusion	NOUN
admet-1042	30	35	broth	broth	NOUN
admet-1042	30	36	(	(	PUNCT
admet-1042	30	37	bhi	bhi	PROPN
admet-1042	30	38	)	)	PUNCT
admet-1042	30	39	to	to	ADP
admet-1042	30	40	the	the	DET
admet-1042	30	41	final	final	ADJ
admet-1042	30	42	concentrations	concentration	NOUN
admet-1042	30	43	of	of	ADP
admet-1042	30	44	500	500	NUM
admet-1042	30	45	µg	µg	NOUN
admet-1042	30	46	/	/	SYM
admet-1042	30	47	ml	ml	NOUN
admet-1042	30	48	,	,	PUNCT
admet-1042	30	49	250	250	NUM
admet-1042	30	50	µg	µg	ADV
admet-1042	30	51	/	/	SYM
admet-1042	30	52	ml	ml	NOUN
admet-1042	30	53	,	,	PUNCT
admet-1042	30	54	125	125	NUM
admet-1042	30	55	µg	µg	ADJ
admet-1042	30	56	/	/	SYM
admet-1042	30	57	ml	ml	NOUN
admet-1042	30	58	,	,	PUNCT
admet-1042	30	59	62.5	62.5	NUM
admet-1042	30	60	µg	µg	NOUN
admet-1042	30	61	/	/	SYM
admet-1042	30	62	ml	ml	NOUN
admet-1042	30	63	,	,	PUNCT
admet-1042	30	64	31.25	31.25	NUM
admet-1042	30	65	µg	µg	NOUN
admet-1042	30	66	/	/	SYM
admet-1042	30	67	ml	ml	NOUN
admet-1042	30	68	.	.	PUNCT
admet-1042	30	69	fentanyl	fentanyl	ADJ
admet-1042	30	70	citrate	citrate	NOUN
admet-1042	30	71	(	(	PUNCT
admet-1042	30	72	abbott	abbott	PROPN
admet-1042	30	73	,	,	PUNCT
admet-1042	30	74	rocky	rocky	PROPN
admet-1042	30	75	mount	mount	PROPN
admet-1042	30	76	,	,	PUNCT
admet-1042	30	77	nc	nc	PROPN
admet-1042	30	78	,	,	PUNCT
admet-1042	30	79	usa	usa	PROPN
admet-1042	30	80	,	,	PUNCT
admet-1042	30	81	supplied	supply	VERB
admet-1042	30	82	in	in	ADP
admet-1042	30	83	a	a	DET
admet-1042	30	84	10	10	NUM
admet-1042	30	85	ml	ml	NOUN
admet-1042	30	86	ampoule	ampoule	NOUN
admet-1042	30	87	containing	contain	VERB
admet-1042	30	88	0,05	0,05	NOUN
admet-1042	30	89	mg	mg	PROPN
admet-1042	30	90	/	/	SYM
admet-1042	30	91	ml	ml	X
admet-1042	30	92	in	in	ADP
admet-1042	30	93	sodium	sodium	NOUN
admet-1042	30	94	chloride	chloride	NOUN
admet-1042	30	95	solution	solution	NOUN
admet-1042	30	96	)	)	PUNCT
admet-1042	30	97	was	be	AUX
admet-1042	30	98	diluted	dilute	VERB
admet-1042	30	99	with	with	ADP
admet-1042	30	100	brain	brain	NOUN
admet-1042	30	101	heart	heart	NOUN
admet-1042	30	102	infusion	infusion	NOUN
admet-1042	30	103	broth	broth	NOUN
admet-1042	30	104	(	(	PUNCT
admet-1042	30	105	bhi	bhi	PROPN
admet-1042	30	106	)	)	PUNCT
admet-1042	30	107	to	to	ADP
admet-1042	30	108	the	the	DET
admet-1042	30	109	final	final	ADJ
admet-1042	30	110	concentrations	concentration	NOUN
admet-1042	30	111	of	of	ADP
admet-1042	30	112	5	5	NUM
admet-1042	30	113	µg	µg	ADV
admet-1042	30	114	/	/	SYM
admet-1042	30	115	ml	ml	NOUN
admet-1042	30	116	,	,	PUNCT
admet-1042	30	117	2.5	2.5	NUM
admet-1042	30	118	µg	µg	NOUN
admet-1042	30	119	/	/	SYM
admet-1042	30	120	ml	ml	NOUN
admet-1042	30	121	,	,	PUNCT
admet-1042	30	122	1.25	1.25	NUM
admet-1042	30	123	µg	µg	NOUN
admet-1042	30	124	/	/	SYM
admet-1042	30	125	ml	ml	NOUN
admet-1042	30	126	,	,	PUNCT
admet-1042	30	127	0.625	0.625	NUM
admet-1042	30	128	µg	µg	NOUN
admet-1042	30	129	/	/	SYM
admet-1042	30	130	ml	ml	NOUN
admet-1042	30	131	,	,	PUNCT
admet-1042	30	132	0.3125	0.3125	NUM
admet-1042	30	133	µg	µg	NOUN
admet-1042	30	134	/	/	SYM
admet-1042	30	135	ml	ml	NOUN
admet-1042	30	136	.	.	PUNCT
admet-1042	30	137	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	30	138	hydrochloride	hydrochloride	NOUN
admet-1042	30	139	(	(	PUNCT
admet-1042	30	140	abbott	abbott	PROPN
admet-1042	30	141	,	,	PUNCT
admet-1042	30	142	rocky	rocky	PROPN
admet-1042	30	143	mount	mount	PROPN
admet-1042	30	144	,	,	PUNCT
admet-1042	30	145	nc	nc	PROPN
admet-1042	30	146	,	,	PUNCT
admet-1042	30	147	usa	usa	PROPN
admet-1042	30	148	,	,	PUNCT
admet-1042	30	149	supplied	supply	VERB
admet-1042	30	150	in	in	ADP
admet-1042	30	151	a	a	DET
admet-1042	30	152	2	2	NUM
admet-1042	30	153	ml	ml	NOUN
admet-1042	30	154	ampoule	ampoule	NOUN
admet-1042	30	155	containing	contain	VERB
admet-1042	30	156	100	100	NUM
admet-1042	30	157	µg	µg	NOUN
admet-1042	30	158	/	/	SYM
admet-1042	30	159	ml	ml	NOUN
admet-1042	30	160	in	in	ADP
admet-1042	30	161	sodium	sodium	NOUN
admet-1042	30	162	chloride	chloride	NOUN
admet-1042	30	163	solution	solution	NOUN
admet-1042	30	164	)	)	PUNCT
admet-1042	30	165	was	be	AUX
admet-1042	30	166	diluted	dilute	VERB
admet-1042	30	167	with	with	ADP
admet-1042	30	168	brain	brain	NOUN
admet-1042	30	169	heart	heart	NOUN
admet-1042	30	170	infusion	infusion	NOUN
admet-1042	30	171	broth	broth	NOUN
admet-1042	30	172	(	(	PUNCT
admet-1042	30	173	bhi	bhi	PROPN
admet-1042	30	174	)	)	PUNCT
admet-1042	30	175	to	to	ADP
admet-1042	30	176	the	the	DET
admet-1042	30	177	final	final	ADJ
admet-1042	30	178	concentrations	concentration	NOUN
admet-1042	30	179	of	of	ADP
admet-1042	30	180	10	10	NUM
admet-1042	30	181	µg	µg	NOUN
admet-1042	30	182	/	/	SYM
admet-1042	30	183	ml	ml	NOUN
admet-1042	30	184	,	,	PUNCT
admet-1042	30	185	5	5	NUM
admet-1042	30	186	µg	µg	ADV
admet-1042	30	187	/	/	SYM
admet-1042	30	188	ml	ml	NOUN
admet-1042	30	189	,	,	PUNCT
admet-1042	30	190	2.5	2.5	NUM
admet-1042	30	191	µg	µg	NOUN
admet-1042	30	192	/	/	SYM
admet-1042	30	193	ml	ml	NOUN
admet-1042	30	194	,	,	PUNCT
admet-1042	30	195	1.25	1.25	NUM
admet-1042	30	196	µg	µg	NOUN
admet-1042	30	197	/	/	SYM
admet-1042	30	198	ml	ml	NOUN
admet-1042	30	199	,	,	PUNCT
admet-1042	30	200	0.625	0.625	NUM
admet-1042	30	201	µg	µg	NOUN
admet-1042	30	202	/	/	SYM
admet-1042	30	203	ml	ml	NOUN
admet-1042	30	204	.	.	PUNCT
admet-1042	31	1	overnight	overnight	ADJ
admet-1042	31	2	broth	broth	ADJ
admet-1042	31	3	cultures	culture	NOUN
admet-1042	31	4	of	of	ADP
admet-1042	31	5	s.	s.	PROPN
admet-1042	31	6	aureus	aureus	PROPN
admet-1042	31	7	atcc	atcc	PROPN
admet-1042	31	8	29213	29213	NUM
admet-1042	31	9	,	,	PUNCT
admet-1042	31	10	k.	k.	PROPN
admet-1042	31	11	pneumoniae	pneumoniae	ADJ
admet-1042	31	12	atcc	atcc	PROPN
admet-1042	31	13	13883	13883	NUM
admet-1042	31	14	,	,	PUNCT
admet-1042	31	15	e.	e.	PROPN
admet-1042	31	16	coli	coli	PROPN
admet-1042	31	17	atcc	atcc	PROPN
admet-1042	31	18	25922	25922	NUM
admet-1042	31	19	,	,	PUNCT
admet-1042	31	20	p.	p.	NOUN
admet-1042	31	21	aeruginosa	aeruginosa	PROPN
admet-1042	31	22	atcc	atcc	PROPN
admet-1042	31	23	27853	27853	NUM
admet-1042	31	24	and	and	CCONJ
admet-1042	31	25	c.	c.	NOUN
admet-1042	31	26	albicans	albican	NOUN
admet-1042	31	27	atcc	atcc	PROPN
admet-1042	31	28	10231	10231	NUM
admet-1042	31	29	were	be	AUX
admet-1042	31	30	adjusted	adjust	VERB
admet-1042	31	31	to	to	ADP
admet-1042	31	32	the	the	DET
admet-1042	31	33	turbidity	turbidity	NOUN
admet-1042	31	34	of	of	ADP
admet-1042	31	35	a	a	DET
admet-1042	31	36	0.5	0.5	NUM
admet-1042	31	37	mcfarland	mcfarland	PROPN
admet-1042	31	38	standard	standard	NOUN
admet-1042	31	39	.	.	PUNCT
admet-1042	32	1	10	10	NUM
admet-1042	32	2	µl	µl	NOUN
admet-1042	32	3	of	of	ADP
admet-1042	32	4	each	each	DET
admet-1042	32	5	strain	strain	NOUN
admet-1042	32	6	were	be	AUX
admet-1042	32	7	inoculated	inoculate	VERB
admet-1042	32	8	to	to	ADP
admet-1042	32	9	each	each	DET
admet-1042	32	10	well	well	ADV
admet-1042	32	11	.	.	PUNCT
admet-1042	33	1	broths	broth	NOUN
admet-1042	33	2	without	without	ADP
admet-1042	33	3	any	any	DET
admet-1042	33	4	analgesic	analgesic	ADJ
admet-1042	33	5	materials	material	NOUN
admet-1042	33	6	were	be	AUX
admet-1042	33	7	served	serve	VERB
admet-1042	33	8	as	as	ADP
admet-1042	33	9	controls	control	NOUN
admet-1042	33	10	for	for	ADP
admet-1042	33	11	comparison	comparison	NOUN
admet-1042	33	12	.	.	PUNCT
admet-1042	34	1	plates	plate	NOUN
admet-1042	34	2	incubated	incubate	VERB
admet-1042	34	3	overnight	overnight	ADV
admet-1042	34	4	and	and	CCONJ
admet-1042	34	5	bacterial	bacterial	ADJ
admet-1042	34	6	growth	growth	NOUN
admet-1042	34	7	in	in	ADP
admet-1042	34	8	each	each	DET
admet-1042	34	9	well	well	ADV
admet-1042	34	10	were	be	AUX
admet-1042	34	11	measured	measure	VERB
admet-1042	34	12	with	with	ADP
admet-1042	34	13	epoch	epoch	PROPN
admet-1042	34	14	spectrophotometer	spectrophotometer	NOUN
admet-1042	34	15	(	(	PUNCT
admet-1042	34	16	biotek	biotek	PROPN
admet-1042	34	17	,	,	PUNCT
admet-1042	34	18	germany	germany	PROPN
admet-1042	34	19	)	)	PUNCT
admet-1042	34	20	at	at	ADP
admet-1042	34	21	600	600	NUM
admet-1042	34	22	nm	nm	NOUN
admet-1042	34	23	.	.	PUNCT
admet-1042	35	1	admet	admet	PROPN
admet-1042	35	2	&	&	CCONJ
admet-1042	35	3	dmpk	dmpk	PROPN
admet-1042	35	4	9(3	9(3	NUM
admet-1042	35	5	)	)	PUNCT
admet-1042	35	6	(	(	PUNCT
admet-1042	35	7	2021	2021	NUM
admet-1042	35	8	)	)	PUNCT
admet-1042	35	9	219	219	NUM
admet-1042	35	10	-	-	SYM
admet-1042	35	11	226	226	NUM
admet-1042	35	12	are	be	AUX
admet-1042	35	13	we	we	PRON
admet-1042	35	14	ready	ready	ADJ
admet-1042	35	15	to	to	PART
admet-1042	35	16	design	design	VERB
admet-1042	35	17	oral	oral	ADJ
admet-1042	35	18	protacs	protacs	PROPN
admet-1042	35	19	®	®	NOUN
admet-1042	35	20	?	?	PUNCT
admet-1042	36	1	doi	doi	PROPN
admet-1042	36	2	:	:	PUNCT
admet-1042	36	3	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	PUNCT
admet-1042	36	4	221	221	NUM
admet-1042	36	5	interaction	interaction	NOUN
admet-1042	36	6	between	between	ADP
admet-1042	36	7	analgesic	analgesic	ADJ
admet-1042	36	8	combinations	combination	NOUN
admet-1042	36	9	via	via	ADP
admet-1042	36	10	broth	broth	ADJ
admet-1042	36	11	microdilution	microdilution	NOUN
admet-1042	36	12	method	method	NOUN
admet-1042	36	13	tramadol	tramadol	NOUN
admet-1042	36	14	hydrochloride	hydrochloride	NOUN
admet-1042	36	15	(	(	PUNCT
admet-1042	36	16	th	th	NOUN
admet-1042	36	17	)	)	PUNCT
admet-1042	36	18	,	,	PUNCT
admet-1042	36	19	fentanyl	fentanyl	ADJ
admet-1042	36	20	citrate	citrate	NOUN
admet-1042	36	21	(	(	PUNCT
admet-1042	36	22	fc	fc	X
admet-1042	36	23	)	)	PUNCT
admet-1042	36	24	and	and	CCONJ
admet-1042	36	25	dexmedetomidine	dexmedetomidine	ADJ
admet-1042	36	26	hydrochloride	hydrochloride	NOUN
admet-1042	36	27	(	(	PUNCT
admet-1042	36	28	dh	dh	NOUN
admet-1042	36	29	)	)	PUNCT
admet-1042	36	30	combinations	combination	NOUN
admet-1042	36	31	were	be	AUX
admet-1042	36	32	diluted	dilute	VERB
admet-1042	36	33	in	in	ADP
admet-1042	36	34	brain	brain	NOUN
admet-1042	36	35	heart	heart	NOUN
admet-1042	36	36	infusion	infusion	NOUN
admet-1042	36	37	broth	broth	NOUN
admet-1042	36	38	(	(	PUNCT
admet-1042	36	39	bhi	bhi	PROPN
admet-1042	36	40	)	)	PUNCT
admet-1042	36	41	with	with	ADP
admet-1042	36	42	or	or	CCONJ
admet-1042	36	43	without	without	ADP
admet-1042	36	44	s.	s.	PROPN
admet-1042	36	45	aureus	aureus	PROPN
admet-1042	36	46	atcc	atcc	PROPN
admet-1042	36	47	29213	29213	NUM
admet-1042	36	48	,	,	PUNCT
admet-1042	36	49	k.	k.	PROPN
admet-1042	36	50	pneumoniae	pneumoniae	ADJ
admet-1042	36	51	atcc	atcc	PROPN
admet-1042	36	52	13883	13883	NUM
admet-1042	36	53	,	,	PUNCT
admet-1042	36	54	e.	e.	PROPN
admet-1042	36	55	coli	coli	PROPN
admet-1042	36	56	atcc	atcc	PROPN
admet-1042	36	57	25922	25922	NUM
admet-1042	36	58	,	,	PUNCT
admet-1042	36	59	p.	p.	NOUN
admet-1042	36	60	aeruginosa	aeruginosa	PROPN
admet-1042	36	61	atcc	atcc	PROPN
admet-1042	36	62	27853	27853	NUM
admet-1042	36	63	and	and	CCONJ
admet-1042	36	64	c.	c.	NOUN
admet-1042	36	65	albicans	albican	NOUN
admet-1042	36	66	atcc	atcc	PROPN
admet-1042	36	67	10231	10231	NUM
admet-1042	36	68	were	be	AUX
admet-1042	36	69	adjusted	adjust	VERB
admet-1042	36	70	to	to	ADP
admet-1042	36	71	the	the	DET
admet-1042	36	72	turbidity	turbidity	NOUN
admet-1042	36	73	of	of	ADP
admet-1042	36	74	a	a	DET
admet-1042	36	75	0.5	0.5	NUM
admet-1042	36	76	mcfarland	mcfarland	PROPN
admet-1042	36	77	standard	standard	NOUN
admet-1042	36	78	.	.	PUNCT
admet-1042	37	1	10	10	NUM
admet-1042	37	2	µl	µl	NOUN
admet-1042	37	3	of	of	ADP
admet-1042	37	4	each	each	DET
admet-1042	37	5	strain	strain	NOUN
admet-1042	37	6	were	be	AUX
admet-1042	37	7	inoculated	inoculate	VERB
admet-1042	37	8	to	to	ADP
admet-1042	37	9	each	each	DET
admet-1042	37	10	well	well	ADV
admet-1042	37	11	.	.	PUNCT
admet-1042	38	1	broths	broth	NOUN
admet-1042	38	2	without	without	ADP
admet-1042	38	3	any	any	DET
admet-1042	38	4	analgesic	analgesic	ADJ
admet-1042	38	5	materials	material	NOUN
admet-1042	38	6	were	be	AUX
admet-1042	38	7	served	serve	VERB
admet-1042	38	8	as	as	ADP
admet-1042	38	9	controls	control	NOUN
admet-1042	38	10	for	for	ADP
admet-1042	38	11	comparison	comparison	NOUN
admet-1042	38	12	.	.	PUNCT
admet-1042	39	1	plates	plate	NOUN
admet-1042	39	2	were	be	AUX
admet-1042	39	3	incubated	incubate	VERB
admet-1042	39	4	overnight	overnight	ADV
admet-1042	39	5	and	and	CCONJ
admet-1042	39	6	bacterial	bacterial	ADJ
admet-1042	39	7	growth	growth	NOUN
admet-1042	39	8	in	in	ADP
admet-1042	39	9	each	each	DET
admet-1042	39	10	well	well	ADV
admet-1042	39	11	were	be	AUX
admet-1042	39	12	measured	measure	VERB
admet-1042	39	13	with	with	ADP
admet-1042	39	14	epoch	epoch	PROPN
admet-1042	39	15	spectrophotometer	spectrophotometer	NOUN
admet-1042	39	16	(	(	PUNCT
admet-1042	39	17	biotek	biotek	PROPN
admet-1042	39	18	,	,	PUNCT
admet-1042	39	19	germany	germany	PROPN
admet-1042	39	20	)	)	PUNCT
admet-1042	39	21	at	at	ADP
admet-1042	39	22	600	600	NUM
admet-1042	39	23	nm	nm	NOUN
admet-1042	39	24	.	.	PUNCT
admet-1042	40	1	the	the	DET
admet-1042	40	2	preparation	preparation	NOUN
admet-1042	40	3	of	of	ADP
admet-1042	40	4	the	the	DET
admet-1042	40	5	microdilution	microdilution	NOUN
admet-1042	40	6	in	in	ADP
admet-1042	40	7	microwells	microwell	NOUN
admet-1042	40	8	with	with	ADP
admet-1042	40	9	single	single	ADJ
admet-1042	40	10	agent	agent	NOUN
admet-1042	40	11	concentrations	concentration	NOUN
admet-1042	40	12	of	of	ADP
admet-1042	40	13	the	the	DET
admet-1042	40	14	analgesic	analgesic	NOUN
admet-1042	40	15	to	to	PART
admet-1042	40	16	determine	determine	VERB
admet-1042	40	17	the	the	DET
admet-1042	40	18	minimum	minimum	ADJ
admet-1042	40	19	inhibitory	inhibitory	ADJ
admet-1042	40	20	concentration	concentration	NOUN
admet-1042	40	21	(	(	PUNCT
admet-1042	40	22	mic	mic	NOUN
admet-1042	40	23	)	)	PUNCT
admet-1042	40	24	,	,	PUNCT
admet-1042	40	25	control	control	NOUN
admet-1042	40	26	wells	well	NOUN
admet-1042	40	27	and	and	CCONJ
admet-1042	40	28	paired	pair	VERB
admet-1042	40	29	combinations	combination	NOUN
admet-1042	40	30	of	of	ADP
admet-1042	40	31	the	the	DET
admet-1042	40	32	analgesics	analgesic	NOUN
admet-1042	40	33	were	be	AUX
admet-1042	40	34	used	use	VERB
admet-1042	40	35	in	in	ADP
admet-1042	40	36	unique	unique	ADJ
admet-1042	40	37	concentrations	concentration	NOUN
admet-1042	40	38	to	to	PART
admet-1042	40	39	determine	determine	VERB
admet-1042	40	40	the	the	DET
admet-1042	40	41	fractional	fractional	ADJ
admet-1042	40	42	inhibitory	inhibitory	ADJ
admet-1042	40	43	concentration	concentration	NOUN
admet-1042	40	44	(	(	PUNCT
admet-1042	40	45	fic	fic	NOUN
admet-1042	40	46	)	)	PUNCT
admet-1042	40	47	.	.	PUNCT
admet-1042	41	1	the	the	DET
admet-1042	41	2	value	value	NOUN
admet-1042	41	3	of	of	ADP
admet-1042	41	4	the	the	DET
admet-1042	41	5	∑fic	∑fic	ADJ
admet-1042	41	6	index	index	NOUN
admet-1042	41	7	is	be	AUX
admet-1042	41	8	then	then	ADV
admet-1042	41	9	used	use	VERB
admet-1042	41	10	to	to	PART
admet-1042	41	11	determine	determine	VERB
admet-1042	41	12	whether	whether	SCONJ
admet-1042	41	13	synergism	synergism	NOUN
admet-1042	41	14	,	,	PUNCT
admet-1042	41	15	indifference	indifference	NOUN
admet-1042	41	16	or	or	CCONJ
admet-1042	41	17	antagonism	antagonism	NOUN
admet-1042	41	18	occurred	occur	VERB
admet-1042	41	19	between	between	ADP
admet-1042	41	20	the	the	DET
admet-1042	41	21	antimicrobial	antimicrobial	ADJ
admet-1042	41	22	agents	agent	NOUN
admet-1042	41	23	and	and	CCONJ
admet-1042	41	24	it	it	PRON
admet-1042	41	25	was	be	AUX
admet-1042	41	26	used	use	VERB
admet-1042	41	27	to	to	PART
admet-1042	41	28	interpret	interpret	VERB
admet-1042	41	29	the	the	DET
admet-1042	41	30	nature	nature	NOUN
admet-1042	41	31	of	of	ADP
admet-1042	41	32	the	the	DET
admet-1042	41	33	interactions	interaction	NOUN
admet-1042	41	34	:	:	PUNCT
admet-1042	41	35	synergism	synergism	NOUN
admet-1042	41	36	≤0.5	≤0.5	NOUN
admet-1042	41	37	,	,	PUNCT
admet-1042	41	38	indifference	indifference	NOUN
admet-1042	41	39	>	>	X
admet-1042	41	40	0.5	0.5	NUM
admet-1042	41	41	to	to	ADP
admet-1042	41	42	≤4	≤4	NOUN
admet-1042	41	43	,	,	PUNCT
admet-1042	41	44	antagonism	antagonism	NOUN
admet-1042	41	45	>	>	ADV
admet-1042	41	46	4	4	NUM
admet-1042	41	47	according	accord	VERB
admet-1042	41	48	to	to	ADP
admet-1042	41	49	american	american	ADJ
admet-1042	41	50	society	society	NOUN
admet-1042	41	51	of	of	ADP
admet-1042	41	52	microbiology	microbiology	NOUN
admet-1042	41	53	[	[	X
admet-1042	41	54	10	10	NUM
admet-1042	41	55	]	]	PUNCT
admet-1042	41	56	.	.	PUNCT
admet-1042	42	1	results	result	VERB
admet-1042	42	2	antimicrobial	antimicrobial	ADJ
admet-1042	42	3	activity	activity	NOUN
admet-1042	42	4	for	for	ADP
admet-1042	42	5	analgesics	analgesic	NOUN
admet-1042	42	6	antimicrobial	antimicrobial	ADJ
admet-1042	42	7	susceptibility	susceptibility	NOUN
admet-1042	42	8	results	result	NOUN
admet-1042	42	9	revealed	reveal	VERB
admet-1042	42	10	that	that	SCONJ
admet-1042	42	11	500	500	NUM
admet-1042	42	12	µg	µg	NOUN
admet-1042	42	13	/	/	SYM
admet-1042	42	14	ml	ml	NOUN
admet-1042	42	15	tramadol	tramadol	NOUN
admet-1042	42	16	hydrochloride	hydrochloride	NOUN
admet-1042	42	17	inhibited	inhibit	VERB
admet-1042	42	18	the	the	DET
admet-1042	42	19	growth	growth	NOUN
admet-1042	42	20	of	of	ADP
admet-1042	42	21	k.	k.	PROPN
admet-1042	42	22	pneumoniae	pneumoniae	ADJ
admet-1042	42	23	100	100	NUM
admet-1042	42	24	%	%	NOUN
admet-1042	42	25	.	.	PUNCT
admet-1042	43	1	also	also	ADV
admet-1042	43	2	,	,	PUNCT
admet-1042	43	3	inhibition	inhibition	NOUN
admet-1042	43	4	rates	rate	NOUN
admet-1042	43	5	for	for	ADP
admet-1042	43	6	p.	p.	PROPN
admet-1042	43	7	aeruginosa	aeruginosa	PROPN
admet-1042	43	8	,	,	PUNCT
admet-1042	43	9	s.	s.	PROPN
admet-1042	43	10	aureus	aureus	PROPN
admet-1042	43	11	,	,	PUNCT
admet-1042	43	12	e.	e.	PROPN
admet-1042	43	13	coli	coli	PROPN
admet-1042	43	14	,	,	PUNCT
admet-1042	43	15	and	and	CCONJ
admet-1042	43	16	c.	c.	NOUN
admet-1042	43	17	albicans	albican	NOUN
admet-1042	43	18	were	be	AUX
admet-1042	43	19	40	40	NUM
admet-1042	43	20	,	,	PUNCT
admet-1042	43	21	35	35	NUM
admet-1042	43	22	,	,	PUNCT
admet-1042	43	23	28.8	28.8	NUM
admet-1042	43	24	and	and	CCONJ
admet-1042	43	25	37.5	37.5	NUM
admet-1042	43	26	%	%	NOUN
admet-1042	43	27	,	,	PUNCT
admet-1042	43	28	respectively	respectively	ADV
admet-1042	43	29	.	.	PUNCT
admet-1042	44	1	moreover	moreover	ADV
admet-1042	44	2	,	,	PUNCT
admet-1042	44	3	the	the	DET
admet-1042	44	4	inhibitory	inhibitory	ADJ
admet-1042	44	5	effects	effect	NOUN
admet-1042	44	6	of	of	ADP
admet-1042	44	7	tramadol	tramadol	NOUN
admet-1042	44	8	hydrochloride	hydrochloride	NOUN
admet-1042	44	9	were	be	AUX
admet-1042	44	10	observed	observe	VERB
admet-1042	44	11	at	at	ADP
admet-1042	44	12	descending	descend	VERB
admet-1042	44	13	rates	rate	NOUN
admet-1042	44	14	until	until	ADP
admet-1042	44	15	the	the	DET
admet-1042	44	16	lowest	low	ADJ
admet-1042	44	17	concentration	concentration	NOUN
admet-1042	44	18	tested	test	VERB
admet-1042	44	19	which	which	PRON
admet-1042	44	20	was	be	AUX
admet-1042	44	21	31,25	31,25	NUM
admet-1042	44	22	µg	µg	NOUN
admet-1042	44	23	/	/	SYM
admet-1042	44	24	ml	ml	X
admet-1042	44	25	for	for	ADP
admet-1042	44	26	k.	k.	PROPN
admet-1042	44	27	pneumoniae	pneumoniae	PROPN
admet-1042	44	28	,	,	PUNCT
admet-1042	44	29	e.	e.	PROPN
admet-1042	44	30	coli	coli	PROPN
admet-1042	44	31	,	,	PUNCT
admet-1042	44	32	and	and	CCONJ
admet-1042	44	33	c.	c.	NOUN
admet-1042	44	34	albicans	albican	NOUN
admet-1042	44	35	.	.	PUNCT
admet-1042	45	1	in	in	ADP
admet-1042	45	2	addition	addition	NOUN
admet-1042	45	3	,	,	PUNCT
admet-1042	45	4	5	5	NUM
admet-1042	45	5	µg	µg	NOUN
admet-1042	45	6	/	/	SYM
admet-1042	45	7	ml	ml	NOUN
admet-1042	45	8	fentanyl	fentanyl	ADJ
admet-1042	45	9	citrate	citrate	NOUN
admet-1042	45	10	inhibited	inhibit	VERB
admet-1042	45	11	the	the	DET
admet-1042	45	12	growth	growth	NOUN
admet-1042	45	13	of	of	ADP
admet-1042	45	14	s.	s.	PROPN
admet-1042	45	15	aureus	aureus	PROPN
admet-1042	45	16	,	,	PUNCT
admet-1042	45	17	p.	p.	NOUN
admet-1042	45	18	aeruginosa	aeruginosa	PROPN
admet-1042	45	19	,	,	PUNCT
admet-1042	45	20	e.	e.	PROPN
admet-1042	45	21	coli	coli	PROPN
admet-1042	45	22	,	,	PUNCT
admet-1042	45	23	and	and	CCONJ
admet-1042	45	24	c.	c.	NOUN
admet-1042	45	25	albicans	albican	NOUN
admet-1042	45	26	at	at	ADP
admet-1042	45	27	the	the	DET
admet-1042	45	28	following	follow	VERB
admet-1042	45	29	rates	rate	NOUN
admet-1042	45	30	38	38	NUM
admet-1042	45	31	,	,	PUNCT
admet-1042	45	32	13.3	13.3	NUM
admet-1042	45	33	,	,	PUNCT
admet-1042	45	34	4.5	4.5	NUM
admet-1042	45	35	and	and	CCONJ
admet-1042	45	36	7.5	7.5	NUM
admet-1042	45	37	%	%	NOUN
admet-1042	45	38	,	,	PUNCT
admet-1042	45	39	respectively	respectively	ADV
admet-1042	45	40	.	.	PUNCT
admet-1042	46	1	also	also	ADV
admet-1042	46	2	,	,	PUNCT
admet-1042	46	3	fentanyl	fentanyl	ADJ
admet-1042	46	4	citrate	citrate	NOUN
admet-1042	46	5	did	do	AUX
admet-1042	46	6	not	not	PART
admet-1042	46	7	show	show	VERB
admet-1042	46	8	any	any	DET
admet-1042	46	9	inhibitory	inhibitory	ADJ
admet-1042	46	10	effect	effect	NOUN
admet-1042	46	11	on	on	ADP
admet-1042	46	12	the	the	DET
admet-1042	46	13	growth	growth	NOUN
admet-1042	46	14	of	of	ADP
admet-1042	46	15	k.	k.	PROPN
admet-1042	46	16	pneumoniae	pneumoniae	NOUN
admet-1042	46	17	at	at	ADP
admet-1042	46	18	maximum	maximum	ADJ
admet-1042	46	19	concentration	concentration	NOUN
admet-1042	46	20	tested	test	VERB
admet-1042	46	21	,	,	PUNCT
admet-1042	46	22	whereas	whereas	SCONJ
admet-1042	46	23	it	it	PRON
admet-1042	46	24	inhibited	inhibit	VERB
admet-1042	46	25	growth	growth	NOUN
admet-1042	46	26	9.5	9.5	NUM
admet-1042	46	27	%	%	NOUN
admet-1042	46	28	in	in	ADP
admet-1042	46	29	its	its	PRON
admet-1042	46	30	minimum	minimum	ADJ
admet-1042	46	31	concentration	concentration	NOUN
admet-1042	46	32	(	(	PUNCT
admet-1042	46	33	3,125	3,125	NUM
admet-1042	46	34	µg	µg	NOUN
admet-1042	46	35	/	/	SYM
admet-1042	46	36	ml	ml	NOUN
admet-1042	46	37	)	)	PUNCT
admet-1042	46	38	.	.	PUNCT
admet-1042	47	1	moreover	moreover	ADV
admet-1042	47	2	,	,	PUNCT
admet-1042	47	3	10	10	NUM
admet-1042	47	4	µg	µg	NOUN
admet-1042	47	5	/	/	SYM
admet-1042	47	6	ml	ml	X
admet-1042	47	7	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	47	8	had	have	VERB
admet-1042	47	9	an	an	DET
admet-1042	47	10	inhibitory	inhibitory	ADJ
admet-1042	47	11	effect	effect	NOUN
admet-1042	47	12	on	on	ADP
admet-1042	47	13	the	the	DET
admet-1042	47	14	growth	growth	NOUN
admet-1042	47	15	of	of	ADP
admet-1042	47	16	s.	s.	PROPN
admet-1042	47	17	aureus	aureus	PROPN
admet-1042	47	18	,	,	PUNCT
admet-1042	47	19	k.	k.	PROPN
admet-1042	48	1	pneumoniae	pneumoniae	NOUN
admet-1042	48	2	and	and	CCONJ
admet-1042	48	3	p.	p.	NOUN
admet-1042	48	4	aeruginosa	aeruginosa	NOUN
admet-1042	48	5	at	at	ADP
admet-1042	48	6	the	the	DET
admet-1042	48	7	rates	rate	NOUN
admet-1042	48	8	of	of	ADP
admet-1042	48	9	34	34	NUM
admet-1042	48	10	,	,	PUNCT
admet-1042	48	11	21	21	NUM
admet-1042	48	12	and	and	CCONJ
admet-1042	48	13	12.1	12.1	NUM
admet-1042	48	14	%	%	NOUN
admet-1042	48	15	,	,	PUNCT
admet-1042	48	16	respectively	respectively	ADV
admet-1042	48	17	.	.	PUNCT
admet-1042	49	1	also	also	ADV
admet-1042	49	2	,	,	PUNCT
admet-1042	49	3	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	49	4	did	do	AUX
admet-1042	49	5	not	not	PART
admet-1042	49	6	show	show	VERB
admet-1042	49	7	any	any	DET
admet-1042	49	8	inhibitory	inhibitory	ADJ
admet-1042	49	9	effect	effect	NOUN
admet-1042	49	10	on	on	ADP
admet-1042	49	11	the	the	DET
admet-1042	49	12	growth	growth	NOUN
admet-1042	49	13	of	of	ADP
admet-1042	49	14	e.coli	e.coli	NOUN
admet-1042	49	15	at	at	ADP
admet-1042	49	16	maximum	maximum	ADJ
admet-1042	49	17	concentration	concentration	NOUN
admet-1042	49	18	tested	test	VERB
admet-1042	49	19	,	,	PUNCT
admet-1042	49	20	whereas	whereas	SCONJ
admet-1042	49	21	it	it	PRON
admet-1042	49	22	inhibited	inhibit	VERB
admet-1042	49	23	growth	growth	NOUN
admet-1042	49	24	5	5	NUM
admet-1042	49	25	%	%	NOUN
admet-1042	49	26	in	in	ADP
admet-1042	49	27	its	its	PRON
admet-1042	49	28	minimum	minimum	ADJ
admet-1042	49	29	concentration	concentration	NOUN
admet-1042	49	30	.	.	PUNCT
admet-1042	50	1	moreover	moreover	ADV
admet-1042	50	2	,	,	PUNCT
admet-1042	50	3	it	it	PRON
admet-1042	50	4	has	have	AUX
admet-1042	50	5	been	be	AUX
admet-1042	50	6	observed	observe	VERB
admet-1042	50	7	that	that	SCONJ
admet-1042	50	8	the	the	DET
admet-1042	50	9	growth	growth	NOUN
admet-1042	50	10	of	of	ADP
admet-1042	50	11	c.	c.	NOUN
admet-1042	50	12	albicans	albican	NOUN
admet-1042	50	13	inhibited	inhibit	VERB
admet-1042	50	14	8.4	8.4	NUM
admet-1042	50	15	%	%	NOUN
admet-1042	50	16	at	at	ADP
admet-1042	50	17	the	the	DET
admet-1042	50	18	maximum	maximum	ADJ
admet-1042	50	19	concentration	concentration	NOUN
admet-1042	50	20	of	of	ADP
admet-1042	50	21	the	the	DET
admet-1042	50	22	analgesic	analgesic	ADJ
admet-1042	50	23	while	while	SCONJ
admet-1042	50	24	it	it	PRON
admet-1042	50	25	has	have	AUX
admet-1042	50	26	been	be	AUX
admet-1042	50	27	inhibited	inhibit	VERB
admet-1042	50	28	28	28	NUM
admet-1042	50	29	%	%	NOUN
admet-1042	50	30	at	at	ADP
admet-1042	50	31	the	the	DET
admet-1042	50	32	minimum	minimum	ADJ
admet-1042	50	33	concentration	concentration	NOUN
admet-1042	50	34	tested	test	VERB
admet-1042	50	35	.	.	PUNCT
admet-1042	51	1	all	all	DET
admet-1042	51	2	the	the	DET
admet-1042	51	3	results	result	NOUN
admet-1042	51	4	of	of	ADP
admet-1042	51	5	microdilution	microdilution	NOUN
admet-1042	51	6	assays	assay	NOUN
admet-1042	51	7	for	for	ADP
admet-1042	51	8	tramadol	tramadol	NOUN
admet-1042	51	9	hydrochloride	hydrochloride	NOUN
admet-1042	51	10	,	,	PUNCT
admet-1042	51	11	fentanyl	fentanyl	ADJ
admet-1042	51	12	citrate	citrate	NOUN
admet-1042	51	13	and	and	CCONJ
admet-1042	51	14	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	51	15	were	be	AUX
admet-1042	51	16	given	give	VERB
admet-1042	51	17	in	in	ADP
admet-1042	51	18	table	table	NOUN
admet-1042	51	19	1	1	NUM
admet-1042	51	20	,	,	PUNCT
admet-1042	51	21	table	table	NOUN
admet-1042	51	22	2	2	NUM
admet-1042	51	23	and	and	CCONJ
admet-1042	51	24	table	table	NOUN
admet-1042	51	25	3	3	NUM
admet-1042	51	26	,	,	PUNCT
admet-1042	51	27	respectively	respectively	ADV
admet-1042	51	28	.	.	PUNCT
admet-1042	51	29	table	table	NOUN
admet-1042	51	30	1	1	NUM
admet-1042	51	31	.	.	PUNCT
admet-1042	51	32	antimicrobial	antimicrobial	ADJ
admet-1042	51	33	effects	effect	NOUN
admet-1042	51	34	of	of	ADP
admet-1042	51	35	tramadol	tramadol	NOUN
admet-1042	51	36	hydrochloride	hydrochloride	NOUN
admet-1042	51	37	in	in	ADP
admet-1042	51	38	different	different	ADJ
admet-1042	51	39	concentrations	concentration	NOUN
admet-1042	51	40	against	against	ADP
admet-1042	51	41	to	to	ADP
admet-1042	51	42	tested	test	VERB
admet-1042	51	43	microorganisms	microorganism	NOUN
admet-1042	51	44	microorganisms	microorganism	NOUN
admet-1042	51	45	500	500	NUM
admet-1042	51	46	µg	µg	NOUN
admet-1042	51	47	/	/	SYM
admet-1042	51	48	ml	ml	PROPN
admet-1042	51	49	250	250	NUM
admet-1042	51	50	µg	µg	NOUN
admet-1042	51	51	/	/	SYM
admet-1042	51	52	ml	ml	NOUN
admet-1042	51	53	125	125	NUM
admet-1042	51	54	µg	µg	NOUN
admet-1042	51	55	/	/	SYM
admet-1042	51	56	ml	ml	PROPN
admet-1042	51	57	62.5	62.5	NUM
admet-1042	51	58	µg	µg	NOUN
admet-1042	51	59	/	/	SYM
admet-1042	51	60	ml	ml	PROPN
admet-1042	51	61	31.25	31.25	NUM
admet-1042	51	62	µg	µg	NOUN
admet-1042	51	63	/	/	SYM
admet-1042	51	64	ml	ml	NOUN
admet-1042	51	65	k.	k.	NOUN
admet-1042	51	66	pneumoniae	pneumoniae	ADJ
admet-1042	51	67	100.00	100.00	NUM
admet-1042	51	68	%	%	NOUN
admet-1042	51	69	80.02	80.02	NUM
admet-1042	51	70	%	%	NOUN
admet-1042	51	71	58.41	58.41	NUM
admet-1042	51	72	%	%	NOUN
admet-1042	51	73	58.06	58.06	NUM
admet-1042	51	74	%	%	NOUN
admet-1042	51	75	60.63	60.63	NUM
admet-1042	51	76	%	%	NOUN
admet-1042	51	77	p.	p.	NOUN
admet-1042	51	78	aeruginosa	aeruginosa	NOUN
admet-1042	52	1	40.03	40.03	NUM
admet-1042	52	2	%	%	NOUN
admet-1042	52	3	0.00	0.00	NUM
admet-1042	52	4	%	%	NOUN
admet-1042	52	5	0.00	0.00	NUM
admet-1042	52	6	%	%	NOUN
admet-1042	52	7	0.00	0.00	NUM
admet-1042	52	8	%	%	NOUN
admet-1042	52	9	0.00	0.00	NUM
admet-1042	52	10	%	%	NOUN
admet-1042	52	11	e.	e.	PROPN
admet-1042	52	12	coli	coli	PROPN
admet-1042	52	13	28.74	28.74	NUM
admet-1042	52	14	%	%	NOUN
admet-1042	52	15	28.74	28.74	NUM
admet-1042	52	16	%	%	NOUN
admet-1042	52	17	20.49	20.49	NUM
admet-1042	52	18	%	%	NOUN
admet-1042	52	19	7.77	7.77	NUM
admet-1042	52	20	%	%	NOUN
admet-1042	52	21	3.89	3.89	NUM
admet-1042	52	22	%	%	NOUN
admet-1042	52	23	s.	s.	PROPN
admet-1042	52	24	aureus	aureus	PROPN
admet-1042	52	25	34.62	34.62	NUM
admet-1042	52	26	%	%	NOUN
admet-1042	52	27	33.46	33.46	NUM
admet-1042	52	28	%	%	NOUN
admet-1042	52	29	26.25	26.25	NUM
admet-1042	52	30	%	%	NOUN
admet-1042	52	31	7.21	7.21	NUM
admet-1042	52	32	%	%	NOUN
admet-1042	52	33	0.00	0.00	NUM
admet-1042	52	34	%	%	NOUN
admet-1042	52	35	c.	c.	NOUN
admet-1042	52	36	albicans	albican	VERB
admet-1042	52	37	35.55	35.55	NUM
admet-1042	52	38	%	%	NOUN
admet-1042	52	39	26.39	26.39	NUM
admet-1042	52	40	%	%	NOUN
admet-1042	52	41	27.47	27.47	NUM
admet-1042	52	42	%	%	NOUN
admet-1042	52	43	27.11	27.11	NUM
admet-1042	52	44	%	%	NOUN
admet-1042	52	45	27.65	27.65	NUM
admet-1042	52	46	%	%	NOUN
admet-1042	53	1	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	NOUN
admet-1042	53	2	sevgi	sevgi	PROPN
admet-1042	53	3	kesici	kesici	PROPN
admet-1042	53	4	et	et	PROPN
admet-1042	53	5	al	al	PROPN
admet-1042	53	6	.	.	PROPN
admet-1042	53	7	admet	admet	PROPN
admet-1042	53	8	&	&	CCONJ
admet-1042	53	9	dmpk	dmpk	PROPN
admet-1042	53	10	9(3	9(3	NUM
admet-1042	53	11	)	)	PUNCT
admet-1042	53	12	(	(	PUNCT
admet-1042	53	13	2021	2021	NUM
admet-1042	53	14	)	)	PUNCT
admet-1042	53	15	219	219	NUM
admet-1042	53	16	-	-	SYM
admet-1042	53	17	226	226	NUM
admet-1042	53	18	222	222	NUM
admet-1042	53	19	table	table	NOUN
admet-1042	53	20	2	2	NUM
admet-1042	53	21	.	.	PUNCT
admet-1042	53	22	antimicrobial	antimicrobial	ADJ
admet-1042	53	23	effects	effect	NOUN
admet-1042	53	24	of	of	ADP
admet-1042	53	25	fentanyl	fentanyl	ADJ
admet-1042	53	26	citrate	citrate	NOUN
admet-1042	53	27	in	in	ADP
admet-1042	53	28	different	different	ADJ
admet-1042	53	29	concentrations	concentration	NOUN
admet-1042	53	30	against	against	ADP
admet-1042	53	31	to	to	ADP
admet-1042	53	32	tested	test	VERB
admet-1042	53	33	microorganisms	microorganism	NOUN
admet-1042	53	34	microorganisms	microorganism	NOUN
admet-1042	53	35	5	5	NUM
admet-1042	53	36	µg	µg	NOUN
admet-1042	53	37	/	/	SYM
admet-1042	53	38	ml	ml	PROPN
admet-1042	53	39	2.5	2.5	NUM
admet-1042	53	40	µg	µg	NOUN
admet-1042	53	41	/	/	SYM
admet-1042	53	42	ml	ml	PROPN
admet-1042	53	43	1.25	1.25	NUM
admet-1042	53	44	µg	µg	NOUN
admet-1042	53	45	/	/	SYM
admet-1042	53	46	ml	ml	ADP
admet-1042	53	47	0.625	0.625	NUM
admet-1042	53	48	µg	µg	NOUN
admet-1042	53	49	/	/	SYM
admet-1042	53	50	ml	ml	NOUN
admet-1042	53	51	0.3125	0.3125	NUM
admet-1042	53	52	µg	µg	NOUN
admet-1042	53	53	/	/	SYM
admet-1042	53	54	ml	ml	NOUN
admet-1042	53	55	k.	k.	NOUN
admet-1042	53	56	pneumoniae	pneumoniae	ADJ
admet-1042	53	57	0.00	0.00	NUM
admet-1042	53	58	%	%	NOUN
admet-1042	53	59	4.09	4.09	NUM
admet-1042	53	60	%	%	NOUN
admet-1042	53	61	6.78	6.78	NUM
admet-1042	53	62	%	%	NOUN
admet-1042	53	63	6.89	6.89	NUM
admet-1042	53	64	%	%	NOUN
admet-1042	53	65	9.58	9.58	NUM
admet-1042	53	66	%	%	NOUN
admet-1042	53	67	p.	p.	NOUN
admet-1042	53	68	aeruginosa	aeruginosa	NOUN
admet-1042	54	1	13.34	13.34	NUM
admet-1042	54	2	%	%	NOUN
admet-1042	54	3	8.67	8.67	NUM
admet-1042	54	4	%	%	NOUN
admet-1042	54	5	4.85	4.85	NUM
admet-1042	54	6	%	%	NOUN
admet-1042	54	7	1.04	1.04	NUM
admet-1042	54	8	%	%	NOUN
admet-1042	54	9	0.69	0.69	NUM
admet-1042	54	10	%	%	NOUN
admet-1042	54	11	e.	e.	PROPN
admet-1042	54	12	coli	coli	PROPN
admet-1042	54	13	4.59	4.59	NUM
admet-1042	54	14	%	%	NOUN
admet-1042	54	15	6.60	6.60	NUM
admet-1042	54	16	%	%	NOUN
admet-1042	54	17	6.95	6.95	NUM
admet-1042	54	18	%	%	NOUN
admet-1042	54	19	6.48	6.48	NUM
admet-1042	54	20	%	%	NOUN
admet-1042	54	21	7.77	7.77	NUM
admet-1042	54	22	%	%	NOUN
admet-1042	54	23	s.	s.	PROPN
admet-1042	54	24	aureus	aureus	PROPN
admet-1042	54	25	38.22	38.22	NUM
admet-1042	54	26	%	%	NOUN
admet-1042	54	27	39.64	39.64	NUM
admet-1042	54	28	%	%	NOUN
admet-1042	54	29	34.75	34.75	NUM
admet-1042	54	30	%	%	NOUN
admet-1042	54	31	21.24	21.24	NUM
admet-1042	54	32	%	%	NOUN
admet-1042	54	33	1.93	1.93	NUM
admet-1042	54	34	%	%	NOUN
admet-1042	54	35	c.	c.	NOUN
admet-1042	54	36	albicans	albican	VERB
admet-1042	54	37	7.54	7.54	NUM
admet-1042	54	38	%	%	NOUN
admet-1042	54	39	26.57	26.57	NUM
admet-1042	54	40	%	%	NOUN
admet-1042	54	41	36.45	36.45	NUM
admet-1042	54	42	%	%	NOUN
admet-1042	54	43	38.24	38.24	NUM
admet-1042	54	44	%	%	NOUN
admet-1042	54	45	30.70	30.70	NUM
admet-1042	54	46	%	%	NOUN
admet-1042	54	47	table	table	NOUN
admet-1042	54	48	3	3	NUM
admet-1042	54	49	.	.	PUNCT
admet-1042	54	50	antimicrobial	antimicrobial	ADJ
admet-1042	54	51	effects	effect	NOUN
admet-1042	54	52	of	of	ADP
admet-1042	54	53	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	54	54	in	in	ADP
admet-1042	54	55	different	different	ADJ
admet-1042	54	56	concentrations	concentration	NOUN
admet-1042	54	57	against	against	ADP
admet-1042	54	58	to	to	ADP
admet-1042	54	59	tested	test	VERB
admet-1042	54	60	microorganisms	microorganism	NOUN
admet-1042	54	61	microorganisms	microorganism	NOUN
admet-1042	54	62	10	10	NUM
admet-1042	54	63	µg	µg	NOUN
admet-1042	54	64	/	/	SYM
admet-1042	54	65	ml	ml	NOUN
admet-1042	54	66	5	5	NUM
admet-1042	54	67	µg	µg	NOUN
admet-1042	54	68	/	/	SYM
admet-1042	54	69	ml	ml	PROPN
admet-1042	54	70	2.5	2.5	NUM
admet-1042	54	71	µg	µg	NOUN
admet-1042	54	72	/	/	SYM
admet-1042	54	73	ml	ml	PROPN
admet-1042	54	74	1.25	1.25	NUM
admet-1042	54	75	µg	µg	NOUN
admet-1042	54	76	/	/	SYM
admet-1042	54	77	ml	ml	ADP
admet-1042	54	78	0.625	0.625	NUM
admet-1042	54	79	µg	µg	NOUN
admet-1042	54	80	/	/	SYM
admet-1042	54	81	ml	ml	NOUN
admet-1042	54	82	k.	k.	NOUN
admet-1042	54	83	pneumoniae	pneumoniae	ADJ
admet-1042	54	84	21.14	21.14	NUM
admet-1042	54	85	%	%	NOUN
admet-1042	54	86	8.53	8.53	NUM
admet-1042	54	87	%	%	NOUN
admet-1042	54	88	3.04	3.04	NUM
admet-1042	54	89	%	%	NOUN
admet-1042	54	90	0.00	0.00	NUM
admet-1042	54	91	%	%	NOUN
admet-1042	54	92	0.00	0.00	NUM
admet-1042	54	93	%	%	NOUN
admet-1042	54	94	p.	p.	NOUN
admet-1042	54	95	aeruginosa	aeruginosa	NOUN
admet-1042	54	96	12.13	12.13	NUM
admet-1042	54	97	%	%	NOUN
admet-1042	54	98	13.00	13.00	NUM
admet-1042	54	99	%	%	NOUN
admet-1042	54	100	12.11	12.11	NUM
admet-1042	54	101	%	%	NOUN
admet-1042	54	102	5.37	5.37	NUM
admet-1042	54	103	%	%	NOUN
admet-1042	54	104	0.69	0.69	NUM
admet-1042	54	105	%	%	NOUN
admet-1042	54	106	e.	e.	PROPN
admet-1042	54	107	coli	coli	PROPN
admet-1042	54	108	0.00	0.00	NUM
admet-1042	54	109	%	%	NOUN
admet-1042	54	110	6.83	6.83	NUM
admet-1042	54	111	%	%	NOUN
admet-1042	54	112	6.12	6.12	NUM
admet-1042	54	113	%	%	NOUN
admet-1042	54	114	3.42	3.42	NUM
admet-1042	54	115	%	%	NOUN
admet-1042	54	116	4.83	4.83	NUM
admet-1042	54	117	%	%	NOUN
admet-1042	54	118	s.	s.	PROPN
admet-1042	54	119	aureus	aureus	PROPN
admet-1042	54	120	33.98	33.98	NUM
admet-1042	54	121	%	%	NOUN
admet-1042	54	122	26.00	26.00	NUM
admet-1042	54	123	%	%	NOUN
admet-1042	54	124	33.20	33.20	NUM
admet-1042	54	125	%	%	NOUN
admet-1042	54	126	20.21	20.21	NUM
admet-1042	54	127	%	%	NOUN
admet-1042	54	128	6.31	6.31	NUM
admet-1042	54	129	%	%	NOUN
admet-1042	54	130	c.	c.	NOUN
admet-1042	54	131	albicans	albican	VERB
admet-1042	54	132	8.44	8.44	NUM
admet-1042	54	133	%	%	NOUN
admet-1042	54	134	28.73	28.73	NUM
admet-1042	54	135	%	%	NOUN
admet-1042	54	136	33.75	33.75	NUM
admet-1042	54	137	%	%	NOUN
admet-1042	54	138	24.78	24.78	NUM
admet-1042	54	139	%	%	NOUN
admet-1042	54	140	20.83	20.83	NUM
admet-1042	54	141	%	%	NOUN
admet-1042	54	142	according	accord	VERB
admet-1042	54	143	to	to	ADP
admet-1042	54	144	microdilution	microdilution	NOUN
admet-1042	54	145	results	result	NOUN
admet-1042	54	146	,	,	PUNCT
admet-1042	54	147	tramadol	tramadol	NOUN
admet-1042	54	148	hydrochloride	hydrochloride	NOUN
admet-1042	54	149	had	have	VERB
admet-1042	54	150	the	the	DET
admet-1042	54	151	most	most	ADV
admet-1042	54	152	powerful	powerful	ADJ
admet-1042	54	153	effect	effect	NOUN
admet-1042	54	154	against	against	ADP
admet-1042	54	155	bacterial	bacterial	ADJ
admet-1042	54	156	growth	growth	NOUN
admet-1042	54	157	.	.	PUNCT
admet-1042	55	1	moreover	moreover	ADV
admet-1042	55	2	,	,	PUNCT
admet-1042	55	3	antimicrobial	antimicrobial	ADJ
admet-1042	55	4	susceptibility	susceptibility	NOUN
admet-1042	55	5	results	result	NOUN
admet-1042	55	6	suggest	suggest	VERB
admet-1042	55	7	that	that	SCONJ
admet-1042	55	8	antimicrobial	antimicrobial	ADJ
admet-1042	55	9	effect	effect	NOUN
admet-1042	55	10	of	of	ADP
admet-1042	55	11	analgesics	analgesic	NOUN
admet-1042	55	12	vary	vary	VERB
admet-1042	55	13	according	accord	VERB
admet-1042	55	14	to	to	ADP
admet-1042	55	15	the	the	DET
admet-1042	55	16	type	type	NOUN
admet-1042	55	17	of	of	ADP
admet-1042	55	18	the	the	DET
admet-1042	55	19	analgesic	analgesic	ADJ
admet-1042	55	20	,	,	PUNCT
admet-1042	55	21	pathogen	pathogen	NOUN
admet-1042	55	22	and	and	CCONJ
admet-1042	55	23	the	the	DET
admet-1042	55	24	concentration	concentration	NOUN
admet-1042	55	25	of	of	ADP
admet-1042	55	26	the	the	DET
admet-1042	55	27	material	material	NOUN
admet-1042	55	28	.	.	PUNCT
admet-1042	56	1	also	also	ADV
admet-1042	56	2	,	,	PUNCT
admet-1042	56	3	higher	high	ADJ
admet-1042	56	4	concentration	concentration	NOUN
admet-1042	56	5	does	do	AUX
admet-1042	56	6	not	not	PART
admet-1042	56	7	always	always	ADV
admet-1042	56	8	result	result	VERB
admet-1042	56	9	higher	high	ADJ
admet-1042	56	10	antimicrobial	antimicrobial	ADJ
admet-1042	56	11	effect	effect	NOUN
admet-1042	56	12	.	.	PUNCT
admet-1042	57	1	interaction	interaction	NOUN
admet-1042	57	2	between	between	ADP
admet-1042	57	3	analgesic	analgesic	ADJ
admet-1042	57	4	combinations	combination	NOUN
admet-1042	57	5	∑fic	∑fic	NOUN
admet-1042	57	6	index	index	NOUN
admet-1042	57	7	for	for	ADP
admet-1042	57	8	tramadol	tramadol	NOUN
admet-1042	57	9	hydrochloride	hydrochloride	NOUN
admet-1042	57	10	,	,	PUNCT
admet-1042	57	11	fentanyl	fentanyl	ADJ
admet-1042	57	12	citrate	citrate	NOUN
admet-1042	57	13	and	and	CCONJ
admet-1042	57	14	dexmedetomidine	dexmedetomidine	ADJ
admet-1042	57	15	hydrochloride	hydrochloride	NOUN
admet-1042	57	16	combinations	combination	NOUN
admet-1042	57	17	against	against	ADP
admet-1042	57	18	standard	standard	ADJ
admet-1042	57	19	strains	strain	NOUN
admet-1042	57	20	were	be	AUX
admet-1042	57	21	shown	show	VERB
admet-1042	57	22	in	in	ADP
admet-1042	57	23	table	table	NOUN
admet-1042	57	24	4	4	NUM
admet-1042	57	25	.	.	PUNCT
admet-1042	57	26	table	table	NOUN
admet-1042	57	27	4	4	NUM
admet-1042	57	28	.	.	PUNCT
admet-1042	57	29	∑fic	∑fic	ADJ
admet-1042	57	30	index	index	NOUN
admet-1042	57	31	for	for	ADP
admet-1042	57	32	tramadol	tramadol	NOUN
admet-1042	57	33	hydrochloride	hydrochloride	NOUN
admet-1042	57	34	,	,	PUNCT
admet-1042	57	35	fentanyl	fentanyl	ADJ
admet-1042	57	36	citrate	citrate	NOUN
admet-1042	57	37	and	and	CCONJ
admet-1042	57	38	dexmedetomidine	dexmedetomidine	ADJ
admet-1042	57	39	hydrochloride	hydrochloride	NOUN
admet-1042	57	40	combinations	combination	NOUN
admet-1042	57	41	against	against	ADP
admet-1042	57	42	standard	standard	ADJ
admet-1042	57	43	strains	strain	NOUN
admet-1042	57	44	.	.	PUNCT
admet-1042	57	45	∑fic	∑fic	PUNCT
admet-1042	58	1	th+fc	th+fc	X
admet-1042	59	1	th+dh	th+dh	VERB
admet-1042	59	2	fc	fc	PROPN
admet-1042	60	1	+	+	CCONJ
admet-1042	60	2	dh	dh	PROPN
admet-1042	60	3	th+fc+dh	th+fc+dh	PROPN
admet-1042	60	4	c.	c.	PROPN
admet-1042	60	5	albicans	albican	VERB
admet-1042	60	6	1.17	1.17	NUM
admet-1042	60	7	0.58	0.58	NUM
admet-1042	60	8	1.53	1.53	NUM
admet-1042	60	9	0.45	0.45	NUM
admet-1042	60	10	e.	e.	PROPN
admet-1042	60	11	coli	coli	PROPN
admet-1042	60	12	1.46	1.46	NUM
admet-1042	60	13	0.64	0.64	NUM
admet-1042	60	14	0.23	0.23	NUM
admet-1042	60	15	0.29	0.29	NUM
admet-1042	60	16	s.	s.	PROPN
admet-1042	60	17	aureus	aureus	PROPN
admet-1042	60	18	1.17	1.17	NUM
admet-1042	60	19	0.90	0.90	NUM
admet-1042	60	20	1.34	1.34	NUM
admet-1042	60	21	0.89	0.89	NUM
admet-1042	60	22	k.	k.	NOUN
admet-1042	61	1	pneumoniae	pneumoniae	VERB
admet-1042	61	2	0.72	0.72	NUM
admet-1042	61	3	0.90	0.90	NUM
admet-1042	61	4	3.23	3.23	NUM
admet-1042	61	5	0.53	0.53	NUM
admet-1042	61	6	p.	p.	NOUN
admet-1042	61	7	aeruginosa	aeruginosa	NOUN
admet-1042	61	8	1.69	1.69	NUM
admet-1042	61	9	1.60	1.60	NUM
admet-1042	61	10	0.43	0.43	NUM
admet-1042	61	11	0.74	0.74	NUM
admet-1042	61	12	*	*	PUNCT
admet-1042	61	13	tramadol	tramadol	NOUN
admet-1042	61	14	hydrochloride	hydrochloride	NOUN
admet-1042	61	15	(	(	PUNCT
admet-1042	61	16	th	th	NOUN
admet-1042	61	17	)	)	PUNCT
admet-1042	61	18	,	,	PUNCT
admet-1042	61	19	fentanyl	fentanyl	ADJ
admet-1042	61	20	citrate	citrate	NOUN
admet-1042	61	21	(	(	PUNCT
admet-1042	61	22	fc	fc	X
admet-1042	61	23	)	)	PUNCT
admet-1042	61	24	and	and	CCONJ
admet-1042	61	25	dexmedetomidine	dexmedetomidine	ADJ
admet-1042	61	26	hydrochloride	hydrochloride	NOUN
admet-1042	61	27	(	(	PUNCT
admet-1042	61	28	dh	dh	NOUN
admet-1042	61	29	)	)	PUNCT
admet-1042	61	30	when	when	SCONJ
admet-1042	61	31	the	the	DET
admet-1042	61	32	interactions	interaction	NOUN
admet-1042	61	33	between	between	ADP
admet-1042	61	34	analgesic	analgesic	ADJ
admet-1042	61	35	materials	material	NOUN
admet-1042	61	36	were	be	AUX
admet-1042	61	37	analyzed	analyze	VERB
admet-1042	61	38	,	,	PUNCT
admet-1042	61	39	it	it	PRON
admet-1042	61	40	was	be	AUX
admet-1042	61	41	found	find	VERB
admet-1042	62	1	that	that	SCONJ
admet-1042	62	2	fc	fc	PROPN
admet-1042	62	3	+	+	CCONJ
admet-1042	62	4	dh	dh	NOUN
admet-1042	62	5	combination	combination	NOUN
admet-1042	62	6	had	have	VERB
admet-1042	62	7	a	a	DET
admet-1042	62	8	synergistic	synergistic	ADJ
admet-1042	62	9	antimicrobial	antimicrobial	ADJ
admet-1042	62	10	effect	effect	NOUN
admet-1042	62	11	on	on	ADP
admet-1042	62	12	the	the	DET
admet-1042	62	13	growth	growth	NOUN
admet-1042	62	14	of	of	ADP
admet-1042	62	15	e.	e.	PROPN
admet-1042	62	16	coli	coli	PROPN
admet-1042	62	17	and	and	CCONJ
admet-1042	62	18	p.	p.	NOUN
admet-1042	62	19	aeruginosa	aeruginosa	PROPN
admet-1042	62	20	standard	standard	PROPN
admet-1042	62	21	strains	strain	VERB
admet-1042	62	22	.	.	PUNCT
admet-1042	63	1	moreover	moreover	ADV
admet-1042	63	2	,	,	PUNCT
admet-1042	63	3	it	it	PRON
admet-1042	63	4	has	have	AUX
admet-1042	63	5	been	be	AUX
admet-1042	63	6	observed	observe	VERB
admet-1042	63	7	that	that	SCONJ
admet-1042	63	8	th	th	X
admet-1042	64	1	+	+	X
admet-1042	64	2	fc	fc	PROPN
admet-1042	65	1	+	+	CCONJ
admet-1042	65	2	dh	dh	NOUN
admet-1042	65	3	combination	combination	NOUN
admet-1042	65	4	had	have	VERB
admet-1042	65	5	a	a	DET
admet-1042	65	6	synergistic	synergistic	ADJ
admet-1042	65	7	antimicrobial	antimicrobial	ADJ
admet-1042	65	8	effect	effect	NOUN
admet-1042	65	9	on	on	ADP
admet-1042	65	10	e.	e.	PROPN
admet-1042	65	11	coli	coli	PROPN
admet-1042	65	12	and	and	CCONJ
admet-1042	65	13	c.	c.	NOUN
admet-1042	65	14	albicans	albican	NOUN
admet-1042	65	15	standard	standard	ADJ
admet-1042	65	16	strains	strain	NOUN
admet-1042	65	17	.	.	PUNCT
admet-1042	66	1	discussion	discussion	NOUN
admet-1042	66	2	in	in	ADP
admet-1042	66	3	this	this	DET
admet-1042	66	4	study	study	NOUN
admet-1042	66	5	,	,	PUNCT
admet-1042	66	6	we	we	PRON
admet-1042	66	7	have	have	AUX
admet-1042	66	8	observed	observe	VERB
admet-1042	66	9	that	that	SCONJ
admet-1042	66	10	10	10	NUM
admet-1042	66	11	g	g	NOUN
admet-1042	66	12	/	/	SYM
admet-1042	66	13	ml	ml	ADP
admet-1042	66	14	concentrated	concentrate	VERB
admet-1042	66	15	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	66	16	has	have	VERB
admet-1042	66	17	antimicrobial	antimicrobial	ADJ
admet-1042	66	18	effects	effect	NOUN
admet-1042	66	19	on	on	ADP
admet-1042	66	20	s.aureus	s.aureus	NOUN
admet-1042	66	21	,	,	PUNCT
admet-1042	66	22	k.	k.	PROPN
admet-1042	67	1	pneumoniae	pneumoniae	NOUN
admet-1042	67	2	and	and	CCONJ
admet-1042	67	3	p.	p.	NOUN
admet-1042	67	4	aeruginosa	aeruginosa	PROPN
admet-1042	67	5	.	.	PUNCT
admet-1042	68	1	these	these	DET
admet-1042	68	2	findings	finding	NOUN
admet-1042	68	3	were	be	AUX
admet-1042	68	4	slightly	slightly	ADV
admet-1042	68	5	different	different	ADJ
admet-1042	68	6	from	from	ADP
admet-1042	68	7	a	a	DET
admet-1042	68	8	previous	previous	ADJ
admet-1042	68	9	study	study	NOUN
admet-1042	68	10	in	in	ADP
admet-1042	68	11	which	which	PRON
admet-1042	68	12	researchers	researcher	NOUN
admet-1042	68	13	have	have	AUX
admet-1042	68	14	established	establish	VERB
admet-1042	68	15	the	the	DET
admet-1042	68	16	same	same	ADJ
admet-1042	68	17	activity	activity	NOUN
admet-1042	68	18	with	with	ADP
admet-1042	68	19	higher	high	ADJ
admet-1042	68	20	(	(	PUNCT
admet-1042	68	21	32	32	NUM
admet-1042	68	22	g	g	NOUN
admet-1042	68	23	/	/	SYM
admet-1042	68	24	ml	ml	NOUN
admet-1042	68	25	)	)	PUNCT
admet-1042	68	26	concentrations	concentration	NOUN
admet-1042	68	27	[	[	X
admet-1042	68	28	10	10	NUM
admet-1042	68	29	]	]	PUNCT
admet-1042	68	30	.	.	PUNCT
admet-1042	69	1	even	even	ADV
admet-1042	69	2	though	though	SCONJ
admet-1042	69	3	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	69	4	is	be	AUX
admet-1042	69	5	a	a	DET
admet-1042	69	6	more	more	ADV
admet-1042	69	7	preferred	preferred	ADJ
admet-1042	69	8	sedative	sedative	ADJ
admet-1042	69	9	drug	drug	NOUN
admet-1042	69	10	than	than	ADP
admet-1042	69	11	midazolam	midazolam	PROPN
admet-1042	69	12	recently	recently	ADV
admet-1042	69	13	;	;	PUNCT
admet-1042	69	14	antimicrobial	antimicrobial	ADJ
admet-1042	69	15	effects	effect	NOUN
admet-1042	69	16	were	be	AUX
admet-1042	69	17	not	not	PART
admet-1042	69	18	described	describe	VERB
admet-1042	69	19	as	as	ADV
admet-1042	69	20	well	well	ADV
admet-1042	69	21	as	as	SCONJ
admet-1042	69	22	it	it	PRON
admet-1042	69	23	has	have	AUX
admet-1042	69	24	been	be	AUX
admet-1042	69	25	studied	study	VERB
admet-1042	69	26	for	for	ADP
admet-1042	69	27	midazolam	midazolam	PROPN
admet-1042	69	28	.	.	PUNCT
admet-1042	70	1	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	70	2	seems	seem	VERB
admet-1042	70	3	to	to	PART
admet-1042	70	4	inhibit	inhibit	VERB
admet-1042	70	5	bacterial	bacterial	ADJ
admet-1042	70	6	growth	growth	NOUN
admet-1042	70	7	when	when	SCONJ
admet-1042	70	8	prepared	prepare	VERB
admet-1042	70	9	in	in	ADP
admet-1042	70	10	correct	correct	ADJ
admet-1042	70	11	concentrations	concentration	NOUN
admet-1042	70	12	.	.	PUNCT
admet-1042	71	1	commonly	commonly	ADV
admet-1042	71	2	used	use	VERB
admet-1042	71	3	infusions	infusion	NOUN
admet-1042	71	4	are	be	AUX
admet-1042	71	5	prepared	prepare	VERB
admet-1042	71	6	at	at	ADP
admet-1042	71	7	a	a	DET
admet-1042	71	8	concentration	concentration	NOUN
admet-1042	71	9	of	of	ADP
admet-1042	71	10	4	4	NUM
admet-1042	71	11	g	g	NOUN
admet-1042	71	12	/	/	SYM
admet-1042	71	13	ml	ml	NOUN
admet-1042	71	14	and	and	CCONJ
admet-1042	71	15	according	accord	VERB
admet-1042	71	16	to	to	ADP
admet-1042	71	17	our	our	PRON
admet-1042	71	18	results	result	NOUN
admet-1042	71	19	,	,	PUNCT
admet-1042	71	20	10	10	NUM
admet-1042	71	21	g	g	NOUN
admet-1042	71	22	/	/	SYM
admet-1042	71	23	ml	ml	NOUN
admet-1042	71	24	infusion	infusion	NOUN
admet-1042	71	25	fluids	fluid	NOUN
admet-1042	71	26	might	might	AUX
admet-1042	71	27	be	be	AUX
admet-1042	71	28	sufficient	sufficient	ADJ
admet-1042	71	29	enough	enough	ADJ
admet-1042	71	30	admet	admet	PROPN
admet-1042	71	31	&	&	CCONJ
admet-1042	71	32	dmpk	dmpk	PROPN
admet-1042	71	33	9(3	9(3	NUM
admet-1042	71	34	)	)	PUNCT
admet-1042	71	35	(	(	PUNCT
admet-1042	71	36	2021	2021	NUM
admet-1042	71	37	)	)	PUNCT
admet-1042	71	38	219	219	NUM
admet-1042	71	39	-	-	SYM
admet-1042	71	40	226	226	NUM
admet-1042	71	41	are	be	AUX
admet-1042	71	42	we	we	PRON
admet-1042	71	43	ready	ready	ADJ
admet-1042	71	44	to	to	PART
admet-1042	71	45	design	design	VERB
admet-1042	71	46	oral	oral	ADJ
admet-1042	71	47	protacs	protacs	PROPN
admet-1042	71	48	®	®	NOUN
admet-1042	71	49	?	?	PUNCT
admet-1042	72	1	doi	doi	PROPN
admet-1042	72	2	:	:	PUNCT
admet-1042	72	3	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	NOUN
admet-1042	72	4	223	223	NUM
admet-1042	72	5	to	to	PART
admet-1042	72	6	prevent	prevent	VERB
admet-1042	72	7	bacterial	bacterial	ADJ
admet-1042	72	8	colonization	colonization	NOUN
admet-1042	72	9	.	.	PUNCT
admet-1042	73	1	one	one	PRON
admet-1042	73	2	should	should	AUX
admet-1042	73	3	declare	declare	VERB
admet-1042	73	4	that	that	SCONJ
admet-1042	73	5	keles	kele	NOUN
admet-1042	73	6	et	et	PROPN
admet-1042	73	7	al	al	PROPN
admet-1042	73	8	.	.	PUNCT
admet-1042	74	1	[	[	X
admet-1042	74	2	9	9	NUM
admet-1042	74	3	]	]	PUNCT
admet-1042	74	4	have	have	AUX
admet-1042	74	5	not	not	PART
admet-1042	74	6	found	find	VERB
admet-1042	74	7	any	any	DET
admet-1042	74	8	antimicrobial	antimicrobial	ADJ
admet-1042	74	9	effect	effect	NOUN
admet-1042	74	10	of	of	ADP
admet-1042	74	11	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	74	12	.	.	PUNCT
admet-1042	75	1	however	however	ADV
admet-1042	75	2	,	,	PUNCT
admet-1042	75	3	this	this	DET
admet-1042	75	4	difference	difference	NOUN
admet-1042	75	5	may	may	AUX
admet-1042	75	6	be	be	AUX
admet-1042	75	7	caused	cause	VERB
admet-1042	75	8	by	by	ADP
admet-1042	75	9	the	the	DET
admet-1042	75	10	chosen	choose	VERB
admet-1042	75	11	microbiological	microbiological	ADJ
admet-1042	75	12	assays	assay	NOUN
admet-1042	75	13	.	.	PUNCT
admet-1042	76	1	we	we	PRON
admet-1042	76	2	have	have	AUX
admet-1042	76	3	performed	perform	VERB
admet-1042	76	4	spectrophotometry	spectrophotometry	NOUN
admet-1042	76	5	after	after	ADP
admet-1042	76	6	microdilution	microdilution	NOUN
admet-1042	76	7	in	in	ADP
admet-1042	76	8	bhi	bhi	PROPN
admet-1042	76	9	which	which	PRON
admet-1042	76	10	is	be	AUX
admet-1042	76	11	more	more	ADV
admet-1042	76	12	sensitive	sensitive	ADJ
admet-1042	76	13	than	than	ADP
admet-1042	76	14	incubation	incubation	NOUN
admet-1042	76	15	in	in	ADP
admet-1042	76	16	blood	blood	NOUN
admet-1042	76	17	agar	agar	NOUN
admet-1042	76	18	that	that	PRON
admet-1042	76	19	keles	kele	NOUN
admet-1042	76	20	and	and	CCONJ
admet-1042	76	21	her	her	PRON
admet-1042	76	22	colleagues	colleague	NOUN
admet-1042	76	23	chose	choose	VERB
admet-1042	76	24	.	.	PUNCT
admet-1042	77	1	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	77	2	hydrochloride	hydrochloride	NOUN
admet-1042	77	3	does	do	AUX
admet-1042	77	4	not	not	PART
admet-1042	77	5	contain	contain	VERB
admet-1042	77	6	preservatives	preservative	NOUN
admet-1042	77	7	or	or	CCONJ
admet-1042	77	8	stabilizers	stabilizer	NOUN
admet-1042	77	9	.	.	PUNCT
admet-1042	78	1	therefore	therefore	ADV
admet-1042	78	2	the	the	DET
admet-1042	78	3	inhibitor	inhibitor	NOUN
admet-1042	78	4	effect	effect	NOUN
admet-1042	78	5	might	might	AUX
admet-1042	78	6	be	be	AUX
admet-1042	78	7	related	relate	VERB
admet-1042	78	8	to	to	ADP
admet-1042	78	9	its	its	PRON
admet-1042	78	10	chemical	chemical	NOUN
admet-1042	78	11	structure	structure	NOUN
admet-1042	78	12	.	.	PUNCT
admet-1042	79	1	the	the	DET
admet-1042	79	2	actual	actual	ADJ
admet-1042	79	3	mechanism	mechanism	NOUN
admet-1042	79	4	is	be	AUX
admet-1042	79	5	unclear	unclear	ADJ
admet-1042	79	6	and	and	CCONJ
admet-1042	79	7	also	also	ADV
admet-1042	79	8	no	no	DET
admet-1042	79	9	microbial	microbial	ADJ
admet-1042	79	10	growth	growth	NOUN
admet-1042	79	11	due	due	ADP
admet-1042	79	12	to	to	ADP
admet-1042	79	13	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	79	14	was	be	AUX
admet-1042	79	15	declared	declare	VERB
admet-1042	79	16	in	in	ADP
admet-1042	79	17	the	the	DET
admet-1042	79	18	literature	literature	NOUN
admet-1042	79	19	until	until	ADP
admet-1042	79	20	now	now	ADV
admet-1042	79	21	[	[	X
admet-1042	79	22	8,9	8,9	NUM
admet-1042	79	23	]	]	PUNCT
admet-1042	79	24	.	.	PUNCT
admet-1042	80	1	in	in	ADP
admet-1042	80	2	addition	addition	NOUN
admet-1042	80	3	to	to	ADP
admet-1042	80	4	its	its	PRON
admet-1042	80	5	antimicrobial	antimicrobial	ADJ
admet-1042	80	6	effect	effect	NOUN
admet-1042	80	7	,	,	PUNCT
admet-1042	80	8	taniguchi	taniguchi	PROPN
admet-1042	80	9	et	et	PROPN
admet-1042	80	10	al	al	PROPN
admet-1042	80	11	.	.	PUNCT
admet-1042	81	1	[	[	X
admet-1042	81	2	11	11	NUM
admet-1042	81	3	]	]	PUNCT
admet-1042	81	4	have	have	AUX
admet-1042	81	5	demonstrated	demonstrate	VERB
admet-1042	81	6	anti	anti	ADJ
admet-1042	81	7	-	-	ADJ
admet-1042	81	8	inflammatory	inflammatory	ADJ
admet-1042	81	9	features	feature	NOUN
admet-1042	81	10	of	of	ADP
admet-1042	81	11	this	this	DET
admet-1042	81	12	drug	drug	NOUN
admet-1042	81	13	in	in	ADP
admet-1042	81	14	rats	rat	NOUN
admet-1042	81	15	.	.	PUNCT
admet-1042	82	1	according	accord	VERB
admet-1042	82	2	to	to	ADP
admet-1042	82	3	this	this	DET
admet-1042	82	4	study	study	NOUN
admet-1042	82	5	,	,	PUNCT
admet-1042	82	6	2	2	ADJ
admet-1042	82	7	-	-	PUNCT
admet-1042	82	8	adrenoceptor	adrenoceptor	NOUN
admet-1042	82	9	agonist	agonist	NOUN
admet-1042	82	10	has	have	AUX
admet-1042	82	11	modulated	modulate	VERB
admet-1042	82	12	interleukin	interleukin	NOUN
admet-1042	82	13	and	and	CCONJ
admet-1042	82	14	tnf-	tnf-	NOUN
admet-1042	82	15	responses	response	NOUN
admet-1042	82	16	reducing	reduce	VERB
admet-1042	82	17	excessive	excessive	ADJ
admet-1042	82	18	neutrophil	neutrophil	ADJ
admet-1042	82	19	accumulation	accumulation	NOUN
admet-1042	82	20	on	on	ADP
admet-1042	82	21	lung	lung	NOUN
admet-1042	82	22	tissue	tissue	NOUN
admet-1042	82	23	.	.	PUNCT
admet-1042	83	1	with	with	ADP
admet-1042	83	2	that	that	DET
admet-1042	83	3	knowledge	knowledge	NOUN
admet-1042	83	4	,	,	PUNCT
admet-1042	83	5	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	83	6	might	might	AUX
admet-1042	83	7	be	be	AUX
admet-1042	83	8	a	a	DET
admet-1042	83	9	more	more	ADV
admet-1042	83	10	appropriate	appropriate	ADJ
admet-1042	83	11	drug	drug	NOUN
admet-1042	83	12	than	than	ADP
admet-1042	83	13	midazolam	midazolam	PROPN
admet-1042	83	14	in	in	ADP
admet-1042	83	15	septic	septic	ADJ
admet-1042	83	16	patients	patient	NOUN
admet-1042	83	17	who	who	PRON
admet-1042	83	18	are	be	AUX
admet-1042	83	19	in	in	ADP
admet-1042	83	20	need	need	NOUN
admet-1042	83	21	of	of	ADP
admet-1042	83	22	analgesia	analgesia	NOUN
admet-1042	83	23	and	and	CCONJ
admet-1042	83	24	sedation	sedation	NOUN
admet-1042	83	25	which	which	PRON
admet-1042	83	26	requires	require	VERB
admet-1042	83	27	further	further	ADJ
admet-1042	83	28	clinical	clinical	ADJ
admet-1042	83	29	studies	study	NOUN
admet-1042	83	30	.	.	PUNCT
admet-1042	84	1	fentanyl	fentanyl	ADJ
admet-1042	84	2	citrate	citrate	NOUN
admet-1042	84	3	has	have	AUX
admet-1042	84	4	displayed	display	VERB
admet-1042	84	5	evident	evident	ADJ
admet-1042	84	6	inhibitory	inhibitory	ADJ
admet-1042	84	7	potency	potency	NOUN
admet-1042	84	8	on	on	ADP
admet-1042	84	9	the	the	DET
admet-1042	84	10	pathogens	pathogen	NOUN
admet-1042	84	11	except	except	SCONJ
admet-1042	84	12	for	for	ADP
admet-1042	84	13	klebsiella	klebsiella	NOUN
admet-1042	84	14	pneumoniae	pneumoniae	NOUN
admet-1042	84	15	,	,	PUNCT
admet-1042	84	16	nevertheless	nevertheless	ADV
admet-1042	84	17	our	our	PRON
admet-1042	84	18	predefined	predefine	VERB
admet-1042	84	19	minimum	minimum	ADJ
admet-1042	84	20	concentration	concentration	NOUN
admet-1042	84	21	inhibited	inhibit	VERB
admet-1042	84	22	growth	growth	NOUN
admet-1042	84	23	by	by	ADP
admet-1042	84	24	9.5	9.5	NUM
admet-1042	84	25	%	%	NOUN
admet-1042	84	26	.	.	PUNCT
admet-1042	85	1	to	to	ADP
admet-1042	85	2	our	our	PRON
admet-1042	85	3	knowledge	knowledge	NOUN
admet-1042	85	4	,	,	PUNCT
admet-1042	85	5	there	there	PRON
admet-1042	85	6	are	be	VERB
admet-1042	85	7	few	few	ADJ
admet-1042	85	8	studies	study	NOUN
admet-1042	85	9	focused	focus	VERB
admet-1042	85	10	on	on	ADP
admet-1042	85	11	fentanyl	fentanyl	NOUN
admet-1042	85	12	’s	’s	PART
admet-1042	85	13	antimicrobial	antimicrobial	ADJ
admet-1042	85	14	properties	property	NOUN
admet-1042	85	15	and	and	CCONJ
admet-1042	85	16	some	some	PRON
admet-1042	85	17	of	of	ADP
admet-1042	85	18	them	they	PRON
admet-1042	85	19	oppose	oppose	VERB
admet-1042	85	20	our	our	PRON
admet-1042	85	21	results	result	NOUN
admet-1042	85	22	[	[	X
admet-1042	85	23	12	12	NUM
admet-1042	85	24	]	]	PUNCT
admet-1042	85	25	.	.	PUNCT
admet-1042	86	1	for	for	ADP
admet-1042	86	2	instance	instance	NOUN
admet-1042	86	3	;	;	PUNCT
admet-1042	86	4	rota	rota	PROPN
admet-1042	86	5	et	et	PROPN
admet-1042	86	6	al	al	PROPN
admet-1042	86	7	.	.	PUNCT
admet-1042	87	1	[	[	X
admet-1042	87	2	13	13	NUM
admet-1042	87	3	]	]	PUNCT
admet-1042	87	4	were	be	AUX
admet-1042	87	5	not	not	PART
admet-1042	87	6	able	able	ADJ
admet-1042	87	7	to	to	PART
admet-1042	87	8	demonstrate	demonstrate	VERB
admet-1042	87	9	the	the	DET
admet-1042	87	10	inhibiting	inhibit	VERB
admet-1042	87	11	effect	effect	NOUN
admet-1042	87	12	of	of	ADP
admet-1042	87	13	fentanyl	fentanyl	NOUN
admet-1042	87	14	.	.	PUNCT
admet-1042	88	1	in	in	ADP
admet-1042	88	2	contrast	contrast	NOUN
admet-1042	88	3	,	,	PUNCT
admet-1042	88	4	graystone	graystone	PROPN
admet-1042	88	5	et	et	PROPN
admet-1042	88	6	al	al	PROPN
admet-1042	88	7	.	.	PUNCT
admet-1042	89	1	[	[	X
admet-1042	89	2	14	14	NUM
admet-1042	89	3	]	]	PUNCT
admet-1042	89	4	have	have	AUX
admet-1042	89	5	investigated	investigate	VERB
admet-1042	89	6	15	15	NUM
admet-1042	89	7	medications	medication	NOUN
admet-1042	89	8	that	that	PRON
admet-1042	89	9	are	be	AUX
admet-1042	89	10	used	use	VERB
admet-1042	89	11	in	in	ADP
admet-1042	89	12	icu	icu	PROPN
admet-1042	89	13	and	and	CCONJ
admet-1042	89	14	concluded	conclude	VERB
admet-1042	89	15	all	all	PRON
admet-1042	89	16	of	of	ADP
admet-1042	89	17	them	they	PRON
admet-1042	89	18	except	except	SCONJ
admet-1042	89	19	propofol	propofol	NOUN
admet-1042	89	20	were	be	AUX
admet-1042	89	21	bactericidal	bactericidal	ADJ
admet-1042	89	22	including	include	VERB
admet-1042	89	23	fentanyl	fentanyl	NOUN
admet-1042	89	24	.	.	PUNCT
admet-1042	90	1	based	base	VERB
admet-1042	90	2	on	on	ADP
admet-1042	90	3	spectrophotometric	spectrophotometric	ADJ
admet-1042	90	4	calculations	calculation	NOUN
admet-1042	90	5	our	our	PRON
admet-1042	90	6	study	study	NOUN
admet-1042	90	7	method	method	NOUN
admet-1042	90	8	was	be	AUX
admet-1042	90	9	not	not	PART
admet-1042	90	10	designed	design	VERB
admet-1042	90	11	to	to	PART
admet-1042	90	12	investigate	investigate	VERB
admet-1042	90	13	the	the	DET
admet-1042	90	14	bactericidal	bactericidal	ADJ
admet-1042	90	15	effects	effect	NOUN
admet-1042	90	16	of	of	ADP
admet-1042	90	17	the	the	DET
admet-1042	90	18	drugs	drug	NOUN
admet-1042	90	19	.	.	PUNCT
admet-1042	91	1	however	however	ADV
admet-1042	91	2	,	,	PUNCT
admet-1042	91	3	as	as	SCONJ
admet-1042	91	4	interpreted	interpret	VERB
admet-1042	91	5	in	in	ADP
admet-1042	91	6	the	the	DET
admet-1042	91	7	mentioned	mention	VERB
admet-1042	91	8	studies	study	NOUN
admet-1042	91	9	,	,	PUNCT
admet-1042	91	10	we	we	PRON
admet-1042	91	11	may	may	AUX
admet-1042	91	12	propose	propose	VERB
admet-1042	91	13	specific	specific	ADJ
admet-1042	91	14	assumptions	assumption	NOUN
admet-1042	91	15	.	.	PUNCT
admet-1042	92	1	fentanyl	fentanyl	ADJ
admet-1042	92	2	citrate	citrate	NOUN
admet-1042	92	3	ampoules	ampoule	NOUN
admet-1042	92	4	contain	contain	VERB
admet-1042	92	5	500	500	NUM
admet-1042	92	6	g/10	g/10	NOUN
admet-1042	92	7	ml	ml	NOUN
admet-1042	92	8	which	which	PRON
admet-1042	92	9	is	be	AUX
admet-1042	92	10	a	a	DET
admet-1042	92	11	large	large	ADJ
admet-1042	92	12	dose	dose	NOUN
admet-1042	92	13	for	for	ADP
admet-1042	92	14	one	one	NUM
admet-1042	92	15	use	use	NOUN
admet-1042	92	16	only	only	ADV
admet-1042	92	17	.	.	PUNCT
admet-1042	93	1	therefore	therefore	ADV
admet-1042	93	2	,	,	PUNCT
admet-1042	93	3	multi	multi	ADJ
admet-1042	93	4	-	-	ADJ
admet-1042	93	5	dosing	dosing	ADJ
admet-1042	93	6	with	with	ADP
admet-1042	93	7	the	the	DET
admet-1042	93	8	same	same	ADJ
admet-1042	93	9	syringe	syringe	NOUN
admet-1042	93	10	is	be	AUX
admet-1042	93	11	a	a	DET
admet-1042	93	12	quite	quite	ADV
admet-1042	93	13	common	common	ADJ
admet-1042	93	14	application	application	NOUN
admet-1042	93	15	practice	practice	NOUN
admet-1042	93	16	in	in	ADP
admet-1042	93	17	the	the	DET
admet-1042	93	18	icu	icu	PROPN
admet-1042	93	19	settings	setting	NOUN
admet-1042	93	20	[	[	X
admet-1042	93	21	12	12	NUM
admet-1042	93	22	-	-	SYM
admet-1042	93	23	15	15	NUM
admet-1042	93	24	]	]	PUNCT
admet-1042	93	25	.	.	PUNCT
admet-1042	94	1	it	it	PRON
admet-1042	94	2	could	could	AUX
admet-1042	94	3	be	be	AUX
admet-1042	94	4	argued	argue	VERB
admet-1042	94	5	that	that	SCONJ
admet-1042	94	6	the	the	DET
admet-1042	94	7	drug	drug	NOUN
admet-1042	94	8	would	would	AUX
admet-1042	94	9	degrade	degrade	VERB
admet-1042	94	10	and	and	CCONJ
admet-1042	94	11	become	become	VERB
admet-1042	94	12	susceptible	susceptible	ADJ
admet-1042	94	13	to	to	ADP
admet-1042	94	14	contamination	contamination	NOUN
admet-1042	94	15	during	during	ADP
admet-1042	94	16	the	the	DET
admet-1042	94	17	time	time	NOUN
admet-1042	94	18	kept	keep	VERB
admet-1042	94	19	at	at	ADP
admet-1042	94	20	room	room	NOUN
admet-1042	94	21	temperature	temperature	NOUN
admet-1042	94	22	in	in	ADP
admet-1042	94	23	the	the	DET
admet-1042	94	24	same	same	ADJ
admet-1042	94	25	syringe	syringe	NOUN
admet-1042	94	26	.	.	PUNCT
admet-1042	95	1	however	however	ADV
admet-1042	95	2	,	,	PUNCT
admet-1042	95	3	fentanyl	fentanyl	NOUN
admet-1042	95	4	is	be	AUX
admet-1042	95	5	a	a	DET
admet-1042	95	6	physicochemically	physicochemically	ADV
admet-1042	95	7	stable	stable	ADJ
admet-1042	95	8	drug	drug	NOUN
admet-1042	95	9	and	and	CCONJ
admet-1042	95	10	can	can	AUX
admet-1042	95	11	be	be	AUX
admet-1042	95	12	stored	store	VERB
admet-1042	95	13	in	in	ADP
admet-1042	95	14	the	the	DET
admet-1042	95	15	syringe	syringe	NOUN
admet-1042	95	16	up	up	ADP
admet-1042	95	17	to	to	PART
admet-1042	95	18	1	1	NUM
admet-1042	95	19	week	week	NOUN
admet-1042	95	20	as	as	ADP
admet-1042	95	21	a	a	DET
admet-1042	95	22	mixture	mixture	NOUN
admet-1042	95	23	with	with	ADP
admet-1042	95	24	other	other	ADJ
admet-1042	95	25	drugs	drug	NOUN
admet-1042	95	26	such	such	ADJ
admet-1042	95	27	as	as	ADP
admet-1042	95	28	midazolam	midazolam	PROPN
admet-1042	95	29	under	under	ADP
admet-1042	95	30	32	32	NUM
admet-1042	95	31	°	°	NOUN
admet-1042	95	32	c	c	NOUN
admet-1042	95	33	[	[	X
admet-1042	95	34	16	16	NUM
admet-1042	95	35	]	]	PUNCT
admet-1042	95	36	.	.	PUNCT
admet-1042	96	1	refilling	refill	VERB
admet-1042	96	2	of	of	ADP
admet-1042	96	3	the	the	DET
admet-1042	96	4	syringes	syrinx	NOUN
admet-1042	96	5	with	with	ADP
admet-1042	96	6	this	this	DET
admet-1042	96	7	drug	drug	NOUN
admet-1042	96	8	does	do	AUX
admet-1042	96	9	not	not	PART
admet-1042	96	10	cause	cause	VERB
admet-1042	96	11	microbial	microbial	ADJ
admet-1042	96	12	contamination	contamination	NOUN
admet-1042	96	13	as	as	SCONJ
admet-1042	96	14	observed	observe	VERB
admet-1042	96	15	in	in	ADP
admet-1042	96	16	one	one	NUM
admet-1042	96	17	prospective	prospective	ADJ
admet-1042	96	18	longitudinal	longitudinal	ADJ
admet-1042	96	19	study	study	NOUN
admet-1042	96	20	[	[	X
admet-1042	96	21	12	12	NUM
admet-1042	96	22	]	]	PUNCT
admet-1042	96	23	.	.	PUNCT
admet-1042	97	1	the	the	DET
admet-1042	97	2	reliability	reliability	NOUN
admet-1042	97	3	of	of	ADP
admet-1042	97	4	multi	multi	ADJ
admet-1042	97	5	-	-	ADJ
admet-1042	97	6	dosing	dosing	ADJ
admet-1042	97	7	with	with	ADP
admet-1042	97	8	the	the	DET
admet-1042	97	9	same	same	ADJ
admet-1042	97	10	syringe	syringe	NOUN
admet-1042	97	11	is	be	AUX
admet-1042	97	12	often	often	ADV
admet-1042	97	13	questioned	question	VERB
admet-1042	97	14	by	by	ADP
admet-1042	97	15	the	the	DET
admet-1042	97	16	clinicians	clinician	NOUN
admet-1042	97	17	and	and	CCONJ
admet-1042	97	18	considering	consider	VERB
admet-1042	97	19	our	our	PRON
admet-1042	97	20	results	result	NOUN
admet-1042	97	21	this	this	DET
admet-1042	97	22	approach	approach	NOUN
admet-1042	97	23	seems	seem	VERB
admet-1042	97	24	adequate	adequate	ADJ
admet-1042	97	25	.	.	PUNCT
admet-1042	98	1	perhaps	perhaps	ADV
admet-1042	98	2	further	further	ADJ
admet-1042	98	3	clinical	clinical	ADJ
admet-1042	98	4	studies	study	NOUN
admet-1042	98	5	are	be	AUX
admet-1042	98	6	required	require	VERB
admet-1042	98	7	.	.	PUNCT
admet-1042	99	1	a	a	DET
admet-1042	99	2	fentanyl	fentanyl	ADJ
admet-1042	99	3	analog	analog	NOUN
admet-1042	99	4	“	"	PUNCT
admet-1042	99	5	remifentanil	remifentanil	NOUN
admet-1042	99	6	”	"	PUNCT
admet-1042	99	7	was	be	AUX
admet-1042	99	8	investigated	investigate	VERB
admet-1042	99	9	by	by	ADP
admet-1042	99	10	apan	apan	PROPN
admet-1042	99	11	et	et	PROPN
admet-1042	99	12	al	al	PROPN
admet-1042	99	13	.	.	PUNCT
admet-1042	100	1	[	[	X
admet-1042	100	2	17	17	NUM
admet-1042	100	3	]	]	PUNCT
admet-1042	100	4	in	in	ADP
admet-1042	100	5	the	the	DET
admet-1042	100	6	same	same	ADJ
admet-1042	100	7	manner	manner	NOUN
admet-1042	100	8	.	.	PUNCT
admet-1042	101	1	they	they	PRON
admet-1042	101	2	have	have	AUX
admet-1042	101	3	observed	observe	VERB
admet-1042	101	4	similar	similar	ADJ
admet-1042	101	5	microbial	microbial	ADJ
admet-1042	101	6	inhibition	inhibition	NOUN
admet-1042	101	7	on	on	ADP
admet-1042	101	8	s.	s.	PROPN
admet-1042	101	9	aureus	aureus	PROPN
admet-1042	101	10	,	,	PUNCT
admet-1042	101	11	p.	p.	NOUN
admet-1042	101	12	aeruginosa	aeruginosa	PROPN
admet-1042	101	13	,	,	PUNCT
admet-1042	101	14	e.	e.	PROPN
admet-1042	101	15	coli	coli	PROPN
admet-1042	101	16	and	and	CCONJ
admet-1042	101	17	c.	c.	NOUN
admet-1042	101	18	albicans	albican	NOUN
admet-1042	101	19	depending	depend	VERB
admet-1042	101	20	on	on	ADP
admet-1042	101	21	the	the	DET
admet-1042	101	22	concentration	concentration	NOUN
admet-1042	101	23	.	.	PUNCT
admet-1042	102	1	however	however	ADV
admet-1042	102	2	,	,	PUNCT
admet-1042	102	3	this	this	DET
admet-1042	102	4	effect	effect	NOUN
admet-1042	102	5	was	be	AUX
admet-1042	102	6	attributed	attribute	VERB
admet-1042	102	7	to	to	ADP
admet-1042	102	8	“	"	PUNCT
admet-1042	102	9	glycine	glycine	NOUN
admet-1042	102	10	”	"	PUNCT
admet-1042	102	11	which	which	PRON
admet-1042	102	12	is	be	AUX
admet-1042	102	13	present	present	ADJ
admet-1042	102	14	in	in	ADP
admet-1042	102	15	remifentanil	remifentanil	NOUN
admet-1042	102	16	ampoules	ampoule	NOUN
admet-1042	102	17	as	as	ADP
admet-1042	102	18	a	a	DET
admet-1042	102	19	preservative	preservative	NOUN
admet-1042	102	20	.	.	PUNCT
admet-1042	103	1	it	it	PRON
admet-1042	103	2	might	might	AUX
admet-1042	103	3	be	be	AUX
admet-1042	103	4	possible	possible	ADJ
admet-1042	103	5	that	that	SCONJ
admet-1042	103	6	glycine	glycine	NOUN
admet-1042	103	7	has	have	VERB
admet-1042	103	8	bacteriostatic	bacteriostatic	ADJ
admet-1042	103	9	potency	potency	NOUN
admet-1042	103	10	but	but	CCONJ
admet-1042	103	11	since	since	SCONJ
admet-1042	103	12	both	both	CCONJ
admet-1042	103	13	remifentanil	remifentanil	NOUN
admet-1042	103	14	and	and	CCONJ
admet-1042	103	15	fentanyl	fentanyl	NOUN
admet-1042	103	16	are	be	AUX
admet-1042	103	17	4	4	NUM
admet-1042	103	18	-	-	PUNCT
admet-1042	103	19	anilidopiperidine	anilidopiperidine	ADJ
admet-1042	103	20	structured	structured	ADJ
admet-1042	103	21	drugs	drug	NOUN
admet-1042	103	22	,	,	PUNCT
admet-1042	103	23	further	further	ADJ
admet-1042	103	24	evaluations	evaluation	NOUN
admet-1042	103	25	are	be	AUX
admet-1042	103	26	needed	need	VERB
admet-1042	103	27	including	include	VERB
admet-1042	103	28	also	also	ADV
admet-1042	103	29	alfentanil	alfentanil	ADJ
admet-1042	103	30	and	and	CCONJ
admet-1042	103	31	sufentanil	sufentanil	VERB
admet-1042	103	32	[	[	X
admet-1042	103	33	18,19	18,19	NUM
admet-1042	103	34	]	]	PUNCT
admet-1042	103	35	.	.	PUNCT
admet-1042	104	1	fentanyl	fentanyl	ADJ
admet-1042	104	2	citrate	citrate	NOUN
admet-1042	104	3	does	do	AUX
admet-1042	104	4	not	not	PART
admet-1042	104	5	contain	contain	VERB
admet-1042	104	6	preservatives	preservative	NOUN
admet-1042	104	7	.	.	PUNCT
admet-1042	105	1	tramadol	tramadol	NOUN
admet-1042	105	2	is	be	AUX
admet-1042	105	3	known	know	VERB
admet-1042	105	4	to	to	PART
admet-1042	105	5	be	be	AUX
admet-1042	105	6	a	a	DET
admet-1042	105	7	“	"	PUNCT
admet-1042	105	8	good	good	ADJ
admet-1042	105	9	”	"	PUNCT
admet-1042	105	10	analgesic	analgesic	NOUN
admet-1042	105	11	that	that	PRON
admet-1042	105	12	has	have	VERB
admet-1042	105	13	few	few	ADJ
admet-1042	105	14	respiratory	respiratory	ADJ
admet-1042	105	15	and	and	CCONJ
admet-1042	105	16	hemodynamic	hemodynamic	ADJ
admet-1042	105	17	adverse	adverse	ADJ
admet-1042	105	18	effects	effect	NOUN
admet-1042	105	19	[	[	X
admet-1042	105	20	20	20	NUM
admet-1042	105	21	]	]	PUNCT
admet-1042	105	22	.	.	PUNCT
admet-1042	106	1	despite	despite	SCONJ
admet-1042	106	2	being	be	AUX
admet-1042	106	3	a	a	DET
admet-1042	106	4	weak	weak	ADJ
admet-1042	106	5	opioid	opioid	ADJ
admet-1042	106	6	analgesic	analgesic	NOUN
admet-1042	106	7	,	,	PUNCT
admet-1042	106	8	it	it	PRON
admet-1042	106	9	provides	provide	VERB
admet-1042	106	10	adequate	adequate	ADJ
admet-1042	106	11	analgesia	analgesia	NOUN
admet-1042	106	12	especially	especially	ADV
admet-1042	106	13	in	in	ADP
admet-1042	106	14	elder	eld	ADJ
admet-1042	106	15	patients	patient	NOUN
admet-1042	106	16	who	who	PRON
admet-1042	106	17	are	be	AUX
admet-1042	106	18	prone	prone	ADJ
admet-1042	106	19	to	to	ADP
admet-1042	106	20	cognitive	cognitive	ADJ
admet-1042	106	21	dysfunction	dysfunction	NOUN
admet-1042	106	22	[	[	X
admet-1042	106	23	21	21	NUM
admet-1042	106	24	]	]	PUNCT
admet-1042	106	25	.	.	PUNCT
admet-1042	107	1	therefore	therefore	ADV
admet-1042	107	2	,	,	PUNCT
admet-1042	107	3	it	it	PRON
admet-1042	107	4	is	be	AUX
admet-1042	107	5	mostly	mostly	ADV
admet-1042	107	6	used	use	VERB
admet-1042	107	7	for	for	ADP
admet-1042	107	8	the	the	DET
admet-1042	107	9	postoperative	postoperative	ADJ
admet-1042	107	10	period	period	NOUN
admet-1042	107	11	especially	especially	ADV
admet-1042	107	12	after	after	ADP
admet-1042	107	13	orthopedic	orthopedic	ADJ
admet-1042	107	14	surgery	surgery	NOUN
admet-1042	107	15	in	in	ADP
admet-1042	107	16	intensive	intensive	ADJ
admet-1042	107	17	care	care	NOUN
admet-1042	107	18	units	unit	NOUN
admet-1042	107	19	.	.	PUNCT
admet-1042	108	1	many	many	ADJ
admet-1042	108	2	clinicians	clinician	NOUN
admet-1042	108	3	do	do	AUX
admet-1042	108	4	not	not	PART
admet-1042	108	5	reckon	reckon	VERB
admet-1042	108	6	tramadol	tramadol	NOUN
admet-1042	108	7	as	as	ADP
admet-1042	108	8	a	a	DET
admet-1042	108	9	sedative	sedative	ADJ
admet-1042	108	10	agent	agent	NOUN
admet-1042	108	11	.	.	PUNCT
admet-1042	109	1	but	but	CCONJ
admet-1042	109	2	when	when	SCONJ
admet-1042	109	3	combined	combine	VERB
admet-1042	109	4	with	with	ADP
admet-1042	109	5	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	109	6	,	,	PUNCT
admet-1042	109	7	these	these	DET
admet-1042	109	8	drugs	drug	NOUN
admet-1042	109	9	show	show	VERB
admet-1042	109	10	remarkable	remarkable	ADJ
admet-1042	109	11	synergistic	synergistic	ADJ
admet-1042	109	12	effects	effect	NOUN
admet-1042	109	13	[	[	X
admet-1042	109	14	20	20	NUM
admet-1042	109	15	]	]	PUNCT
admet-1042	109	16	.	.	PUNCT
admet-1042	110	1	as	as	ADP
admet-1042	110	2	a	a	DET
admet-1042	110	3	striking	striking	ADJ
admet-1042	110	4	result	result	NOUN
admet-1042	110	5	of	of	ADP
admet-1042	110	6	our	our	PRON
admet-1042	110	7	study	study	NOUN
admet-1042	110	8	tramadol	tramadol	NOUN
admet-1042	110	9	has	have	AUX
admet-1042	110	10	shown	show	VERB
admet-1042	110	11	the	the	DET
admet-1042	110	12	most	most	ADV
admet-1042	110	13	efficient	efficient	ADJ
admet-1042	110	14	antimicrobial	antimicrobial	ADJ
admet-1042	110	15	activity	activity	NOUN
admet-1042	110	16	.	.	PUNCT
admet-1042	111	1	from	from	ADP
admet-1042	111	2	this	this	DET
admet-1042	111	3	aspect	aspect	NOUN
admet-1042	111	4	preparing	prepare	VERB
admet-1042	111	5	combined	combined	ADJ
admet-1042	111	6	infusions	infusion	NOUN
admet-1042	111	7	of	of	ADP
admet-1042	111	8	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	111	9	and	and	CCONJ
admet-1042	111	10	tramadol	tramadol	NOUN
admet-1042	111	11	is	be	AUX
admet-1042	111	12	rather	rather	ADV
admet-1042	111	13	considerable	considerable	ADJ
admet-1042	111	14	due	due	ADP
admet-1042	111	15	to	to	ADP
admet-1042	111	16	their	their	PRON
admet-1042	111	17	fewer	few	ADJ
admet-1042	111	18	side	side	ADJ
admet-1042	111	19	-	-	PUNCT
admet-1042	111	20	effect	effect	NOUN
admet-1042	111	21	properties	property	NOUN
admet-1042	111	22	.	.	PUNCT
admet-1042	112	1	it	it	PRON
admet-1042	112	2	is	be	AUX
admet-1042	112	3	worth	worth	ADJ
admet-1042	112	4	noting	note	VERB
admet-1042	112	5	that	that	SCONJ
admet-1042	112	6	the	the	DET
admet-1042	112	7	synergy	synergy	NOUN
admet-1042	112	8	occurs	occur	VERB
admet-1042	112	9	only	only	ADV
admet-1042	112	10	on	on	ADP
admet-1042	112	11	sedation	sedation	NOUN
admet-1042	112	12	and	and	CCONJ
admet-1042	112	13	analgesia	analgesia	NOUN
admet-1042	112	14	but	but	CCONJ
admet-1042	112	15	not	not	PART
admet-1042	112	16	on	on	ADP
admet-1042	112	17	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	PUNCT
admet-1042	112	18	sevgi	sevgi	PROPN
admet-1042	112	19	kesici	kesici	PROPN
admet-1042	112	20	et	et	PROPN
admet-1042	112	21	al	al	PROPN
admet-1042	112	22	.	.	PROPN
admet-1042	112	23	admet	admet	PROPN
admet-1042	112	24	&	&	CCONJ
admet-1042	112	25	dmpk	dmpk	PROPN
admet-1042	112	26	9(3	9(3	NUM
admet-1042	112	27	)	)	PUNCT
admet-1042	112	28	(	(	PUNCT
admet-1042	112	29	2021	2021	NUM
admet-1042	112	30	)	)	PUNCT
admet-1042	112	31	219	219	NUM
admet-1042	112	32	-	-	SYM
admet-1042	112	33	226	226	NUM
admet-1042	112	34	224	224	NUM
admet-1042	112	35	bacteriostatic	bacteriostatic	ADJ
admet-1042	112	36	activity	activity	NOUN
admet-1042	112	37	.	.	PUNCT
admet-1042	113	1	to	to	ADP
admet-1042	113	2	the	the	DET
admet-1042	113	3	best	good	ADJ
admet-1042	113	4	of	of	ADP
admet-1042	113	5	our	our	PRON
admet-1042	113	6	knowledge	knowledge	NOUN
admet-1042	113	7	,	,	PUNCT
admet-1042	113	8	this	this	PRON
admet-1042	113	9	is	be	AUX
admet-1042	113	10	the	the	DET
admet-1042	113	11	only	only	ADJ
admet-1042	113	12	study	study	NOUN
admet-1042	113	13	examining	examine	VERB
admet-1042	113	14	antimicrobial	antimicrobial	ADJ
admet-1042	113	15	features	feature	NOUN
admet-1042	113	16	of	of	ADP
admet-1042	113	17	tramadol	tramadol	NOUN
admet-1042	113	18	.	.	PUNCT
admet-1042	114	1	intravenous	intravenous	ADJ
admet-1042	114	2	treatments	treatment	NOUN
admet-1042	114	3	are	be	AUX
admet-1042	114	4	generally	generally	ADV
admet-1042	114	5	applied	apply	VERB
admet-1042	114	6	via	via	ADP
admet-1042	114	7	central	central	ADJ
admet-1042	114	8	venous	venous	ADJ
admet-1042	114	9	catheters	catheter	NOUN
admet-1042	114	10	in	in	ADP
admet-1042	114	11	the	the	DET
admet-1042	114	12	icus	icus	NOUN
admet-1042	114	13	.	.	PUNCT
admet-1042	115	1	occasionally	occasionally	ADV
admet-1042	115	2	multiple	multiple	ADJ
admet-1042	115	3	sedative	sedative	ADJ
admet-1042	115	4	drugs	drug	NOUN
admet-1042	115	5	are	be	AUX
admet-1042	115	6	needed	need	VERB
admet-1042	115	7	to	to	PART
admet-1042	115	8	be	be	AUX
admet-1042	115	9	given	give	VERB
admet-1042	115	10	from	from	ADP
admet-1042	115	11	the	the	DET
admet-1042	115	12	same	same	ADJ
admet-1042	115	13	catheter	catheter	NOUN
admet-1042	115	14	line	line	NOUN
admet-1042	115	15	and	and	CCONJ
admet-1042	115	16	usually	usually	ADV
admet-1042	115	17	infused	infuse	VERB
admet-1042	115	18	at	at	ADP
admet-1042	115	19	lower	low	ADJ
admet-1042	115	20	rates	rate	NOUN
admet-1042	115	21	.	.	PUNCT
admet-1042	116	1	whether	whether	SCONJ
admet-1042	116	2	these	these	DET
admet-1042	116	3	drug	drug	NOUN
admet-1042	116	4	combinations	combination	NOUN
admet-1042	116	5	covering	cover	VERB
admet-1042	116	6	the	the	DET
admet-1042	116	7	same	same	ADJ
admet-1042	116	8	line	line	NOUN
admet-1042	116	9	attenuate	attenuate	VERB
admet-1042	116	10	catheter	catheter	NOUN
admet-1042	116	11	related	relate	VERB
admet-1042	116	12	nosocomial	nosocomial	ADJ
admet-1042	116	13	infections	infection	NOUN
admet-1042	116	14	is	be	AUX
admet-1042	116	15	questionable	questionable	ADJ
admet-1042	116	16	.	.	PUNCT
admet-1042	117	1	we	we	PRON
admet-1042	117	2	have	have	AUX
admet-1042	117	3	observed	observe	VERB
admet-1042	117	4	evident	evident	ADJ
admet-1042	117	5	synergy	synergy	NOUN
admet-1042	117	6	with	with	ADP
admet-1042	117	7	the	the	DET
admet-1042	117	8	different	different	ADJ
admet-1042	117	9	combinations	combination	NOUN
admet-1042	117	10	against	against	ADP
admet-1042	117	11	particular	particular	ADJ
admet-1042	117	12	microorganisms	microorganism	NOUN
admet-1042	117	13	in	in	ADP
admet-1042	117	14	our	our	PRON
admet-1042	117	15	study	study	NOUN
admet-1042	117	16	.	.	PUNCT
admet-1042	118	1	fentanyl	fentanyl	PROPN
admet-1042	118	2	and	and	CCONJ
admet-1042	118	3	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	118	4	together	together	ADV
admet-1042	118	5	exhibited	exhibit	VERB
admet-1042	118	6	more	more	ADJ
admet-1042	118	7	antimicrobial	antimicrobial	ADJ
admet-1042	118	8	effects	effect	NOUN
admet-1042	118	9	on	on	ADP
admet-1042	118	10	p.	p.	PROPN
admet-1042	118	11	aeruginosa	aeruginosa	PROPN
admet-1042	118	12	and	and	CCONJ
admet-1042	118	13	e.	e.	PROPN
admet-1042	118	14	coli	coli	NOUN
admet-1042	118	15	growth	growth	NOUN
admet-1042	118	16	.	.	PUNCT
admet-1042	119	1	additionally	additionally	ADV
admet-1042	119	2	,	,	PUNCT
admet-1042	119	3	when	when	SCONJ
admet-1042	119	4	the	the	DET
admet-1042	119	5	three	three	NUM
admet-1042	119	6	drugs	drug	NOUN
admet-1042	119	7	were	be	AUX
admet-1042	119	8	examined	examine	VERB
admet-1042	119	9	together	together	ADV
admet-1042	119	10	,	,	PUNCT
admet-1042	119	11	microbial	microbial	ADJ
admet-1042	119	12	inhibition	inhibition	NOUN
admet-1042	119	13	occurred	occur	VERB
admet-1042	119	14	more	more	ADV
admet-1042	119	15	than	than	SCONJ
admet-1042	119	16	expected	expect	VERB
admet-1042	119	17	on	on	ADP
admet-1042	119	18	e.	e.	PROPN
admet-1042	119	19	coli	coli	PROPN
admet-1042	119	20	again	again	ADV
admet-1042	119	21	and	and	CCONJ
admet-1042	119	22	also	also	ADV
admet-1042	119	23	on	on	ADP
admet-1042	119	24	c.	c.	NOUN
admet-1042	119	25	albicans	albican	NOUN
admet-1042	119	26	growth	growth	NOUN
admet-1042	119	27	.	.	PUNCT
admet-1042	120	1	this	this	DET
admet-1042	120	2	interaction	interaction	NOUN
admet-1042	120	3	needs	need	VERB
admet-1042	120	4	to	to	PART
admet-1042	120	5	be	be	AUX
admet-1042	120	6	evaluated	evaluate	VERB
admet-1042	120	7	more	more	ADJ
admet-1042	120	8	.	.	PUNCT
admet-1042	121	1	since	since	SCONJ
admet-1042	121	2	this	this	PRON
admet-1042	121	3	is	be	AUX
admet-1042	121	4	an	an	DET
admet-1042	121	5	in	in	ADP
admet-1042	121	6	vitro	vitro	X
admet-1042	121	7	study	study	NOUN
admet-1042	121	8	,	,	PUNCT
admet-1042	121	9	in	in	ADP
admet-1042	121	10	vivo	vivo	NOUN
admet-1042	121	11	examinations	examination	NOUN
admet-1042	121	12	are	be	AUX
admet-1042	121	13	necessary	necessary	ADJ
admet-1042	121	14	to	to	PART
admet-1042	121	15	adapt	adapt	VERB
admet-1042	121	16	clinical	clinical	ADJ
admet-1042	121	17	practice	practice	NOUN
admet-1042	121	18	.	.	PUNCT
admet-1042	122	1	as	as	ADV
admet-1042	122	2	far	far	ADV
admet-1042	122	3	as	as	SCONJ
admet-1042	122	4	we	we	PRON
admet-1042	122	5	know	know	VERB
admet-1042	122	6	there	there	PRON
admet-1042	122	7	is	be	VERB
admet-1042	122	8	no	no	DET
admet-1042	122	9	other	other	ADJ
admet-1042	122	10	study	study	NOUN
admet-1042	122	11	in	in	ADP
admet-1042	122	12	the	the	DET
admet-1042	122	13	literature	literature	NOUN
admet-1042	122	14	looking	look	VERB
admet-1042	122	15	into	into	ADP
admet-1042	122	16	the	the	DET
admet-1042	122	17	microbial	microbial	ADJ
admet-1042	122	18	“	"	PUNCT
admet-1042	122	19	interactions	interaction	NOUN
admet-1042	122	20	”	"	PUNCT
admet-1042	122	21	of	of	ADP
admet-1042	122	22	opioids	opioid	NOUN
admet-1042	122	23	and	and	CCONJ
admet-1042	122	24	sedative	sedative	ADJ
admet-1042	122	25	drugs	drug	NOUN
admet-1042	122	26	.	.	PUNCT
admet-1042	123	1	we	we	PRON
admet-1042	123	2	believe	believe	VERB
admet-1042	123	3	these	these	DET
admet-1042	123	4	interactions	interaction	NOUN
admet-1042	123	5	are	be	AUX
admet-1042	123	6	remarkably	remarkably	ADV
admet-1042	123	7	important	important	ADJ
admet-1042	123	8	which	which	PRON
admet-1042	123	9	may	may	AUX
admet-1042	123	10	affect	affect	VERB
admet-1042	123	11	routine	routine	NOUN
admet-1042	123	12	iv	iv	NUM
admet-1042	123	13	therapy	therapy	NOUN
admet-1042	123	14	and	and	CCONJ
admet-1042	123	15	shape	shape	VERB
admet-1042	123	16	the	the	DET
admet-1042	123	17	practitioner	practitioner	NOUN
admet-1042	123	18	’s	’s	PART
admet-1042	123	19	approach	approach	NOUN
admet-1042	123	20	.	.	PUNCT
admet-1042	124	1	as	as	ADP
admet-1042	124	2	a	a	DET
admet-1042	124	3	well	well	ADV
admet-1042	124	4	-	-	PUNCT
admet-1042	124	5	known	know	VERB
admet-1042	124	6	fact	fact	NOUN
admet-1042	124	7	,	,	PUNCT
admet-1042	124	8	critical	critical	ADJ
admet-1042	124	9	patients	patient	NOUN
admet-1042	124	10	receiving	receive	VERB
admet-1042	124	11	total	total	ADJ
admet-1042	124	12	parenteral	parenteral	ADJ
admet-1042	124	13	nutrition	nutrition	NOUN
admet-1042	124	14	via	via	ADP
admet-1042	124	15	the	the	DET
admet-1042	124	16	central	central	ADJ
admet-1042	124	17	venous	venous	ADJ
admet-1042	124	18	catheters	catheter	NOUN
admet-1042	124	19	are	be	AUX
admet-1042	124	20	at	at	ADP
admet-1042	124	21	great	great	ADJ
admet-1042	124	22	risk	risk	NOUN
admet-1042	124	23	for	for	ADP
admet-1042	124	24	candidemia	candidemia	NOUN
admet-1042	124	25	.	.	PUNCT
admet-1042	125	1	the	the	DET
admet-1042	125	2	combination	combination	NOUN
admet-1042	125	3	of	of	ADP
admet-1042	125	4	th	th	NOUN
admet-1042	125	5	,	,	PUNCT
admet-1042	125	6	fc	fc	PROPN
admet-1042	125	7	and	and	CCONJ
admet-1042	125	8	dh	dh	PROPN
admet-1042	125	9	infusion	infusion	NOUN
admet-1042	125	10	is	be	AUX
admet-1042	125	11	worth	worth	ADJ
admet-1042	125	12	investigating	investigate	VERB
admet-1042	125	13	from	from	ADP
admet-1042	125	14	this	this	DET
admet-1042	125	15	aspect	aspect	NOUN
admet-1042	125	16	.	.	PUNCT
admet-1042	126	1	it	it	PRON
admet-1042	126	2	is	be	AUX
admet-1042	126	3	difficult	difficult	ADJ
admet-1042	126	4	to	to	PART
admet-1042	126	5	come	come	VERB
admet-1042	126	6	to	to	ADP
admet-1042	126	7	a	a	DET
admet-1042	126	8	conclusion	conclusion	NOUN
admet-1042	126	9	with	with	ADP
admet-1042	126	10	our	our	PRON
admet-1042	126	11	laboratory	laboratory	NOUN
admet-1042	126	12	results	result	NOUN
admet-1042	126	13	for	for	ADP
admet-1042	126	14	sure	sure	ADJ
admet-1042	126	15	but	but	CCONJ
admet-1042	126	16	further	far	ADV
admet-1042	126	17	in	in	ADP
admet-1042	126	18	vitro	vitro	X
admet-1042	126	19	and	and	CCONJ
admet-1042	126	20	in	in	ADP
admet-1042	126	21	vivo	vivo	ADJ
admet-1042	126	22	studies	study	NOUN
admet-1042	126	23	may	may	AUX
admet-1042	126	24	reveal	reveal	VERB
admet-1042	126	25	clinically	clinically	ADV
admet-1042	126	26	significant	significant	ADJ
admet-1042	126	27	interactions	interaction	NOUN
admet-1042	126	28	.	.	PUNCT
admet-1042	127	1	perhaps	perhaps	ADV
admet-1042	127	2	the	the	DET
admet-1042	127	3	most	most	ADV
admet-1042	127	4	important	important	ADJ
admet-1042	127	5	limitation	limitation	NOUN
admet-1042	127	6	of	of	ADP
admet-1042	127	7	our	our	PRON
admet-1042	127	8	study	study	NOUN
admet-1042	127	9	was	be	AUX
admet-1042	127	10	the	the	DET
admet-1042	127	11	lack	lack	NOUN
admet-1042	127	12	of	of	ADP
admet-1042	127	13	hourly	hourly	ADV
admet-1042	127	14	made	make	VERB
admet-1042	127	15	spectrophotometric	spectrophotometric	ADJ
admet-1042	127	16	calculations	calculation	NOUN
admet-1042	127	17	.	.	PUNCT
admet-1042	128	1	therefore	therefore	ADV
admet-1042	128	2	we	we	PRON
admet-1042	128	3	could	could	AUX
admet-1042	128	4	not	not	PART
admet-1042	128	5	demonstrate	demonstrate	VERB
admet-1042	128	6	microbial	microbial	ADJ
admet-1042	128	7	inhibition	inhibition	NOUN
admet-1042	128	8	or	or	CCONJ
admet-1042	128	9	growth	growth	NOUN
admet-1042	128	10	trend	trend	NOUN
admet-1042	128	11	during	during	ADP
admet-1042	128	12	24	24	NUM
admet-1042	128	13	hours	hour	NOUN
admet-1042	128	14	.	.	PUNCT
admet-1042	129	1	interestingly	interestingly	ADV
admet-1042	129	2	,	,	PUNCT
admet-1042	129	3	graystone	graystone	PROPN
admet-1042	129	4	et	et	PROPN
admet-1042	129	5	al	al	PROPN
admet-1042	129	6	.	.	PUNCT
admet-1042	130	1	[	[	X
admet-1042	130	2	14	14	NUM
admet-1042	130	3	]	]	PUNCT
admet-1042	130	4	have	have	AUX
admet-1042	130	5	observed	observe	VERB
admet-1042	130	6	an	an	DET
admet-1042	130	7	increase	increase	NOUN
admet-1042	130	8	in	in	ADP
admet-1042	130	9	s.	s.	PROPN
admet-1042	130	10	aureus	aureus	PROPN
admet-1042	130	11	number	number	NOUN
admet-1042	130	12	during	during	ADP
admet-1042	130	13	the	the	DET
admet-1042	130	14	first	first	ADJ
admet-1042	130	15	4	4	NUM
admet-1042	130	16	hours	hour	NOUN
admet-1042	130	17	which	which	PRON
admet-1042	130	18	declined	decline	VERB
admet-1042	130	19	later	later	ADV
admet-1042	130	20	with	with	ADP
admet-1042	130	21	all	all	DET
admet-1042	130	22	opioids	opioid	NOUN
admet-1042	130	23	except	except	SCONJ
admet-1042	130	24	fentanyl	fentanyl	NOUN
admet-1042	130	25	.	.	PUNCT
admet-1042	131	1	pyrogenic	pyrogenic	ADJ
admet-1042	131	2	reactions	reaction	NOUN
admet-1042	131	3	are	be	AUX
admet-1042	131	4	reported	report	VERB
admet-1042	131	5	because	because	SCONJ
admet-1042	131	6	of	of	ADP
admet-1042	131	7	extrinsically	extrinsically	ADV
admet-1042	131	8	contaminated	contaminate	VERB
admet-1042	131	9	fluids	fluid	NOUN
admet-1042	131	10	even	even	ADV
admet-1042	131	11	if	if	SCONJ
admet-1042	131	12	there	there	PRON
admet-1042	131	13	is	be	VERB
admet-1042	131	14	no	no	DET
admet-1042	131	15	bacteremia	bacteremia	NOUN
admet-1042	132	1	[	[	X
admet-1042	132	2	22	22	NUM
admet-1042	132	3	]	]	PUNCT
admet-1042	132	4	.	.	PUNCT
admet-1042	133	1	bacterial	bacterial	ADJ
admet-1042	133	2	load	load	NOUN
admet-1042	133	3	in	in	ADP
admet-1042	133	4	infusion	infusion	NOUN
admet-1042	133	5	fluids	fluid	NOUN
admet-1042	133	6	may	may	AUX
admet-1042	133	7	be	be	AUX
admet-1042	133	8	reduced	reduce	VERB
admet-1042	133	9	by	by	ADP
admet-1042	133	10	choosing	choose	VERB
admet-1042	133	11	the	the	DET
admet-1042	133	12	appropriate	appropriate	ADJ
admet-1042	133	13	agent	agent	NOUN
admet-1042	133	14	and	and	CCONJ
admet-1042	133	15	concentration	concentration	NOUN
admet-1042	133	16	to	to	PART
admet-1042	133	17	enhance	enhance	VERB
admet-1042	133	18	patient	patient	ADJ
admet-1042	133	19	comfort	comfort	NOUN
admet-1042	133	20	in	in	ADP
admet-1042	133	21	both	both	DET
admet-1042	133	22	sedation	sedation	NOUN
admet-1042	133	23	and	and	CCONJ
admet-1042	133	24	anti	anti	ADJ
admet-1042	133	25	-	-	ADJ
admet-1042	133	26	inflammatory	inflammatory	ADJ
admet-1042	133	27	meanings	meaning	NOUN
admet-1042	133	28	.	.	PUNCT
admet-1042	134	1	conclusions	conclusion	NOUN
admet-1042	134	2	we	we	PRON
admet-1042	134	3	have	have	AUX
admet-1042	134	4	observed	observe	VERB
admet-1042	134	5	definite	definite	ADJ
admet-1042	134	6	antimicrobial	antimicrobial	ADJ
admet-1042	134	7	properties	property	NOUN
admet-1042	134	8	and	and	CCONJ
admet-1042	134	9	synergy	synergy	NOUN
admet-1042	134	10	with	with	ADP
admet-1042	134	11	the	the	DET
admet-1042	134	12	different	different	ADJ
admet-1042	134	13	combinations	combination	NOUN
admet-1042	134	14	of	of	ADP
admet-1042	134	15	fentanyl	fentanyl	NOUN
admet-1042	134	16	,	,	PUNCT
admet-1042	134	17	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	134	18	and	and	CCONJ
admet-1042	134	19	tramadol	tramadol	NOUN
admet-1042	134	20	against	against	ADP
admet-1042	134	21	the	the	DET
admet-1042	134	22	most	most	ADV
admet-1042	134	23	common	common	ADJ
admet-1042	134	24	nosocomial	nosocomial	ADJ
admet-1042	134	25	infection	infection	NOUN
admet-1042	134	26	agents	agent	NOUN
admet-1042	134	27	in	in	ADP
admet-1042	134	28	the	the	DET
admet-1042	134	29	icu	icu	PROPN
admet-1042	134	30	.	.	PUNCT
admet-1042	135	1	this	this	PRON
admet-1042	135	2	is	be	AUX
admet-1042	135	3	the	the	DET
admet-1042	135	4	first	first	ADJ
admet-1042	135	5	study	study	NOUN
admet-1042	135	6	in	in	ADP
admet-1042	135	7	the	the	DET
admet-1042	135	8	literature	literature	NOUN
admet-1042	135	9	looking	look	VERB
admet-1042	135	10	into	into	ADP
admet-1042	135	11	the	the	DET
admet-1042	135	12	microbial	microbial	ADJ
admet-1042	135	13	“	"	PUNCT
admet-1042	135	14	interactions	interaction	NOUN
admet-1042	135	15	”	"	PUNCT
admet-1042	135	16	of	of	ADP
admet-1042	135	17	opioids	opioid	NOUN
admet-1042	135	18	and	and	CCONJ
admet-1042	135	19	sedative	sedative	ADJ
admet-1042	135	20	drugs	drug	NOUN
admet-1042	135	21	but	but	CCONJ
admet-1042	135	22	more	more	ADJ
admet-1042	135	23	research	research	NOUN
admet-1042	135	24	is	be	AUX
admet-1042	135	25	needed	need	VERB
admet-1042	135	26	in	in	ADP
admet-1042	135	27	order	order	NOUN
admet-1042	135	28	to	to	PART
admet-1042	135	29	define	define	VERB
admet-1042	135	30	clinico	clinico	NOUN
admet-1042	135	31	-	-	PUNCT
admet-1042	135	32	laboratory	laboratory	NOUN
admet-1042	135	33	correlation	correlation	NOUN
admet-1042	135	34	.	.	PUNCT
admet-1042	136	1	limitations	limitation	NOUN
admet-1042	136	2	of	of	ADP
admet-1042	136	3	this	this	DET
admet-1042	136	4	work	work	NOUN
admet-1042	136	5	are	be	AUX
admet-1042	136	6	:	:	PUNCT
admet-1042	136	7	(	(	PUNCT
admet-1042	136	8	i	i	NOUN
admet-1042	136	9	)	)	PUNCT
admet-1042	136	10	the	the	DET
admet-1042	136	11	study	study	NOUN
admet-1042	136	12	is	be	AUX
admet-1042	136	13	in	in	ADP
admet-1042	136	14	vitro	vitro	X
admet-1042	136	15	study	study	NOUN
admet-1042	136	16	and	and	CCONJ
admet-1042	136	17	(	(	PUNCT
admet-1042	136	18	ii	ii	NOUN
admet-1042	136	19	)	)	PUNCT
admet-1042	136	20	clinical	clinical	ADJ
admet-1042	136	21	practice	practice	NOUN
admet-1042	136	22	is	be	AUX
admet-1042	136	23	required	require	VERB
admet-1042	136	24	.	.	PUNCT
admet-1042	137	1	conflict	conflict	NOUN
admet-1042	137	2	of	of	ADP
admet-1042	137	3	interest	interest	NOUN
admet-1042	137	4	:	:	PUNCT
admet-1042	137	5	the	the	DET
admet-1042	137	6	authors	author	NOUN
admet-1042	137	7	declare	declare	VERB
admet-1042	137	8	no	no	DET
admet-1042	137	9	conflict	conflict	NOUN
admet-1042	137	10	of	of	ADP
admet-1042	137	11	interest	interest	NOUN
admet-1042	137	12	.	.	PUNCT
admet-1042	138	1	references	reference	NOUN
admet-1042	138	2	[	[	X
admet-1042	138	3	1	1	NUM
admet-1042	138	4	]	]	X
admet-1042	138	5	m.b	m.b	PROPN
admet-1042	138	6	.	.	PROPN
admet-1042	138	7	sosis	sosis	PROPN
admet-1042	138	8	,	,	PUNCT
admet-1042	138	9	b.	b.	PROPN
admet-1042	138	10	braverman	braverman	PROPN
admet-1042	138	11	.	.	PUNCT
admet-1042	139	1	growth	growth	NOUN
admet-1042	139	2	of	of	ADP
admet-1042	139	3	staphylococcus	staphylococcus	NOUN
admet-1042	139	4	aureus	aureus	NOUN
admet-1042	139	5	in	in	ADP
admet-1042	139	6	four	four	NUM
admet-1042	139	7	intravenous	intravenous	ADJ
admet-1042	139	8	anesthetics	anesthetic	NOUN
admet-1042	139	9	.	.	PUNCT
admet-1042	140	1	anesth	anesth	PROPN
admet-1042	140	2	.	.	PROPN
admet-1042	140	3	analg	analg	PROPN
admet-1042	140	4	.	.	PUNCT
admet-1042	141	1	77	77	NUM
admet-1042	141	2	(	(	PUNCT
admet-1042	141	3	1993	1993	NUM
admet-1042	141	4	)	)	PUNCT
admet-1042	141	5	766	766	NUM
admet-1042	141	6	-	-	SYM
admet-1042	141	7	768	768	NUM
admet-1042	141	8	.	.	PUNCT
admet-1042	142	1	[	[	X
admet-1042	142	2	2	2	NUM
admet-1042	142	3	]	]	X
admet-1042	142	4	c.b	c.b	PROPN
admet-1042	142	5	.	.	PROPN
admet-1042	142	6	berry	berry	PROPN
admet-1042	142	7	,	,	PUNCT
admet-1042	142	8	t.	t.	PROPN
admet-1042	142	9	gillespie	gillespie	PROPN
admet-1042	142	10	,	,	PUNCT
admet-1042	142	11	j.	j.	PROPN
admet-1042	142	12	hood	hood	PROPN
admet-1042	142	13	,	,	PUNCT
admet-1042	142	14	n.b	n.b	PROPN
admet-1042	142	15	.	.	PROPN
admet-1042	142	16	scott	scott	PROPN
admet-1042	142	17	.	.	PUNCT
admet-1042	143	1	growth	growth	NOUN
admet-1042	143	2	of	of	ADP
admet-1042	143	3	micro	micro	NOUN
admet-1042	143	4	-	-	NOUN
admet-1042	143	5	organisms	organism	NOUN
admet-1042	143	6	in	in	ADP
admet-1042	143	7	solutions	solution	NOUN
admet-1042	143	8	of	of	ADP
admet-1042	143	9	intravenous	intravenous	ADJ
admet-1042	143	10	anaesthetic	anaesthetic	ADJ
admet-1042	143	11	agents	agent	NOUN
admet-1042	143	12	.	.	PUNCT
admet-1042	144	1	anaesthesia	anaesthesia	NOUN
admet-1042	144	2	48	48	NUM
admet-1042	144	3	(	(	PUNCT
admet-1042	144	4	1993	1993	NUM
admet-1042	144	5	)	)	PUNCT
admet-1042	144	6	30	30	NUM
admet-1042	144	7	-	-	SYM
admet-1042	144	8	32	32	NUM
admet-1042	144	9	.	.	PUNCT
admet-1042	145	1	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	PROPN
admet-1042	146	1	[	[	X
admet-1042	146	2	3	3	X
admet-1042	146	3	]	]	PUNCT
admet-1042	146	4	j.	j.	PROPN
admet-1042	146	5	crowther	crowther	PROPN
admet-1042	146	6	,	,	PUNCT
admet-1042	146	7	j.	j.	PROPN
admet-1042	146	8	hrazdil	hrazdil	PROPN
admet-1042	146	9	,	,	PUNCT
admet-1042	146	10	d.t	d.t	PROPN
admet-1042	146	11	.	.	PUNCT
admet-1042	147	1	jolly	jolly	PROPN
admet-1042	147	2	,	,	PUNCT
admet-1042	147	3	j.c	j.c	PROPN
admet-1042	147	4	.	.	PROPN
admet-1042	147	5	galbraith	galbraith	PROPN
admet-1042	147	6	,	,	PUNCT
admet-1042	147	7	m.	m.	NOUN
admet-1042	147	8	greacen	greacen	PROPN
admet-1042	147	9	,	,	PUNCT
admet-1042	147	10	m.	m.	NOUN
admet-1042	147	11	grace	grace	NOUN
admet-1042	147	12	.	.	PUNCT
admet-1042	148	1	growth	growth	NOUN
admet-1042	148	2	of	of	ADP
admet-1042	148	3	microorganisms	microorganism	NOUN
admet-1042	148	4	in	in	ADP
admet-1042	148	5	propofol	propofol	NOUN
admet-1042	148	6	,	,	PUNCT
admet-1042	148	7	thiopental	thiopental	NOUN
admet-1042	148	8	,	,	PUNCT
admet-1042	148	9	and	and	CCONJ
admet-1042	148	10	a	a	DET
admet-1042	148	11	1:1	1:1	NUM
admet-1042	148	12	mixture	mixture	NOUN
admet-1042	148	13	of	of	ADP
admet-1042	148	14	propofol	propofol	NOUN
admet-1042	148	15	and	and	CCONJ
admet-1042	148	16	thiopental	thiopental	NOUN
admet-1042	148	17	.	.	PUNCT
admet-1042	149	1	anesth	anesth	PROPN
admet-1042	149	2	.	.	PROPN
admet-1042	149	3	analg	analg	PROPN
admet-1042	149	4	.	.	PUNCT
admet-1042	150	1	82	82	NUM
admet-1042	150	2	(	(	PUNCT
admet-1042	150	3	1996	1996	NUM
admet-1042	150	4	)	)	PUNCT
admet-1042	150	5	475	475	NUM
admet-1042	150	6	-	-	SYM
admet-1042	150	7	478	478	NUM
admet-1042	150	8	.	.	PUNCT
admet-1042	151	1	https://dx.doi.org/10.1097/00000539-199603000-00008	https://dx.doi.org/10.1097/00000539-199603000-00008	PROPN
admet-1042	151	2	.	.	PUNCT
admet-1042	152	1	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	PROPN
admet-1042	152	2	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	https://doi.org/10.1111/j.1365-2044.1993.tb06786.x	PROPN
admet-1042	152	3	https://dx.doi.org/10.1097/00000539-199603000-00008	https://dx.doi.org/10.1097/00000539-199603000-00008	PROPN
admet-1042	152	4	admet	admet	PROPN
admet-1042	152	5	&	&	CCONJ
admet-1042	152	6	dmpk	dmpk	PROPN
admet-1042	152	7	9(3	9(3	NUM
admet-1042	152	8	)	)	PUNCT
admet-1042	152	9	(	(	PUNCT
admet-1042	152	10	2021	2021	NUM
admet-1042	152	11	)	)	PUNCT
admet-1042	152	12	219	219	NUM
admet-1042	152	13	-	-	SYM
admet-1042	152	14	226	226	NUM
admet-1042	152	15	are	be	AUX
admet-1042	152	16	we	we	PRON
admet-1042	152	17	ready	ready	ADJ
admet-1042	152	18	to	to	PART
admet-1042	152	19	design	design	VERB
admet-1042	152	20	oral	oral	ADJ
admet-1042	152	21	protacs	protacs	PROPN
admet-1042	152	22	®	®	NOUN
admet-1042	152	23	?	?	PUNCT
admet-1042	153	1	doi	doi	PROPN
admet-1042	153	2	:	:	PUNCT
admet-1042	153	3	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	PUNCT
admet-1042	153	4	225	225	NUM
admet-1042	153	5	[	[	X
admet-1042	153	6	4	4	X
admet-1042	153	7	]	]	X
admet-1042	153	8	d.v	d.v	PROPN
admet-1042	153	9	.	.	PROPN
admet-1042	153	10	thomas	thomas	PROPN
admet-1042	153	11	.	.	PUNCT
admet-1042	154	1	propofol	propofol	PROPN
admet-1042	154	2	supports	support	VERB
admet-1042	154	3	bacterial	bacterial	ADJ
admet-1042	154	4	growth	growth	NOUN
admet-1042	154	5	.	.	PUNCT
admet-1042	155	1	br	br	X
admet-1042	155	2	.	.	PUNCT
admet-1042	156	1	j.	j.	PROPN
admet-1042	156	2	anaesth	anaesth	PROPN
admet-1042	156	3	.	.	PROPN
admet-1042	157	1	66	66	NUM
admet-1042	157	2	(	(	PUNCT
admet-1042	157	3	1991	1991	NUM
admet-1042	157	4	)	)	PUNCT
admet-1042	157	5	274	274	NUM
admet-1042	157	6	.	.	PUNCT
admet-1042	158	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	158	2	10.1093	10.1093	NUM
admet-1042	158	3	/	/	SYM
admet-1042	158	4	bja/66.2.274	bja/66.2.274	NOUN
admet-1042	158	5	-	-	PUNCT
admet-1042	158	6	a.	a.	NOUN
admet-1042	159	1	[	[	X
admet-1042	159	2	5	5	X
admet-1042	159	3	]	]	PUNCT
admet-1042	159	4	schroeder	schroeder	NOUN
admet-1042	159	5	me	i	PRON
admet-1042	159	6	.	.	PUNCT
admet-1042	160	1	delirium	delirium	NOUN
admet-1042	160	2	in	in	ADP
admet-1042	160	3	the	the	DET
admet-1042	160	4	elderly	elderly	ADJ
admet-1042	160	5	.	.	PUNCT
admet-1042	161	1	in	in	ADP
admet-1042	161	2	:	:	PUNCT
admet-1042	161	3	pain	pain	NOUN
admet-1042	162	1	[	[	X
admet-1042	162	2	internet	internet	NOUN
admet-1042	162	3	]	]	PUNCT
admet-1042	162	4	.	.	PUNCT
admet-1042	163	1	cham	cham	PROPN
admet-1042	163	2	:	:	PUNCT
admet-1042	163	3	springer	springer	NOUN
admet-1042	163	4	international	international	ADJ
admet-1042	163	5	publishing	publishing	NOUN
admet-1042	163	6	;	;	PUNCT
admet-1042	163	7	2019	2019	NUM
admet-1042	163	8	[	[	X
admet-1042	163	9	cited	cite	VERB
admet-1042	163	10	2019	2019	NUM
admet-1042	163	11	jul	jul	PROPN
admet-1042	163	12	10	10	NUM
admet-1042	163	13	]	]	PUNCT
admet-1042	163	14	.	.	PUNCT
admet-1042	164	1	p.	p.	NOUN
admet-1042	164	2	1117–20	1117–20	NUM
admet-1042	164	3	.	.	PUNCT
admet-1042	164	4	available	available	ADJ
admet-1042	164	5	from	from	ADP
admet-1042	164	6	:	:	PUNCT
admet-1042	164	7	http://link.springer.com/10.1007/978-3-31999124-5_238	http://link.springer.com/10.1007/978-3-31999124-5_238	PROPN
admet-1042	164	8	.	.	PUNCT
admet-1042	165	1	[	[	X
admet-1042	165	2	6	6	NUM
admet-1042	165	3	]	]	PUNCT
admet-1042	165	4	f.	f.	PROPN
admet-1042	165	5	santana	santana	PROPN
admet-1042	165	6	santos	santos	PROPN
admet-1042	165	7	,	,	PUNCT
admet-1042	165	8	l.o	l.o	PROPN
admet-1042	165	9	.	.	PROPN
admet-1042	165	10	wahlund	wahlund	PROPN
admet-1042	165	11	,	,	PUNCT
admet-1042	165	12	f.	f.	PROPN
admet-1042	165	13	varli	varli	PROPN
admet-1042	165	14	,	,	PUNCT
admet-1042	165	15	i.	i.	PROPN
admet-1042	165	16	tadeu	tadeu	PROPN
admet-1042	165	17	velasco	velasco	PROPN
admet-1042	165	18	,	,	PUNCT
admet-1042	165	19	m.	m.	NOUN
admet-1042	165	20	eriksdotter	eriksdotter	PROPN
admet-1042	165	21	jonhagen	jonhagen	PROPN
admet-1042	165	22	.	.	PUNCT
admet-1042	166	1	incidence	incidence	NOUN
admet-1042	166	2	,	,	PUNCT
admet-1042	166	3	clinical	clinical	ADJ
admet-1042	166	4	features	feature	NOUN
admet-1042	166	5	and	and	CCONJ
admet-1042	166	6	subtypes	subtype	NOUN
admet-1042	166	7	of	of	ADP
admet-1042	166	8	delirium	delirium	NOUN
admet-1042	166	9	in	in	ADP
admet-1042	166	10	elderly	elderly	ADJ
admet-1042	166	11	patients	patient	NOUN
admet-1042	166	12	treated	treat	VERB
admet-1042	166	13	for	for	ADP
admet-1042	166	14	hip	hip	NOUN
admet-1042	166	15	fractures	fracture	NOUN
admet-1042	166	16	.	.	PUNCT
admet-1042	167	1	dement	dement	NOUN
admet-1042	167	2	.	.	PUNCT
admet-1042	168	1	geriatr	geriatr	PROPN
admet-1042	168	2	.	.	PUNCT
admet-1042	169	1	cogn	cogn	PROPN
admet-1042	169	2	.	.	PUNCT
admet-1042	170	1	disord	disord	PROPN
admet-1042	170	2	.	.	PUNCT
admet-1042	171	1	20	20	NUM
admet-1042	171	2	(	(	PUNCT
admet-1042	171	3	2005	2005	NUM
admet-1042	171	4	)	)	PUNCT
admet-1042	171	5	231	231	NUM
admet-1042	171	6	-	-	SYM
admet-1042	171	7	237	237	NUM
admet-1042	171	8	.	.	PUNCT
admet-1042	172	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	172	2	10.1159/000087311	10.1159/000087311	NUM
admet-1042	172	3	.	.	PUNCT
admet-1042	173	1	[	[	X
admet-1042	173	2	7	7	X
admet-1042	173	3	]	]	X
admet-1042	173	4	n.	n.	PROPN
admet-1042	173	5	bhana	bhana	PROPN
admet-1042	173	6	,	,	PUNCT
admet-1042	173	7	k.l	k.l	PROPN
admet-1042	173	8	.	.	PROPN
admet-1042	173	9	goa	goa	PROPN
admet-1042	173	10	,	,	PUNCT
admet-1042	173	11	k.j	k.j	PROPN
admet-1042	173	12	.	.	PUNCT
admet-1042	173	13	mcclellan	mcclellan	PROPN
admet-1042	173	14	.	.	PUNCT
admet-1042	173	15	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	173	16	.	.	PUNCT
admet-1042	174	1	drugs	drug	NOUN
admet-1042	174	2	59	59	NUM
admet-1042	174	3	(	(	PUNCT
admet-1042	174	4	2000	2000	NUM
admet-1042	174	5	)	)	PUNCT
admet-1042	174	6	263	263	NUM
admet-1042	174	7	-	-	SYM
admet-1042	174	8	268	268	NUM
admet-1042	174	9	;	;	PUNCT
admet-1042	174	10	discussion	discussion	NOUN
admet-1042	174	11	269	269	NUM
admet-1042	174	12	-	-	SYM
admet-1042	174	13	270	270	NUM
admet-1042	174	14	.	.	PUNCT
admet-1042	175	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	175	2	10.2165/00003495	10.2165/00003495	NUM
admet-1042	175	3	-	-	SYM
admet-1042	175	4	200059020	200059020	NUM
admet-1042	175	5	-	-	SYM
admet-1042	175	6	00012	00012	NUM
admet-1042	175	7	.	.	PUNCT
admet-1042	176	1	[	[	X
admet-1042	176	2	8	8	X
admet-1042	176	3	]	]	X
admet-1042	176	4	h.	h.	PROPN
admet-1042	176	5	ayoglu	ayoglu	PROPN
admet-1042	176	6	,	,	PUNCT
admet-1042	176	7	c.	c.	PROPN
admet-1042	176	8	kulah	kulah	PROPN
admet-1042	176	9	,	,	PUNCT
admet-1042	176	10	i.	i.	PROPN
admet-1042	176	11	turan	turan	PROPN
admet-1042	176	12	.	.	PUNCT
admet-1042	177	1	antimicrobial	antimicrobial	ADJ
admet-1042	177	2	effects	effect	NOUN
admet-1042	177	3	of	of	ADP
admet-1042	177	4	two	two	NUM
admet-1042	177	5	anaesthetic	anaesthetic	ADJ
admet-1042	177	6	agents	agent	NOUN
admet-1042	177	7	:	:	PUNCT
admet-1042	177	8	dexmedetomidine	dexmedetomidine	PROPN
admet-1042	177	9	and	and	CCONJ
admet-1042	177	10	midazolam	midazolam	PROPN
admet-1042	177	11	.	.	PUNCT
admet-1042	177	12	anaesth	anaesth	PROPN
admet-1042	177	13	.	.	PUNCT
admet-1042	178	1	intensive	intensive	ADJ
admet-1042	178	2	care	care	NOUN
admet-1042	178	3	36	36	NUM
admet-1042	178	4	(	(	PUNCT
admet-1042	178	5	2008	2008	NUM
admet-1042	178	6	)	)	PUNCT
admet-1042	178	7	681	681	NUM
admet-1042	178	8	-	-	SYM
admet-1042	178	9	684	684	NUM
admet-1042	178	10	.	.	PUNCT
admet-1042	179	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	180	1	10.1177/0310057x0803600508	10.1177/0310057x0803600508	NUM
admet-1042	180	2	.	.	PUNCT
admet-1042	181	1	[	[	X
admet-1042	181	2	9	9	NUM
admet-1042	181	3	]	]	X
admet-1042	181	4	g.t	g.t	PROPN
admet-1042	181	5	.	.	PROPN
admet-1042	181	6	keleş	keleş	PROPN
admet-1042	181	7	,	,	PUNCT
admet-1042	181	8	s.	s.	PROPN
admet-1042	181	9	kurutepe	kurutepe	PROPN
admet-1042	181	10	,	,	PUNCT
admet-1042	181	11	d.	d.	PROPN
admet-1042	181	12	tok	tok	PROPN
admet-1042	181	13	,	,	PUNCT
admet-1042	181	14	h.	h.	PROPN
admet-1042	181	15	gazi	gazi	PROPN
admet-1042	181	16	,	,	PUNCT
admet-1042	181	17	g.	g.	PROPN
admet-1042	181	18	dinç	dinç	PROPN
admet-1042	181	19	.	.	PUNCT
admet-1042	182	1	comparison	comparison	NOUN
admet-1042	182	2	of	of	ADP
admet-1042	182	3	antimicrobial	antimicrobial	ADJ
admet-1042	182	4	effects	effect	NOUN
admet-1042	182	5	of	of	ADP
admet-1042	182	6	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	182	7	and	and	CCONJ
admet-1042	182	8	etomidate	etomidate	NOUN
admet-1042	182	9	-	-	PUNCT
admet-1042	182	10	lipuro	lipuro	NOUN
admet-1042	182	11	with	with	ADP
admet-1042	182	12	those	those	PRON
admet-1042	182	13	of	of	ADP
admet-1042	182	14	propofol	propofol	NOUN
admet-1042	182	15	and	and	CCONJ
admet-1042	182	16	midazolam	midazolam	PROPN
admet-1042	182	17	.	.	PUNCT
admet-1042	183	1	eur	eur	PROPN
admet-1042	183	2	.	.	PUNCT
admet-1042	184	1	j.	j.	PROPN
admet-1042	184	2	anaesthesiol	anaesthesiol	PROPN
admet-1042	184	3	.	.	PUNCT
admet-1042	185	1	23	23	NUM
admet-1042	185	2	(	(	PUNCT
admet-1042	185	3	2006	2006	NUM
admet-1042	185	4	)	)	PUNCT
admet-1042	185	5	1037	1037	NUM
admet-1042	185	6	-	-	SYM
admet-1042	185	7	1040	1040	NUM
admet-1042	185	8	.	.	PUNCT
admet-1042	186	1	https://dx.doi.org/10.1017/s0265021506000949	https://dx.doi.org/10.1017/s0265021506000949	X
admet-1042	186	2	.	.	PUNCT
admet-1042	187	1	[	[	X
admet-1042	187	2	10	10	NUM
admet-1042	187	3	]	]	X
admet-1042	187	4	m.g	m.g	PROPN
admet-1042	187	5	.	.	PROPN
admet-1042	187	6	botelho	botelho	PROPN
admet-1042	187	7	.	.	PUNCT
admet-1042	188	1	fractional	fractional	ADJ
admet-1042	188	2	inhibitory	inhibitory	ADJ
admet-1042	188	3	concentration	concentration	NOUN
admet-1042	188	4	index	index	NOUN
admet-1042	188	5	of	of	ADP
admet-1042	188	6	combinations	combination	NOUN
admet-1042	188	7	of	of	ADP
admet-1042	188	8	antibacterial	antibacterial	ADJ
admet-1042	188	9	agents	agent	NOUN
admet-1042	188	10	against	against	ADP
admet-1042	188	11	cariogenic	cariogenic	ADJ
admet-1042	188	12	organisms	organism	NOUN
admet-1042	188	13	.	.	PUNCT
admet-1042	189	1	j.	j.	PROPN
admet-1042	189	2	dent	dent	PROPN
admet-1042	189	3	.	.	PUNCT
admet-1042	190	1	28	28	NUM
admet-1042	190	2	(	(	PUNCT
admet-1042	190	3	2000	2000	NUM
admet-1042	190	4	)	)	PUNCT
admet-1042	190	5	565	565	NUM
admet-1042	190	6	-	-	SYM
admet-1042	190	7	570	570	NUM
admet-1042	190	8	.	.	PUNCT
admet-1042	191	1	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	NOUN
admet-1042	191	2	.	.	PUNCT
admet-1042	192	1	[	[	X
admet-1042	192	2	11	11	NUM
admet-1042	192	3	]	]	PUNCT
admet-1042	192	4	t.	t.	PROPN
admet-1042	192	5	taniguchi	taniguchi	PROPN
admet-1042	192	6	,	,	PUNCT
admet-1042	192	7	y.	y.	PROPN
admet-1042	192	8	kidani	kidani	PROPN
admet-1042	192	9	,	,	PUNCT
admet-1042	192	10	h.	h.	PROPN
admet-1042	192	11	kanakura	kanakura	PROPN
admet-1042	192	12	,	,	PUNCT
admet-1042	192	13	y.	y.	PROPN
admet-1042	192	14	takemoto	takemoto	PROPN
admet-1042	192	15	,	,	PUNCT
admet-1042	192	16	k.	k.	PROPN
admet-1042	192	17	yamamoto	yamamoto	PROPN
admet-1042	192	18	.	.	PUNCT
admet-1042	193	1	effects	effect	NOUN
admet-1042	193	2	of	of	ADP
admet-1042	193	3	dexmedetomidine	dexmedetomidine	NOUN
admet-1042	193	4	on	on	ADP
admet-1042	193	5	mortality	mortality	NOUN
admet-1042	193	6	rate	rate	NOUN
admet-1042	193	7	and	and	CCONJ
admet-1042	193	8	inflammatory	inflammatory	ADJ
admet-1042	193	9	responses	response	NOUN
admet-1042	193	10	to	to	ADP
admet-1042	193	11	endotoxin	endotoxin	NOUN
admet-1042	193	12	-	-	PUNCT
admet-1042	193	13	induced	induce	VERB
admet-1042	193	14	shock	shock	NOUN
admet-1042	193	15	in	in	ADP
admet-1042	193	16	rats	rat	NOUN
admet-1042	193	17	.	.	PUNCT
admet-1042	194	1	crit	crit	PROPN
admet-1042	194	2	.	.	PUNCT
admet-1042	194	3	care	care	PROPN
admet-1042	194	4	med	me	VERB
admet-1042	194	5	.	.	PUNCT
admet-1042	195	1	[	[	X
admet-1042	195	2	internet	internet	NOUN
admet-1042	195	3	]	]	PUNCT
admet-1042	195	4	32	32	NUM
admet-1042	195	5	(	(	PUNCT
admet-1042	195	6	2000	2000	NUM
admet-1042	195	7	)	)	PUNCT
admet-1042	195	8	1322–1326	1322–1326	NUM
admet-1042	195	9	.	.	PUNCT
admet-1042	196	1	https://doi.org/10.1097/01.ccm.0000128579.84228.2a	https://doi.org/10.1097/01.ccm.0000128579.84228.2a	PROPN
admet-1042	196	2	.	.	PUNCT
admet-1042	197	1	[	[	X
admet-1042	197	2	12	12	NUM
admet-1042	197	3	]	]	X
admet-1042	197	4	g.	g.	PROPN
admet-1042	197	5	morgan	morgan	PROPN
admet-1042	197	6	.	.	PUNCT
admet-1042	198	1	microbial	microbial	ADJ
admet-1042	198	2	growth	growth	NOUN
admet-1042	198	3	in	in	ADP
admet-1042	198	4	a	a	DET
admet-1042	198	5	mixture	mixture	NOUN
admet-1042	198	6	of	of	ADP
admet-1042	198	7	hyperbaric	hyperbaric	ADJ
admet-1042	198	8	bupivacaine	bupivacaine	NOUN
admet-1042	198	9	and	and	CCONJ
admet-1042	198	10	fentanyl	fentanyl	NOUN
admet-1042	198	11	prepared	prepare	VERB
admet-1042	198	12	in	in	ADP
admet-1042	198	13	a	a	DET
admet-1042	198	14	multi	multi	ADJ
admet-1042	198	15	-	-	ADJ
admet-1042	198	16	dose	dose	ADJ
admet-1042	198	17	syringe	syringe	NOUN
admet-1042	198	18	in	in	ADP
admet-1042	198	19	the	the	DET
admet-1042	198	20	operating	operating	NOUN
admet-1042	198	21	theatre	theatre	NOUN
admet-1042	198	22	environment	environment	NOUN
admet-1042	198	23	.	.	PUNCT
admet-1042	199	1	south	south	ADJ
admet-1042	199	2	african	african	PROPN
admet-1042	199	3	j.	j.	PROPN
admet-1042	199	4	anaesth	anaesth	PROPN
admet-1042	199	5	.	.	PROPN
admet-1042	199	6	analg	analg	PROPN
admet-1042	199	7	.	.	PUNCT
admet-1042	200	1	16	16	NUM
admet-1042	200	2	(	(	PUNCT
admet-1042	200	3	2010	2010	NUM
admet-1042	200	4	)	)	PUNCT
admet-1042	200	5	17–21	17–21	NUM
admet-1042	200	6	.	.	PUNCT
admet-1042	201	1	https://doi.org/10.1080/22201173.2010.10872661	https://doi.org/10.1080/22201173.2010.10872661	PROPN
admet-1042	201	2	.	.	PUNCT
admet-1042	202	1	[	[	X
admet-1042	202	2	13	13	NUM
admet-1042	202	3	]	]	PUNCT
admet-1042	202	4	s.	s.	PROPN
admet-1042	202	5	rota	rota	PROPN
admet-1042	202	6	,	,	PUNCT
admet-1042	202	7	k.	k.	PROPN
admet-1042	202	8	kaya	kaya	PROPN
admet-1042	202	9	,	,	PUNCT
admet-1042	202	10	o.	o.	PROPN
admet-1042	202	11	timliothlu	timliothlu	NOUN
admet-1042	202	12	,	,	PUNCT
admet-1042	202	13	o.	o.	PROPN
admet-1042	202	14	karaca	karaca	PROPN
admet-1042	202	15	,	,	PUNCT
admet-1042	202	16	s.	s.	PROPN
admet-1042	202	17	yzdep	yzdep	PROPN
admet-1042	202	18	,	,	PUNCT
admet-1042	202	19	e.	e.	PROPN
admet-1042	202	20	ocal	ocal	PROPN
admet-1042	202	21	.	.	PUNCT
admet-1042	203	1	do	do	AUX
admet-1042	203	2	the	the	DET
admet-1042	203	3	opioids	opioid	NOUN
admet-1042	203	4	have	have	VERB
admet-1042	203	5	an	an	DET
admet-1042	203	6	antibacterial	antibacterial	ADJ
admet-1042	203	7	effect	effect	NOUN
admet-1042	203	8	.	.	PUNCT
admet-1042	204	1	can	can	AUX
admet-1042	204	2	.	.	PUNCT
admet-1042	205	1	j.	j.	PROPN
admet-1042	205	2	anaesth	anaesth	PROPN
admet-1042	205	3	.	.	PROPN
admet-1042	206	1	44	44	NUM
admet-1042	206	2	(	(	PUNCT
admet-1042	206	3	1997	1997	NUM
admet-1042	206	4	)	)	PUNCT
admet-1042	206	5	679	679	NUM
admet-1042	206	6	-	-	SYM
admet-1042	206	7	680	680	NUM
admet-1042	206	8	.	.	PUNCT
admet-1042	207	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	207	2	10.1007	10.1007	NUM
admet-1042	207	3	/	/	SYM
admet-1042	207	4	bf03015460	bf03015460	NOUN
admet-1042	207	5	.	.	PUNCT
admet-1042	208	1	[	[	X
admet-1042	208	2	14	14	NUM
admet-1042	208	3	]	]	X
admet-1042	208	4	s.	s.	PROPN
admet-1042	208	5	graystone	graystone	PROPN
admet-1042	208	6	,	,	PUNCT
admet-1042	208	7	m.f	m.f	PROPN
admet-1042	208	8	.	.	PUNCT
admet-1042	208	9	wells	wells	PROPN
admet-1042	208	10	,	,	PUNCT
admet-1042	208	11	d.j	d.j	PROPN
admet-1042	208	12	.	.	PROPN
admet-1042	208	13	farrell	farrell	PROPN
admet-1042	208	14	.	.	PUNCT
admet-1042	209	1	do	do	AUX
admet-1042	209	2	intensive	intensive	ADJ
admet-1042	209	3	care	care	NOUN
admet-1042	209	4	drug	drug	NOUN
admet-1042	209	5	infusions	infusion	NOUN
admet-1042	209	6	support	support	VERB
admet-1042	209	7	microbial	microbial	ADJ
admet-1042	209	8	growth	growth	NOUN
admet-1042	209	9	.	.	PUNCT
admet-1042	210	1	anaesth	anaesth	PROPN
admet-1042	210	2	.	.	PUNCT
admet-1042	211	1	intensive	intensive	ADJ
admet-1042	211	2	care	care	NOUN
admet-1042	211	3	25	25	NUM
admet-1042	211	4	(	(	PUNCT
admet-1042	211	5	1997	1997	NUM
admet-1042	211	6	)	)	PUNCT
admet-1042	211	7	640	640	NUM
admet-1042	211	8	-	-	SYM
admet-1042	211	9	642	642	NUM
admet-1042	211	10	.	.	PUNCT
admet-1042	212	1	https://dx.doi.org/	https://dx.doi.org/	PROPN
admet-1042	212	2	10.1177/0310057x9702500608	10.1177/0310057x9702500608	PROPN
admet-1042	212	3	.	.	PUNCT
admet-1042	213	1	[	[	X
admet-1042	213	2	15	15	NUM
admet-1042	213	3	]	]	X
admet-1042	213	4	s.	s.	PROPN
admet-1042	213	5	segal	segal	PROPN
admet-1042	213	6	,	,	PUNCT
admet-1042	213	7	a.	a.	PROPN
admet-1042	213	8	gunawan	gunawan	PROPN
admet-1042	213	9	,	,	PUNCT
admet-1042	213	10	d.h	d.h	PROPN
admet-1042	213	11	.	.	PROPN
admet-1042	213	12	mclaughlin	mclaughlin	PROPN
admet-1042	213	13	,	,	PUNCT
admet-1042	213	14	e.	e.	PROPN
admet-1042	213	15	palavecino	palavecino	PROPN
admet-1042	213	16	.	.	PUNCT
admet-1042	214	1	microbial	microbial	ADJ
admet-1042	214	2	stability	stability	NOUN
admet-1042	214	3	of	of	ADP
admet-1042	214	4	syringes	syrinx	NOUN
admet-1042	214	5	of	of	ADP
admet-1042	214	6	anesthetic	anesthetic	ADJ
admet-1042	214	7	drugs	drug	NOUN
admet-1042	214	8	prepared	prepare	VERB
admet-1042	214	9	in	in	ADP
admet-1042	214	10	the	the	DET
admet-1042	214	11	operating	operating	NOUN
admet-1042	214	12	room	room	NOUN
admet-1042	214	13	.	.	PUNCT
admet-1042	215	1	j.	j.	PROPN
admet-1042	215	2	clin	clin	PROPN
admet-1042	215	3	.	.	PUNCT
admet-1042	216	1	anesth	anesth	PROPN
admet-1042	216	2	.	.	PUNCT
admet-1042	217	1	55	55	NUM
admet-1042	217	2	(	(	PUNCT
admet-1042	217	3	2019	2019	NUM
admet-1042	217	4	)	)	PUNCT
admet-1042	217	5	20	20	NUM
admet-1042	217	6	-	-	SYM
admet-1042	217	7	23	23	NUM
admet-1042	217	8	.	.	PUNCT
admet-1042	218	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	218	2	10.1016	10.1016	NUM
admet-1042	218	3	/	/	SYM
admet-1042	218	4	j.jclinane.2018.12.029	j.jclinane.2018.12.029	PROPN
admet-1042	218	5	.	.	PUNCT
admet-1042	219	1	[	[	X
admet-1042	219	2	16	16	NUM
admet-1042	219	3	]	]	X
admet-1042	219	4	g.m	g.m	PROPN
admet-1042	219	5	.	.	PROPN
admet-1042	219	6	peterson	peterson	PROPN
admet-1042	219	7	,	,	PUNCT
admet-1042	219	8	k.a	k.a	PROPN
admet-1042	219	9	.	.	PROPN
admet-1042	219	10	miller	miller	PROPN
admet-1042	219	11	,	,	PUNCT
admet-1042	219	12	j.g	j.g	PROPN
admet-1042	219	13	.	.	PROPN
admet-1042	219	14	galloway	galloway	PROPN
admet-1042	219	15	,	,	PUNCT
admet-1042	219	16	p.f	p.f	PROPN
admet-1042	219	17	.	.	PROPN
admet-1042	219	18	dunne	dunne	PROPN
admet-1042	219	19	.	.	PUNCT
admet-1042	219	20	compatibility	compatibility	NOUN
admet-1042	219	21	and	and	CCONJ
admet-1042	219	22	stability	stability	NOUN
admet-1042	219	23	of	of	ADP
admet-1042	219	24	fentanyl	fentanyl	ADJ
admet-1042	219	25	admixtures	admixture	NOUN
admet-1042	219	26	in	in	ADP
admet-1042	219	27	polypropylene	polypropylene	NOUN
admet-1042	219	28	syringes	syrinx	NOUN
admet-1042	219	29	.	.	PUNCT
admet-1042	220	1	j.	j.	PROPN
admet-1042	220	2	clin	clin	PROPN
admet-1042	220	3	.	.	PUNCT
admet-1042	221	1	pharm	pharm	PROPN
admet-1042	221	2	.	.	PUNCT
admet-1042	222	1	ther	ther	INTJ
admet-1042	222	2	.	.	PUNCT
admet-1042	223	1	23	23	NUM
admet-1042	223	2	(	(	PUNCT
admet-1042	223	3	1998	1998	NUM
admet-1042	223	4	)	)	PUNCT
admet-1042	223	5	67	67	NUM
admet-1042	223	6	-	-	SYM
admet-1042	223	7	72	72	NUM
admet-1042	223	8	.	.	PUNCT
admet-1042	224	1	https://dx.doi.org/	https://dx.doi.org/	X
admet-1042	224	2	10.1046	10.1046	NUM
admet-1042	224	3	/	/	SYM
admet-1042	224	4	j.1365	j.1365	NOUN
admet-1042	224	5	-	-	PUNCT
admet-1042	224	6	2710.1998.00141.x	2710.1998.00141.x	NUM
admet-1042	224	7	.	.	PUNCT
admet-1042	225	1	[	[	X
admet-1042	225	2	17	17	NUM
admet-1042	225	3	]	]	X
admet-1042	225	4	t.z	t.z	PROPN
admet-1042	225	5	.	.	PROPN
admet-1042	225	6	apan	apan	PROPN
admet-1042	225	7	,	,	PUNCT
admet-1042	225	8	a.	a.	PROPN
admet-1042	225	9	apan	apan	PROPN
admet-1042	225	10	,	,	PUNCT
admet-1042	225	11	s.	s.	PROPN
admet-1042	225	12	sahin	sahin	PROPN
admet-1042	225	13	,	,	PUNCT
admet-1042	225	14	m.	m.	NOUN
admet-1042	225	15	cakirca	cakirca	PROPN
admet-1042	225	16	.	.	PUNCT
admet-1042	226	1	antibacterial	antibacterial	ADJ
admet-1042	226	2	activity	activity	NOUN
admet-1042	226	3	of	of	ADP
admet-1042	226	4	remifentanil	remifentanil	NOUN
admet-1042	226	5	and	and	CCONJ
admet-1042	226	6	mixtures	mixture	NOUN
admet-1042	226	7	of	of	ADP
admet-1042	226	8	remifentanil	remifentanil	NOUN
admet-1042	226	9	and	and	CCONJ
admet-1042	226	10	propofol	propofol	NOUN
admet-1042	226	11	.	.	PUNCT
admet-1042	227	1	j.	j.	PROPN
admet-1042	227	2	clin	clin	PROPN
admet-1042	227	3	.	.	PUNCT
admet-1042	228	1	anesth	anesth	PROPN
admet-1042	228	2	.	.	PROPN
admet-1042	229	1	19	19	NUM
admet-1042	229	2	(	(	PUNCT
admet-1042	229	3	2007	2007	NUM
admet-1042	229	4	)	)	PUNCT
admet-1042	229	5	346	346	NUM
admet-1042	229	6	-	-	SYM
admet-1042	229	7	350	350	NUM
admet-1042	229	8	.	.	PUNCT
admet-1042	230	1	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	PROPN
admet-1042	230	2	.	.	PUNCT
admet-1042	231	1	[	[	X
admet-1042	231	2	18	18	NUM
admet-1042	231	3	]	]	PUNCT
admet-1042	231	4	a.	a.	NOUN
admet-1042	231	5	obayashi	obayashi	PROPN
admet-1042	231	6	,	,	PUNCT
admet-1042	231	7	s.	s.	PROPN
admet-1042	231	8	oie	oie	PROPN
admet-1042	231	9	,	,	PUNCT
admet-1042	231	10	a.	a.	PROPN
admet-1042	231	11	kamiya	kamiya	PROPN
admet-1042	231	12	.	.	PUNCT
admet-1042	232	1	microbial	microbial	ADJ
admet-1042	232	2	viability	viability	NOUN
admet-1042	232	3	in	in	ADP
admet-1042	232	4	preparations	preparation	NOUN
admet-1042	232	5	packaged	package	VERB
admet-1042	232	6	for	for	ADP
admet-1042	232	7	single	single	ADJ
admet-1042	232	8	use	use	NOUN
admet-1042	232	9	.	.	PUNCT
admet-1042	233	1	biol	biol	PROPN
admet-1042	233	2	.	.	PUNCT
admet-1042	234	1	pharm	pharm	PROPN
admet-1042	234	2	.	.	PUNCT
admet-1042	235	1	bull	bull	NOUN
admet-1042	235	2	.	.	PUNCT
admet-1042	236	1	26	26	NUM
admet-1042	236	2	(	(	PUNCT
admet-1042	236	3	2003	2003	NUM
admet-1042	236	4	)	)	PUNCT
admet-1042	236	5	667	667	NUM
admet-1042	236	6	-	-	SYM
admet-1042	236	7	670	670	NUM
admet-1042	236	8	.	.	PUNCT
admet-1042	237	1	https://dx.doi.org/10.1248/bpb.26.667	https://dx.doi.org/10.1248/bpb.26.667	ADV
admet-1042	237	2	.	.	PUNCT
admet-1042	238	1	[	[	X
admet-1042	238	2	19	19	NUM
admet-1042	238	3	]	]	X
admet-1042	238	4	r.s	r.s	PROPN
admet-1042	238	5	.	.	PROPN
admet-1042	238	6	vardanyan	vardanyan	PROPN
admet-1042	238	7	,	,	PUNCT
admet-1042	238	8	v.j	v.j	PROPN
admet-1042	238	9	.	.	PROPN
admet-1042	238	10	hruby	hruby	PROPN
admet-1042	238	11	.	.	PUNCT
admet-1042	239	1	fentanyl	fentanyl	NOUN
admet-1042	239	2	-	-	PUNCT
admet-1042	239	3	related	relate	VERB
admet-1042	239	4	compounds	compound	NOUN
admet-1042	239	5	and	and	CCONJ
admet-1042	239	6	derivatives	derivative	NOUN
admet-1042	239	7	:	:	PUNCT
admet-1042	239	8	current	current	ADJ
admet-1042	239	9	status	status	NOUN
admet-1042	239	10	and	and	CCONJ
admet-1042	239	11	future	future	ADJ
admet-1042	239	12	prospects	prospect	NOUN
admet-1042	239	13	for	for	ADP
admet-1042	239	14	pharmaceutical	pharmaceutical	ADJ
admet-1042	239	15	applications	application	NOUN
admet-1042	239	16	.	.	PUNCT
admet-1042	240	1	future	future	ADJ
admet-1042	240	2	med	med	PROPN
admet-1042	240	3	.	.	PROPN
admet-1042	240	4	chem	chem	PROPN
admet-1042	240	5	.	.	PUNCT
admet-1042	241	1	6	6	NUM
admet-1042	241	2	(	(	PUNCT
admet-1042	241	3	2014	2014	NUM
admet-1042	241	4	)	)	PUNCT
admet-1042	241	5	385	385	NUM
admet-1042	241	6	-	-	SYM
admet-1042	241	7	412	412	NUM
admet-1042	241	8	.	.	PUNCT
admet-1042	242	1	https://dx.doi.org/10.4155/fmc.13.215	https://dx.doi.org/10.4155/fmc.13.215	VERB
admet-1042	242	2	.	.	PUNCT
admet-1042	243	1	[	[	X
admet-1042	243	2	20	20	NUM
admet-1042	243	3	]	]	X
admet-1042	243	4	c.r	c.r	PROPN
admet-1042	243	5	.	.	PROPN
admet-1042	243	6	lee	lee	PROPN
admet-1042	243	7	,	,	PUNCT
admet-1042	243	8	d.	d.	PROPN
admet-1042	243	9	mctavish	mctavish	PROPN
admet-1042	243	10	,	,	PUNCT
admet-1042	243	11	e.m	e.m	PROPN
admet-1042	243	12	.	.	PROPN
admet-1042	243	13	sorkin	sorkin	PROPN
admet-1042	243	14	.	.	PUNCT
admet-1042	244	1	tramadol	tramadol	NOUN
admet-1042	244	2	.	.	PUNCT
admet-1042	245	1	a	a	DET
admet-1042	245	2	preliminary	preliminary	ADJ
admet-1042	245	3	review	review	NOUN
admet-1042	245	4	of	of	ADP
admet-1042	245	5	its	its	PRON
admet-1042	245	6	pharmacodynamic	pharmacodynamic	ADJ
admet-1042	245	7	and	and	CCONJ
admet-1042	245	8	pharmacokinetic	pharmacokinetic	ADJ
admet-1042	245	9	properties	property	NOUN
admet-1042	245	10	,	,	PUNCT
admet-1042	245	11	and	and	CCONJ
admet-1042	245	12	therapeutic	therapeutic	ADJ
admet-1042	245	13	potential	potential	NOUN
admet-1042	245	14	in	in	ADP
admet-1042	245	15	acute	acute	ADJ
admet-1042	245	16	and	and	CCONJ
admet-1042	245	17	chronic	chronic	ADJ
admet-1042	245	18	pain	pain	NOUN
admet-1042	245	19	states	state	NOUN
admet-1042	245	20	.	.	PUNCT
admet-1042	246	1	drugs	drug	NOUN
admet-1042	246	2	46	46	NUM
admet-1042	246	3	(	(	PUNCT
admet-1042	246	4	1993	1993	NUM
admet-1042	246	5	)	)	PUNCT
admet-1042	246	6	313	313	NUM
admet-1042	246	7	-	-	SYM
admet-1042	246	8	340	340	NUM
admet-1042	246	9	.	.	PUNCT
admet-1042	247	1	https://dx.doi.org/10.2165/00003495-199346020-00008	https://dx.doi.org/10.2165/00003495-199346020-00008	PROPN
admet-1042	247	2	.	.	PUNCT
admet-1042	248	1	[	[	X
admet-1042	248	2	21	21	NUM
admet-1042	248	3	]	]	X
admet-1042	248	4	e.	e.	PROPN
admet-1042	248	5	freye	freye	PROPN
admet-1042	248	6	,	,	PUNCT
admet-1042	248	7	j.v	j.v	PROPN
admet-1042	248	8	.	.	PROPN
admet-1042	248	9	levy	levy	NOUN
admet-1042	248	10	.	.	PUNCT
admet-1042	249	1	the	the	DET
admet-1042	249	2	effects	effect	NOUN
admet-1042	249	3	of	of	ADP
admet-1042	249	4	tramadol	tramadol	NOUN
admet-1042	249	5	on	on	ADP
admet-1042	249	6	pain	pain	NOUN
admet-1042	249	7	relief	relief	NOUN
admet-1042	249	8	,	,	PUNCT
admet-1042	249	9	fast	fast	ADJ
admet-1042	249	10	eeg	eeg	NOUN
admet-1042	249	11	-	-	PUNCT
admet-1042	249	12	power	power	NOUN
admet-1042	249	13	spectrum	spectrum	NOUN
admet-1042	249	14	and	and	CCONJ
admet-1042	249	15	cognitive	cognitive	ADJ
admet-1042	249	16	function	function	NOUN
admet-1042	249	17	in	in	ADP
admet-1042	249	18	elderly	elderly	ADJ
admet-1042	249	19	patients	patient	NOUN
admet-1042	249	20	with	with	ADP
admet-1042	249	21	chronic	chronic	ADJ
admet-1042	249	22	osteoarthritis	osteoarthritis	NOUN
admet-1042	249	23	(	(	PUNCT
admet-1042	249	24	oa	oa	PROPN
admet-1042	249	25	)	)	PUNCT
admet-1042	249	26	.	.	PUNCT
admet-1042	250	1	acute	acute	ADJ
admet-1042	250	2	pain	pain	NOUN
admet-1042	250	3	8	8	NUM
admet-1042	250	4	(	(	PUNCT
admet-1042	250	5	2006	2006	NUM
admet-1042	250	6	)	)	PUNCT
admet-1042	250	7	55–61	55–61	NUM
admet-1042	250	8	.	.	PUNCT
admet-1042	251	1	https://doi.org/10.1016/j.acpain.2006.03.001	https://doi.org/10.1016/j.acpain.2006.03.001	VERB
admet-1042	251	2	.	.	PUNCT
admet-1042	252	1	http://dx.doi.org/10.5599/admet.1042	http://dx.doi.org/10.5599/admet.1042	X
admet-1042	252	2	https://dx.doi.org/%2010.1093/bja/66.2.274-a	https://dx.doi.org/%2010.1093/bja/66.2.274-a	PROPN
admet-1042	252	3	https://dx.doi.org/%2010.1093/bja/66.2.274-a	https://dx.doi.org/%2010.1093/bja/66.2.274-a	PROPN
admet-1042	252	4	http://link.springer.com/10.1007/978-3-319-99124-5_238	http://link.springer.com/10.1007/978-3-319-99124-5_238	ADJ
admet-1042	252	5	http://link.springer.com/10.1007/978-3-319-99124-5_238	http://link.springer.com/10.1007/978-3-319-99124-5_238	PROPN
admet-1042	252	6	https://dx.doi.org/%2010.1159/000087311	https://dx.doi.org/%2010.1159/000087311	NOUN
admet-1042	252	7	https://dx.doi.org/%2010.2165/00003495-200059020-00012	https://dx.doi.org/%2010.2165/00003495-200059020-00012	PROPN
admet-1042	252	8	https://dx.doi.org/%2010.1177/0310057x0803600508	https://dx.doi.org/%2010.1177/0310057x0803600508	PROPN
admet-1042	252	9	https://dx.doi.org/%2010.1177/0310057x0803600508	https://dx.doi.org/%2010.1177/0310057x0803600508	PROPN
admet-1042	252	10	https://dx.doi.org/10.1017/s0265021506000949	https://dx.doi.org/10.1017/s0265021506000949	PROPN
admet-1042	252	11	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	PROPN
admet-1042	252	12	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	https://dx.doi.org/10.1016/s0300-5712(00)00039-7	PROPN
admet-1042	252	13	https://doi.org/10.1097/01.ccm.0000128579.84228.2a	https://doi.org/10.1097/01.ccm.0000128579.84228.2a	PROPN
admet-1042	252	14	https://doi.org/10.1080/22201173.2010.10872661	https://doi.org/10.1080/22201173.2010.10872661	ADV
admet-1042	252	15	https://dx.doi.org/%2010.1007/bf03015460	https://dx.doi.org/%2010.1007/bf03015460	PUNCT
admet-1042	252	16	https://dx.doi.org/%2010.1177/0310057x9702500608	https://dx.doi.org/%2010.1177/0310057x9702500608	VERB
admet-1042	252	17	https://dx.doi.org/%2010.1016/j.jclinane.2018.12.029	https://dx.doi.org/%2010.1016/j.jclinane.2018.12.029	NOUN
admet-1042	252	18	https://dx.doi.org/%2010.1016/j.jclinane.2018.12.029	https://dx.doi.org/%2010.1016/j.jclinane.2018.12.029	NOUN
admet-1042	252	19	https://dx.doi.org/10.1046/j.1365-2710.1998.00141.x	https://dx.doi.org/10.1046/j.1365-2710.1998.00141.x	NOUN
admet-1042	252	20	https://dx.doi.org/10.1046/j.1365-2710.1998.00141.x	https://dx.doi.org/10.1046/j.1365-2710.1998.00141.x	NOUN
admet-1042	252	21	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	PROPN
admet-1042	252	22	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	https://dx.doi.org/10.1016/j.jclinane.2007.02.005	PROPN
admet-1042	252	23	https://dx.doi.org/10.1248/bpb.26.667	https://dx.doi.org/10.1248/bpb.26.667	ADV
admet-1042	253	1	https://dx.doi.org/10.4155/fmc.13.215	https://dx.doi.org/10.4155/fmc.13.215	VERB
admet-1042	253	2	https://dx.doi.org/10.4155/fmc.13.215	https://dx.doi.org/10.4155/fmc.13.215	PROPN
admet-1042	253	3	https://dx.doi.org/10.2165/00003495-199346020-00008	https://dx.doi.org/10.2165/00003495-199346020-00008	PRON
admet-1042	253	4	https://doi.org/10.1016/j.acpain.2006.03.001	https://doi.org/10.1016/j.acpain.2006.03.001	VERB
admet-1042	254	1	https://doi.org/10.1016/j.acpain.2006.03.001	https://doi.org/10.1016/j.acpain.2006.03.001	NUM
admet-1042	254	2	sevgi	sevgi	NOUN
admet-1042	254	3	kesici	kesici	PROPN
admet-1042	254	4	et	et	PROPN
admet-1042	254	5	al	al	PROPN
admet-1042	254	6	.	.	PROPN
admet-1042	254	7	admet	admet	PROPN
admet-1042	254	8	&	&	CCONJ
admet-1042	254	9	dmpk	dmpk	PROPN
admet-1042	254	10	9(3	9(3	NUM
admet-1042	254	11	)	)	PUNCT
admet-1042	254	12	(	(	PUNCT
admet-1042	254	13	2021	2021	NUM
admet-1042	254	14	)	)	PUNCT
admet-1042	254	15	219	219	NUM
admet-1042	254	16	-	-	SYM
admet-1042	254	17	226	226	NUM
admet-1042	254	18	226	226	NUM
admet-1042	254	19	[	[	X
admet-1042	254	20	22	22	NUM
admet-1042	254	21	]	]	X
admet-1042	254	22	s.n	s.n	PROPN
admet-1042	254	23	.	.	PROPN
admet-1042	254	24	bennett	bennett	PROPN
admet-1042	254	25	,	,	PUNCT
admet-1042	254	26	m.m	m.m	PROPN
admet-1042	254	27	.	.	PROPN
admet-1042	254	28	mcneil	mcneil	PROPN
admet-1042	254	29	,	,	PUNCT
admet-1042	254	30	l.a	l.a	PROPN
admet-1042	254	31	.	.	PROPN
admet-1042	254	32	bland	bland	PROPN
admet-1042	254	33	,	,	PUNCT
admet-1042	254	34	m.j	m.j	PROPN
admet-1042	254	35	.	.	PROPN
admet-1042	254	36	arduino	arduino	PROPN
admet-1042	254	37	,	,	PUNCT
admet-1042	254	38	m.e	m.e	PROPN
admet-1042	254	39	.	.	PROPN
admet-1042	254	40	villarino	villarino	PROPN
admet-1042	254	41	,	,	PUNCT
admet-1042	254	42	d.m	d.m	PROPN
admet-1042	254	43	.	.	PROPN
admet-1042	255	1	perrotta	perrotta	PROPN
admet-1042	255	2	,	,	PUNCT
admet-1042	255	3	d.r	d.r	PROPN
admet-1042	255	4	.	.	PROPN
admet-1042	255	5	burwen	burwen	PROPN
admet-1042	255	6	,	,	PUNCT
admet-1042	255	7	s.f	s.f	PROPN
admet-1042	255	8	.	.	PROPN
admet-1042	255	9	welbel	welbel	PROPN
admet-1042	255	10	,	,	PUNCT
admet-1042	255	11	d.a	d.a	PROPN
admet-1042	255	12	.	.	PROPN
admet-1042	255	13	pegues	pegue	NOUN
admet-1042	255	14	,	,	PUNCT
admet-1042	255	15	l.	l.	PROPN
admet-1042	255	16	stroud	stroud	PROPN
admet-1042	255	17	.	.	PUNCT
admet-1042	256	1	postoperative	postoperative	ADJ
admet-1042	256	2	infections	infection	NOUN
admet-1042	256	3	traced	trace	VERB
admet-1042	256	4	to	to	ADP
admet-1042	256	5	contamination	contamination	NOUN
admet-1042	256	6	of	of	ADP
admet-1042	256	7	an	an	DET
admet-1042	256	8	intravenous	intravenous	ADJ
admet-1042	256	9	anesthetic	anesthetic	NOUN
admet-1042	256	10	,	,	PUNCT
admet-1042	256	11	propofol	propofol	NOUN
admet-1042	256	12	.	.	PUNCT
admet-1042	257	1	n.	n.	PROPN
admet-1042	257	2	engl	engl	PROPN
admet-1042	257	3	.	.	PUNCT
admet-1042	258	1	j.	j.	PROPN
admet-1042	258	2	med	med	PROPN
admet-1042	258	3	.	.	PROPN
admet-1042	259	1	333	333	NUM
admet-1042	259	2	(	(	PUNCT
admet-1042	259	3	1995	1995	NUM
admet-1042	259	4	)	)	PUNCT
admet-1042	259	5	147	147	NUM
admet-1042	259	6	-	-	SYM
admet-1042	259	7	154	154	NUM
admet-1042	259	8	.	.	PUNCT
admet-1042	260	1	https://dx.doi.org/10.1056/nejm199507203330303	https://dx.doi.org/10.1056/nejm199507203330303	PROPN
admet-1042	260	2	.	.	PUNCT
admet-1042	261	1	©	©	NOUN
admet-1042	261	2	2021	2021	NUM
admet-1042	261	3	by	by	ADP
admet-1042	261	4	the	the	DET
admet-1042	261	5	authors	author	NOUN
admet-1042	261	6	;	;	PUNCT
admet-1042	261	7	licensee	licensee	PROPN
admet-1042	261	8	iapc	iapc	PROPN
admet-1042	261	9	,	,	PUNCT
admet-1042	261	10	zagreb	zagreb	PROPN
admet-1042	261	11	,	,	PUNCT
admet-1042	261	12	croatia	croatia	PROPN
admet-1042	261	13	.	.	PUNCT
admet-1042	262	1	this	this	DET
admet-1042	262	2	article	article	NOUN
admet-1042	262	3	is	be	AUX
admet-1042	262	4	an	an	DET
admet-1042	262	5	open	open	ADJ
admet-1042	262	6	-	-	PUNCT
admet-1042	262	7	access	access	NOUN
admet-1042	262	8	article	article	NOUN
admet-1042	262	9	distributed	distribute	VERB
admet-1042	262	10	under	under	ADP
admet-1042	262	11	the	the	DET
admet-1042	262	12	terms	term	NOUN
admet-1042	262	13	and	and	CCONJ
admet-1042	262	14	conditions	condition	NOUN
admet-1042	262	15	of	of	ADP
admet-1042	262	16	the	the	DET
admet-1042	262	17	creative	creative	ADJ
admet-1042	262	18	commons	common	NOUN
admet-1042	262	19	attribution	attribution	NOUN
admet-1042	262	20	license	license	NOUN
admet-1042	262	21	(	(	PUNCT
admet-1042	262	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	NOUN
admet-1042	262	23	)	)	PUNCT
admet-1042	262	24	https://dx.doi.org/10.1056/nejm199507203330303	https://dx.doi.org/10.1056/nejm199507203330303	AUX
admet-1042	262	25	https://dx.doi.org/10.1056/nejm199507203330303	https://dx.doi.org/10.1056/nejm199507203330303	VERB
admet-1042	262	26	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN